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ABSTRACT 
 
Extracellular matrix (ECM) nanofibers such as collagen and elastin make up an important 
component of natural tissues. These structural components serve to impart mechanical 
strength and provide locations for cell attachment and biomolecule storage. Cells respond to 
their structural environment in a wide variety of ways beyond physical support, and it has 
been demonstrated that this environment directly modulates cell behaviors such as, 
morphology, differentiation, ECM production, attachment, and migration. ECM nanofibers 
also play an important role as a template for tissue formation during development, 
remodeling, and regeneration. Nanofiber based tissue engineering strategies aim to mimic the 
geometry of the natural fibrous component of the ECM to promote tissue regeneration. 
Nanofiber based approaches are of special interest in regeneration of aligned tissues such as, 
nerve, blood vessel, muscle, and connective tissue because they are able to promote aligned 
morphologies in resident cells.   
 While there are many different nanofiber fabrication methods available, the 
electrospinning method may be the most promising due its simplicity, versatility and 
scalability. Many different types of materials can be easily electrospun into nanofibers with a 
wide variety of morphologies, sizes, and structural arrangements. However, the potential of 
the electrospinning method in tissue engineering applications is limited by the available 
assembly techniques. It was our goal to investigate new technologies that allow more precise 
assembly of electrospun nanofibers into useful complex structures. 
 First, the parallel plate technique for collecting aligned nanofiber arrays was 
investigated systematically. Results of this study provided valuable insights into the 
relationships of fiber length to collection rate and collecting plate size, which were used in 
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designing novel loose fiber collection technologies. One of our technologies utilizes parallel 
mobile tracks to collect and distribute aligned electrospun nanofibers into loose 3D arrays. 
Advantages of this technology include indefinitely continuous steady state nanofiber 
collection, and the capability to simultaneously collect nanofibers from an electrospinning jet 
in one location and assemble them into complex structures at another. In addition, nanofibers 
are allowed an indefinite amount of time to dry between collection and assembly, thus 
eliminating complications related to fiber-to-fiber adhesions. This technology demonstrates 
potential in complex nanofiber structure assembly, and in industrial scale up.  
Precision assembly, facilitated by the mobile track technology, led to the 
development of technologies to fabricate composite nanofiber/protein matrix thin films. 
These composites combined the strengths of each component as a scaffold for regenerating 
different types of tissues. Precision assembly technologies also facilitated the development of 
hybrid two components fibrous structures with finely tuned biomimetic microstructures. The 
mechanical properties of these structures were similar to those of natural tissues. It was 
demonstrated that the biomimetic mechanical properties of the hybrid materials were derived 
from precise nanofiber arrangement at the mechanical properties were highly responsive to 
subtle changes nanofiber arrangement. 
Nanofibrous structures were evaluated as tissue engineering scaffolds in vitro and in 
vitro. C2C12 myoblasts seeded on aligned nanofibers scaffolds attached, aligned, and grew to 
confluence to form thin cell/nanofiber sheets and cell/nanofiber/protein matrix films. Three 
dimensional skeletal muscle scaffolds were further assembled by stacking these constructs 
layer-by-layer or by assembling them into 3D bundled structures. Integration of multilayered 
grafts with natural muscle was evaluated in vivo. Tubular vascular grafts were also fabricated 
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with biomimetic wavy stiff nanofibers and straight elastic fibers. These grafts demonstrated a 
remarkably similar mechanical profile to natural blood vessels when the microstructure was 
optimized. In vivo evaluation of vascular grafts was conducted in a rabbit carotid artery 
replacement model.  
Our studies indicate that advances in nanofiber assembly allow for the design of 
tissue engineering scaffolds with improved control over fiber density, placement, and 
microstructure. These advances offer the potential for the design of better tissue engineering 
scaffolds for regeneration of many tissues such as skeletal muscle, blood vessels, nerve, 
tendon, skin, and so on.  
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CHAPTER 1 
1.   INTRODUCTION 
1.1 Role of the fibrous component in regenerating aligned tissues  
Natural tissues have a fibrous extracellular matrix (ECM) component made up of collagen, 
elastin, keratin, or other similar types or natural nanofibers. This nanofibrous ECM provides 
mechanical strength, storage locations for biomolecules, and structural support for cell 
attachment, and organization. It also serves as a template for tissue formation in 
development, regeneration, and remodeling. For example, ECM deposition precedes cell 
migration in embryonic branching morphogenesis, nerve cells grow along aligned ECM tubes 
in peripheral nerve regeneration, and hydroxyapatite calcifies on collagen nanofibers to form 
bone during remodeling.  Polymeric nanofibers have received a great amount of attention in 
recent years due to their potential to fill some of the roles of ECM nanofibers in tissue 
engineering. Polymeric nanofibers have proven to be excellent substrates for cell attachment 
and growth, and the microstructure of polymeric nanofiber grafts can predictably modulate 
cell behaviors such as morphology, differentiation, ECM deposition, and migration. In 
addition, the bioactivity of polymer nanofibers can be easily optimized due to a wide variety 
of available molecular compositions, methods of biomolecule incorporation, and surface 
modification techniques.   
 Many types of tissues such as muscle, nerve, and connective tissue, require a well 
aligned cellular and ECM organization for proper tissue function. Nerves are able to transmit 
signals throughout the body quickly through long well aligned axons, and muscles, blood 
vessels, and tendons are able to apply and resist loads efficiently due to the aligned 
organization of cells and ECM fibers. Cells that are cultured in vitro on aligned nanofibrous 
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scaffolds adopt an aligned elongated morphology that mimics the natural morphology of cells 
in aligned tissues in vivo. In addition to cell shape and organization, aligned nanofiber 
substrates have shown the ability to modulate cell behaviors such as differentiation, 
migration, and ECM assembly. It is of the highest importance that a tissue engineering 
scaffold used to mimic aligned tissues is able to impart uniaxial alignment in its resident cells 
to induce biomimetic organization and desired cellular responses. Challenges in tissue 
engineering applications of aligned nanofiber scaffolds include optimizing substrate 
topographical cues to promote desired cell responses and designing scaffolds with 
architecture conductive to the formation of tissue-like structures in vitro and in vivo.  
1.2 Nanofiber scaffold fabrication with Electrospinning 
Methods associated with many different fiber fabrication techniques are available for 
production of aligned nanofibers. However, the vast majority of research in this field is 
focused of aligned nanofiber fabrication using electrospinning. Electrospinning is an 
electrostatic method of fabricating polymer nanofibers that has generated widespread interest 
in the tissue engineering field due to its simplicity and immense versatility. Electrospinning 
utilizes an electric field to eject a polymer solution or melt from a needle or small orifice as a 
thin liquid jet. The electric field generates forces on the polymer solution that overcome 
surface tension forces in the needle resulting in the ejection of a jet that is accelerated toward 
a grounded target. Violent whipping motions thin the jet as it travels toward the target and 
thus increasing its surface area. A very high surface area to volume ratio promotes 
evaporation of the solvent, or cooling of a melt, resulting in the formation of solid polymer 
fibers at the target. When a flat target is used as the collecting area, a random fibrous mesh is 
formed, but many different variations of the electrospinning setup have been employed to 
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allow fabrication of nanofibers with uniaxial alignment. There are two basic methods that are 
most commonly used to fabricate aligned nanofiber structures: (1) Mechanical alignment 
using a high speed target, and (2) electrostatic alignment by a manipulated electric field. The 
preferred method of high speed target collection is the rotating mandrel technique and the 
preferred method of electric field manipulation is the parallel plate technique.  
1.3 Limitations and approaches 
Electrospun polymer nanofibers have demonstrated a great amount of promise in a variety of 
disciplines, but their application to actual products has been severely limited due to 
limitations in structural assembly techniques. The electrospinning jet is highly charged and 
subject to violent whipping instabilities that make it very difficult to assemble complex 
structures directly from the jet. Nanofiber structures fabricated from an electrospinning jet 
are most commonly randomly aligned non-woven meshes, aligned fiber meshes with very 
high fiber packing densities, or aligned fiber meshes with very low fiber packing densities.  
Our goal was to develop new technologies that will allow greater control over fiber 
assembly and thus greater versatility in structure fabrication. We hypothesized that better 
tissue engineering scaffolds could be designed if a more suitable system of electrospun 
nanofiber collection were available. This work presents a way to continuously collect and 
deliver stable arrays of loose aligned individual nanofibers. The described technology allows 
for precise control of parameters such as drying time, charge dissipation and fiber placement 
that cannot be attained by any other electrospinning method. Two additional technologies 
were developed that extended the capabilities of our first technology to make composite and 
hybrid nanofiber scaffolds with architectures and mechanical properties that are well suited 
for tissue engineering applications. Several specific tissue engineering scaffolds were 
 4 
 
fabricated and evaluated. 
1.3 Specific Aims 
Aim 1: To develop a novel technology for fabricating electrospun nanofibers that allows 
more precise control over structural assembly. 
Rationale: The major factors which make it difficult to fabricate complex structures from an 
electrospinning jet are the high charge, high velocity, and random whipping instabilities 
associated with it. Current approaches to nanofiber scaffold fabrication are limited because 
they are assembled directly from the jet. It is our hypothesis that more precise structures 
could be assembled if an intermediate step is added between fiber collection and structure 
assembly.  
 
Aim 2: To fabricate aligned nanofiber arrays with precise structural arrangements 
Rationale: We hope to use our electrospinning approach to fabricate structures with precise 
nanofiber placement and orientation. It is our hypothesis that our new approach will facilitate 
fabrication of aligned nanofiber arrays with precise fiber densities and geometries and allow 
assembly of complex composite structures.  
 
Aim 3: Assemble nanofiber based structures for aligned tissue regeneration applications 
Rationale: Complex aligned nanofiber structures may be optimized for tissue engineering 
applications. We hypothesis that aligned sheets, cylinders and tubes can be fabricated with 
fiber densities and geometries that optimize structural and mechanical properties useful in 
aligned tissue engineering applications.  
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Aim 4: Evaluate nanofiber based tissue engineering structures 
Rationale: Aligned nanofiber scaffolds will be evaluated in vitro and in vivo to test their 
potential as tissue engineering scaffolds. It is our hypothesis that our new tools can be used to 
design several nanofiber structures that demonstrate potential as functional tissue engineering 
scaffolds.  
1.4 Dissertation arrangement 
The following manuscript is arranged in chapters that highlight individual studies that relate 
to the overall aims of the project. In Chapter 2 we present a detailed literature review of 
nanofiber based tissue engineering. This chapter explores different methods of nanofiber 
fabrication and methods of functionalizing nanofiber for biological applications. Cell 
interactions, organized by specific cell processes that are affected by culture on nanofiber 
substrates, are described in detail. Finally, current strategies to make better tissue engineering 
scaffolds using the electrospinning fabrication method are reviewed. Chapter 3 describes an 
investigation of the parameters and limitations of the parallel plate electrospinning method. 
The results of this experiment were used in designing the novel electrospinning technology 
described in Chapter 4. The new technology utilizes mobile tracks to collect and stabilize 
aligned nanofibers, while simultaneously assembling them into secondary structures. This 
device facilitated fabrication of large area ultra thin aligned nanofiber arrays that could be 
used to make nanofiber/protein matrix composite films as described in Chapter 5. These 
composites effectively combined the strengths of each component as a tissue engineering 
scaffold, while addressing their individual weaknesses. Chapter 6 described a method of 
fabricating hybrid straight-wavy nanofiber scaffolds with precisely arranged microstructure 
that mimics the arrangement of natural fibers in tissue. It was demonstrated that this 
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biomimetic microstructure resulted in mechanical properties that mimicked natural tissues 
such as blood vessels. In Chapter 7 a vascular graft with straight-wavy composite nanofiber 
based microstructure as described in Chapter 6 was tested in a rabbit carotid replacement 
model. Straight-wavy nanofiber based grafts demonstrate mechanical behavior that is 
remarkably similar to that of natural blood vessels before implantation and after retrieval. In 
Chapter 8 skeletal muscle tissue engineering scaffolds were fabricated by seeding C2C12 
myoblast cells on aligned nanofiber scaffolds. C2C12 cells were able to align, grow to 
confluence, and differentiate on free suspended aligned nanofiber/cell sheets and aligned 
nanofiber/cell/fibrin gel films. Three dimensional skeletal muscle tissue engineering 
constructs were fabricated by stacking sheets and films layer-by-layer, and by bundling them. 
Fabricated structures were implanted into the paravertebral muscle of the mouse to evaluate 
their integration with natural muscle. Chapter 9 summarizes overall conclusions drawn from 
the body of work and discusses challenges and future developments related to the presented 
research.  
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CHAPTER 2  
2.  POLYMER NANOFIBROUS STRUCTURES: FABRICATION, 
BIOFUNCTIONALIZATION, AND CELL INTERACTIONS 
2.1 Introduction 
The fibrous component of the extracellular matrix (ECM) in the tissue is made up of protein 
fibers such as collagens, elastin, keratin, laminins, fibronectin and vitronectin. These protein 
fibers provide structural support to tissues and regulate many aspects of cell behavior. The 
building blocks of protein nanofibers are synthesized intracellularly by cells, and then 
secreted into the extracellular space by exocytosis. Soluble precursors are enzymatically 
modified within the ECM for formation into fibers. ECM fibers provide structural support 
and mechanical integrity to tissues as well as locations for cell adhesion and regulation of cell 
functions such as proliferation, shape, migration, and differentiation [1]. Tissues requiring 
high levels of mechanical strength such as tendons, ligaments, and bone, have high levels of 
organized fibers to impart mechanical strength, while some soft tissues have much higher 
levels of unorganized fibers. Composition and arrangement of ECM fibers in a tissue can 
impart fine tuned mechanical properties. For example, arteries exhibit precise mechanical 
behavior characterized by highly elastic behavior at low levels of distension and stiffer 
behaviors at high levels of distention due to a highly organized microstructure of elastin and 
collagen fibers [2]. ECM fibers also offer locations for cell adhesion and can regulate cell 
shape and migration patterns based on composition and arrangement. Structural fibrous 
proteins can also act as storage locations for the release of small bioactive peptides and 
growth factors upon release by proteolytic cleavage. The ECM in natural tissue is constantly 
being remodeled by proteolytic cleavage and cellular reassembly, and accelerated ECM 
remodeling is critical during embryonic development and during tissue regeneration. For 
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example, assembly of a fibrillar matrix from fibronectin is crucial for embryonic  
development and wound healing [3] and multiple ECM fibrous proteins, such as fibronectin 
and laminin are required for the process of branching morphogenesis evident in the 
development of organs such as the kidney, lung, and prostate [4,5]. Remodeling in adult bone 
tissue involves an initial assembly of collagen fibers with entrapped cells, followed by 
calcium salt precipitation on the collagen fibers to form bone. In the peripheral nervous 
system after axonal degeneration following injury, regenerating axons grow back to their 
targets by following the laminin and fibronectin containing basal lamina tube that surrounded 
the original nerve fiber [6]. Tissue engineering strategies utilizing fibrous components 
attempt to fill the role of fibrous components in natural tissue. Fibrous components of tissue 
engineering scaffolds can impart mechanical strength, structure for cell attachment, and act as 
reservoirs for biomolecule delivery in much the same way as the natural fibrous components 
of the ECM. For example, in many bone tissue engineering strategies a fibrous mesh is used 
as a template for subsequent mineralization in a similar way to collagen fibers in natural 
remodeling. The fabricated matrix forms a bonelike structure and provides an attractive 
microenvironment for osteogenic function in resident cells. Blood vessel tissue engineering 
with nanofibrous scaffolds benefits from its properties of high tensile strength, good cell 
attachment properties for endothelium formation, and directional alignment for smooth 
muscle cells in the vessel wall. In vivo, injectable self-assembling nanofibrous networks 
introduced to injury sites have been used to provide a 3-dimensional structural environment 
that has been shown to increase the infiltration and retention of endogenous cells [7,8]. 
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2.2 Methods of polymer nanofiber scaffold fabrication 
Polymer nanofibers have been fabricated using a number of different techniques. The 
methods of nanofiber fabrication are varied and utilize physical, chemical, thermal, and 
electrostatic fabrication techniques. The methods of polymer nanofiber fabrication most 
commonly associated with tissue engineering scaffolds in the literature are electrospinning, 
self assembling peptide reactions, and phase separation [9–11]. There are however several 
other ways to fabricate polymer nanofibers as well. Several of these fabrication methods are 
briefly described in the following section and some of the advantages and disadvantages of 
each method are listed in Table 2.1. 
2.2.1 Electrospinning 
Electrospinning is an electrostatically driven method of fabricating polymer nanofibers. 
Nanofibers are formed from a liquid polymer solution or melt that is feed through a capillary 
tube into a region of high electric field. The electric field is most commonly generated by 
connecting a high voltage power source in the kilovolt range to the capillary tip (Figure 2.1). 
As electrostatic forces overcome the surface tension of the liquid, a Taylor cone is formed 
and a thin jet is rapidly accelerated to a grounded or oppositely charged collecting target. 
Instabilities in this jet cause violent whipping motions that elongate and thin the jet allowing 
the evaporation of some of the solvent or cooling of melts to form solid nanofibers on the 
target site. Nanofiber size and microstructure can be controlled by several processing 
parameters including: solution viscosity, voltage, feed rate, solution conductivity, capillary-
to-collector distance, and orifice size [12]. The electrospinning technique is very versatile and 
a wide range of polymer and copolymer materials with a wide range of fiber diameters 
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Table 2.1:  Comparison of methods for fabricating polymer nanofiber scaffolds
 
(several nanometers to several microns) can be fabricated using this technique. Many 
different types of molecules can be easily incorporated during the electrospinning fabrication 
process to produce functionalized nanofibers. Electrospun nanofibers are usually collected 
from an electrospinning jet as non-woven randomly or uniaxially aligned sheets or arrays. 
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Figure 2.1:  (A) schematic of a standard electrospinning setup (reproduced with permission from Year 
2006 Dove Medical Press Ltd. [11]) and a scanning electron microscope (SEM) image (B) of electrospun 
polyurethane nanofibers. 
2.2.2 Self assembly 
Self assembly is a process by which molecules organize and arrange themselves into patterns 
or structures through non-covalent forces such as hydrogen bonding, hydrophobic forces, and 
electrostatic reactions. Dialkyl chain amphiphiles containing peptides were developed to 
mimic the ECM. These peptide amphiphiles (PA), derived from a collagen ligand, allow for a 
self assembling system that consists of a hydrophobic tail group and a hydrophilic head group 
(Figure 2.2) [13]. The specific composition of amino acid chains in peptide amphiphile 
systems determines the assembly, chemical, and biological properties of the system, and 
therefore PA systems can be tailored to specific applications [14,15]. Nanofibers with 
diameters around 5–25nm can be formed by the self assembly process, and systems have 
been developed where nanofiber assembly can be induced by appropriate pH values [16,17]. 
Cells can be encapsulated in a nanofibrous PA structure if they are added during the self 
assembly process and PAs can also be injected in vivo where they subsequently self assemble 
into a nanofibrous network. It has been demonstrated that self assembled peptide nanofibers 
can spontaneously undergo reassembly back to a nanofiber scaffold after destruction by 
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sonication, and after multiple cycles of destruction and reassembly, the peptide nanofiber 
scaffolds were still indistiquishable from their original structures [18]. While peptides are 
most commonly used in self assembly of tissue engineering structures, synthetic polymer 
nanofibers have also been fabricated by self assembly [19,20].  
 
Figure 2.2:  Schematics of the (A) molecular structure and (B) nanostructure, and images of the (C) 
micro and macro structure of a self assembling peptide amphiphile nanofiber network (reproduced with 
permission from Year 2005 Wiley-VCH Verlag GmbH & Co. KGaA [21]). 
2.2.3 Phase separation 
Nanofibrous foam materials have been fabricated by a technique called thermally induced 
liquid-liquid phase separation [22]. This fabrication procedure involves (a) the dissolution of 
polymer in solvent (b) phase separation and polymer gelatination in low temperature (c) 
solvent exchange by immersion in water and (d) freezing and freeze-drying (Figure 2.3). The 
morphology of these structures can be controlled by fabrication parameters such as 
gelatination temperature and polymer concentration. Interconnected porous nanofiber 
networks have been formed from polymers such as, poly-L-lactide acid (PLLA), poly-lactic-
co-glycolic acid (PLGA), and poly-DL-lactic acid (PDLLA) with fiber diameters from 50–
500 nm, and porosities up to 98.5%. 
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Figure 2.3:  A schematic (A) of nanofiber formation by phase separation (reproduced with permission 
from Year 2005 World Scientific Publishing [23]), and an SEM image (B) of nanofibrous structure 
fabricated by this technique [22]. 
2.2.4 Bacterial cellulose 
Cellulose nanofibers produced by bacteria have been long used in a variety of applications, 
including biomedical applications [24]. Cellulose synthesis by Acetobacter involves the 
polymerization of glucose residues into chains, followed by the extracellullar secretion, 
assembly and crystallization of the chains into hierarchically composed ribbons (Figure 2.4). 
Networks of cellulose nanofibers with diameters less than 100nm are readily produced, and 
fibers with different characteristics may be produced by different strains of bacteria [24]. 
Copolymers have been produced by adding polymers to the growth media of the cellulose 
producing bacteria [25,26]. 
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Figure 2.4:  Schematic of Acetobacter cells depositing cellulose nanofibers (A), and an SEM image of a 
cellulose nanofiber mesh produced by bacteria (B) (reproduced with permission from Year 2007 
American Chemical Society [24]). 
2.2.5 Templating 
Polymer nanofibers can be fabricated using templates such as self-ordered porous alumina. 
Alumina network templates with pore diameters from 25 to 400 nm, and pore depths from 
around 100nm to several 100µm have been be fabricated. Polymer nanofiber arrays can be 
released from these molds by destruction of the molds or mechanical detachment (Figure 2.5) 
[27,28]. The length of polycaprolactone (PCL) nanofibers fabricated from alumina templates 
can be controlled as a function of parameters such as melt time and temperature [29]. 
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Figure 2.5:  (A) Schematic of the fabrication of polymer nanofibers using a nondestructive templating 
technique (grey: alumina template, green: resin, blue: polymer nanofibers, pink: silica replica template. 
(B) SEM images of 120nm (B&C) and 1 µm (D&E) polymer fibers fabricated by the above technique 
(reproduced with permission from Year 2008 American Chemical Society [27]). 
2.2.6 Drawing 
Nanofibers can be mechanically drawn from viscous polymer liquids directly [30]. In one 
example, nanofibers were drawn directly when a rod was placed in a polymer melt and 
moved up forming a thin filament that cooled to form a nanofiber (Figure 2.6). This method 
was used to fabricate poly(trimethylene terephthalate) nanofibers with diameters as low as 60 
nm, and lengths up to 500mm [31]. An automated drawing technique utilized a pipette 
dispensing liquid polymer solution while intermittently contacting a substrate and moving the 
x-y direction across the substrate [32]. This process allowed the formation of thin suspended 
nanofibers connecting droplet shaped dots on the substrate. This technique was used to 
fabricate polystyrene nanofibers with diameters ranging from tens nanometers to several 
microns in highly ordered patterns. 
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Figure 2.6:  (A) Schematic of nanofiber fabrication by the drawing technique. (B) Transmission electron 
microscope (TEM) image of a polymer nanofiber fabricated using the drawing technique (reproduced 
with permission from Year 2008 The Optical Society [31]).  
2.2.7 Extraction 
Nanofibers can be extracted from natural materials using chemical and mechanical 
treatments. Cellulose fibrils can be disintegrated from plant cell walls. In one example, 
cellulose nanofibers were extracted from wheat straw and soy hull with diameters ranging 
from 10 to 120nm and lengths up to a few thousand nanometers (Figure 2.7) [33]. 
Invertebrates have also been used as a source for the extraction of nanofibers. Chitin 
nanofibers 3-4nm in diameter and a few micrometers in length were extracted from squid pen 
and Poly-N-acetyl glucosamine nanofibers isolated from a marine diatom demonstrated 
prothrombotic interactions with red blood cells [34,35]. 
 
Figure 2.7:  Images of natural wheat straw [36], wheat straw microfibers [33] after chemical treatment 
and wheat straw nanofibers [33] after chemical treatment. 
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2.2.8 Vapor-phase polymerization 
Polymer nanofibers have also been fabricated from vapor-phase polymerization. Plasma-
induced polymerization of vapor phase vinyltrichlorosilane produced organosiloxane fibers 
with diameters around 25nm and typical lengths of 400–600nm and cyanoacrylate fibers with 
diameters from 100 to 400nm and lengths of hundreds of microns (Figure 2.8) [37,38]. 
 
Figure 2.8:  (A) Schematic describing a proposed mechanism for nanofiber formation by vapor-phase 
polymerization (B) Arial (1) and side views (2) of polymer nanofibers fabricated from vapor-phase 
polymerization at high (B), intermediate (C) and low (D) packing densities [37]. (Reproduced with 
permission from Year 2007 American Chemical Society [37]). 
2.2.9 Kinetically controlled solution synthesis 
Nanofibers and nanowires have been fabricated in solution using linear aligned substrates as 
templating agents such as iron-cation absorbed reverse cylindrical micelles and silver 
nanoparticles [39]. Poly(vinyl alcohol)-poly(methyl methacrylate) nanofibers were fabricated 
using silver nanoparticle that were linearly aligned in solution by vigorous magnetic stirring 
(Figure 2.9) [40]. These nanoparticle chain assemblies acted as a template for further 
polymerization of nanofibers with diameters from 10 to 30nm and lengths up to 60µm. 
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Figure 2.9:  (A) Schematic of silver nanoparticle embedded polymer nanofibers fabrication (B) SEM 
and TEM images of silver nanoparticle embedded polymer nanofibers (reproduced with permission from 
Year 2006 Royal Society of Chemistry [40]). 
2.2.10 Conventional chemical oxidative polymerization of aniline 
Chemical oxidative polymerization of aniline is a traditional method for synthesizing 
polyaniline and during the early stages of this synthesis process polyaniline nanofibers are 
formed (Figure 2.10). Optimization of polymerization conditions such as temperature, mixing 
speed, and mechanical agitation allows the end stage formation of polyaniline nanofibers 
with diameters in the range of 30–120nm [41,42]. 
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Figure 2.10:  Schematic showing the nucleation of polyaniline nanofibers. (I) Under non-ideal 
nucleation conditions aggregate formation is present. (II) When ideal nucleation conditions are 
predominant, well-dispersed polyaniline nanofibers are formed. Typical images of the reaction vials and 
microstructure are displayed next to the schematic (reproduced with permission from Year 2009 
American Chemical Society [42]). 
2.3 Biofunctionalization of polymer nanofibers 
Polymer nanofibers are excellent structures for the design of tissue engineering scaffolds 
because of the wide variety of biocompatible polymer materials that can be formed into 
nanofibrous structures. Different types of biocompatible polymers demonstrate a variety of 
mechanical properties, degradation rates, and cell-material interactions, and new types of 
polymers are continuously being synthesized. In addition to the vast material selection 
available, one of the most favorable characteristics of polymer materials in tissue engineering 
scaffolds are their suitability for biofunctionalization. Biofunctional polymer nanofibers can 
be fabricated entirely from materials found in the ECM, and a variety of biomolecules and 
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drugs can be incorporated into polymer nanofibers during the fabrication process or by using 
post processing surface modification techniques. Biofunctionalization techniques can be 
utilized to fabricate tissue engineering scaffolds that guide cells toward desired behavior and 
function. 
2.3.1 Natural ECM molecule nanofibers  
Molecules that are naturally occurring in the extracellular matrix are ideal materials for cell 
attachment, survival, proliferation, and differentiation. In addition, substrate interactions 
between cells and ECM molecules may modulate certain cell functions. Biofunctional 
nanofibers can be directly fabricated from natural ECM materials or synthetic polymers can 
be blended with natural ECM molecules to form copolymer fibers. Blended nanofibers 
generally benefit from improved physical properties due to the synthetic polymer component 
and improved bioactivity due to the natural ECM component [43,44]. 
2.3.1.1 Collagen 
Pure collagen nanofibers are commonly electrospun from solutions of soluble type I collagen 
dissolved in organic solvents such as 1,1,1,3,3,3-hexafluoro-2- propanol (HFIP) or aqueous 
acids. Bead free pure collagen nanofibers have been fabricated with diameters ranging from 
100 to 500nm [45,46]. Water soluble collagen nanofibers must be crosslinked before use in 
cell culture with crosslinking agents, such as glutaraldehyde vapor, 1,6-diisocyanatohexane, 
genipin, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), and so on 
[45,47,48]. Nanofiber blends containing collagen and synthetic polymers such as PCL are 
also easily fabricated by electrospinning when both materials are dissolved in the same 
solvents [49]. In nanofibers electrospun from single solvent solutions containing collagen and 
PCL, collagen was well dispersed as small spherical aggregates at low concentrations (10 
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wt%) and as much larger irregular shapes at higher concentrations (50 wt%) [50]. Cells 
cultured on synthetic nanofibers blended with collagen have shown better attachment, 
growth, and ECM production than fibers without collagen incorporation [51,52]. Blends 
allow for the fabrication of collagen containing nanofibers with a greater range of mechanical 
properties and fiber diameters. It has been shown that electrospinning collagen from organic 
solvents causes extensive denaturation and it was suggested that similar bioactivity may be 
obtained using gelatin in these cases [53]. However, several studies directly comparing 
electrospun collagen and gelatin nanofibers indicate that electrospun collagen nanofibers may 
retain some favorable bioactivity when compared to gelatin nanofibers despite solvent 
denaturation [51,54,55].  
2.3.1.2 Gelatin 
Gelatin nanofibers have been electrospun by dissolution in organic solvents such as HFIP and 
2,2,2-trifluoroethanol (TFE) or aqueous acids. Pure gelatin nanofibers have been electrospun 
with fiber diameters around 50 to 500nm [45,56]. Gelatin nanofibers are crosslinked before 
use in cell culture with crosslinking agents, such as glutaraldehyde vapor,                           
1,6-diisocyanatohexane, genipin, EDC, and so on [45,48]. Gelatin nanofiber blends can also 
be electrospun by combination of gelatin and other polymers in one solution with a variety of 
fiber diameters. Cells attached and proliferated better on synthetic fibers when they were 
blended with gelatin [51,57–59]. Increases in cell attachment and proliferation have been 
shown to be a function of the ratio of gelatin in the fiber blends [44]. PCL fibers blended with 
gelatin also enhanced nerve differentiation as compared to plain PCL nanofibrous scaffolds 
[57]. 
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2.3.1.3 Elastin  
Alpha-elastin and tropoelastin fibers have been electrospun from HFIP solutions and aqueous 
acids with diameters ranging from 1 to several microns [45,46,48]. Electrospun elastin fibers 
have been observed to possess a ribbon like morphology as opposed to the uniform cross-
section filament shape most common in other electrospun fibers. Elastin nanofibers must be 
crosslinked before use in cell culture with various crosslinking agents such as glutaraldehyde 
vapor, 1,6-diisocyanatohexane, EDC, and so on [45,46,48]. Elastin fiber blends with collagen 
and synthetic materials have also been successfully electrospun [45,60].  
2.3.1.4 Chitosan  
Pure chitosan nanofibers are difficult to electrospin due to limited solubility, ionic character 
and three-dimensional networks of strong hydrogen bonds [61]. High molecular weight 
chitosan nanofibers have however been successfully electrospun using high concentration 
acid solutions (diameter = 130 nm) and organic solvents (diameter = 60–330 nm) [61–63]. 
Chitosan can be mixed with other polymers in organic solvent solutions such as HFIP or acid 
solutions to more easily form blended nanofibers [43]. Chitosan nanofibers have been 
electrospun as blends with very low concentrations of polyethylene oxide (PEO) (10%) with 
diameters from 150 to 200 nm [64]. Chitosan/cellulose blends have also been produced by 
bacteria fabrication with chitosan concentrations of 7–10% dry weight [26]. Nanofiber 
scaffolds containing chitosan have demonstrated favorable properties as tissue engineering 
constructs [64].  
2.3.1.5 Dextran  
Dextran fibers with a wide range of fiber diameters have been electrospun from aqueous 
solutions and organic solvents such as dimethylformamide (DMF) and dimethyl sulfoxide 
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(DMSO) mixtures [65]. Dextran is highly soluble in an aqueous environment, but 
methacrylated dextran nanofibers photocrosslinked after electrospinning formed stable 
hydrogels in the aqueous environment [65]. Blended PLGA/dextran nanofibers have also 
been fabricated and have demonstrated favorable tissue engineering properties [66].  
2.3.1.6 Fibrinogen  
Fibrinogen nanofibers with diameters from 80 to 700 nm have been electrospun from 
solutions of fibrinogen dissolved in HFIP and 10× minimal essential medium (9:1) [67]. 
Fibrinogen nanofiber scaffolds were able to maintain their structure when hydrated without 
crosslinking and demonstrated good interactions with cells in vitro culture conditions [68,69]. 
The protease inhibitor, aprotinin can be added to cell culture media to slow down the 
degradation rate of fibrinogen nanofibers [68,69].  
2.3.1.7 Laminin  
Laminin purified from Engelbreth–Holm–Swarm (EHS) tumor was solubilized in HFIP and 
electrospun into 90 to 300 nm fibers with various amounts of bead composition [70]. 
Bioactivity of laminin nanofibers was confirmed by the in vitro behavior of PC12 and human 
adipose stem cells. Laminin nanofibers were able retain their structure under hydrated 
conditions without crosslinking.  
2.3.1.8 Hyaluronic acid  
Hyaluronic acid nanofibers are very difficult to fabricate, but a combination procedure 
involving electrospinning from an acidic solution with heated air blown around the 
electrospining jet was developed to obtain uniform fibers [71]. Pure hyaluronic acid 
nanofibers (diameter = 110 nm) were also fabricated by electrospinning hyaluronic acid:PEO 
blended nanofibers followed by extraction of the PEO component of the fibers [72,73]. 
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Scaffolds assembled from these hyaluronic acid nanofibers demonstrated good cell 
interaction properties in vitro.  
2.3.2 Surface functionalization  
One of the major advantages of polymeric materials in tissue engineering scaffold design is 
vast versatility for surface modifications. Biomolecules can be absorbed or chemically 
bonded to the surface of polymer nanofibers in order to modulate specific cell functions in 
tissue engineering. In this review only surface functionalization techniques that have 
previously been carried out with polymer nanofiber structures are included, but in theory any 
method of polymer surface modification may be applicable to polymer nanofibers as long as 
some part of the process does not destroy the sometimes fragile nanofiber structures.  
2.3.2.1 Physical absorption  
The simplest method for surface biofunctionalization of polymer nanofibers with 
biomolecules is to incubate nanofiber meshes with solutions containing solubilized 
biomolecules to allow for physical absorption of the biomolecules onto the nanofiber 
surfaces. Biomolecules may adhere to the surface of the nanofibers because of interactions 
such as Van der Waals force, electrostatic forces, hydrophobic interactions, and hydrogen 
bonding. The efficiency of physical adsorption onto hydrophobic nanofiber scaffolds can be 
increased by treatment with air plasma to make them more hydrophilic and allow greater 
infiltration of aqueous solutions containing water soluble biomolecules. Plasma treatment can 
also be used to improve the hydrophilicity of nanofiber meshes for improved covalent 
grafting modifications explained in the following section [74]. The efficiency of plasma 
treatment may be improved by placing a sample a distance downstream of the plasma source 
to allow surface modification while minimizing damages due to etching and ablation [75].  
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2.3.2.2 Covalent surface bonding  
Covalent surface bonding can be used to chemically bond biomolecules to exposed functional 
groups directly on the nanofiber surface. Covalent surface bonding provides a much more 
efficient coating and greater long term retention of biomolecules [76]. Covalent coating of 
biomolecules on nanofibers usually involves at least two requirements: (1) exposed 
functional groups on the fiber surface, (2) covalent bonding of biomolecules to these func-
tional groups.  
2.3.2.2.1 Exposing functional groups  
Depending on the molecular configuration of the specific polymer requiring modification, 
functional groups may already be present, or can be added to the surface by various chemical 
treatments. The functional groups most commonly used in polymer nanofiber surface 
modification reactions in the literature are carboxyl and amine groups. Carboxyl groups can 
be exposed on the surface of nanofibers made from materials, such as PLLA and PCL, by 
treatment with chemicals such as sodium hydroxide (NaOH) [77,78]. Amine groups were 
grafted on the surface of degradable polyester nanofibers by treatment with 1,6-
hexanediamine/propanol solution or ethylenediamine (ED) [79,80]. When the desired func-
tional groups cannot be easily grafted directly on the polymer nanofiber surface then a linker 
molecule with the desired exposed functional groups can be tethered to the fiber surface. 
Acrylic acid in the gas phase was grafted to various polymer nanofibers as a plasma treatment 
to add carboxyl groups [81]. An additional di-aminopoly(ethylene glycol) (di-NH2-PEG) was 
used as a linker molecule to add functional amine groups to polyester nanofibers that had 
previously been soaked in NaOH to expose carboxylic acid groups [82]. Exposed carboxyl 
groups were added to polyethersulfone (PES) nanofibers by photo polymerization grafting of 
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poly (acrylic acid) as a linker molecule [83]. When adding linker molecules to the surface of 
polymer nanofibers it may be important to consider the properties of the specific linker 
molecules used because several research groups have shown that linker properties such as 
length have an effect on the cell response to functionalized polymer nanofibers [83–85]. 
Polymer blends and modified polymers can also be synthesized to include desired exposed 
functional groups on their structure. A PCL-PEG block copolymer was synthesized with 
functional amine groups on the surface via PEG linkers and electrospun into nanofibers that 
were further functionalized [86]. A copolymer of methyl methacrylate (MMA) and acrylic 
acid (AA) was synthesized and electrospun into nanofibers with different carboxyl group 
contents by varying the ratio of MMA to AA [87]. In another case PLGAb-PEG-NH2 di-
block copolymer was directly blended with PLGA in organic solvents and electrospun to 
form PLGA nanofibers with exposed functional amino groups [88].  
2.3.2.2.2 Covalently attaching biomolecules to functional groups.  
Covalently attaching biomolecules to polymer nanofiber surfaces may require the activation 
of exposed functional groups on the polymer surface, the biomolecules or both. Carboxyl 
groups can be activated for reaction with primary amines by treatment with 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC). This method of activation is 
commonly referenced in the literature for bonding biomolecules to polymer nanofibers 
[55,74,75]. The efficiency of EDC initiated bonding can be improved by adding N-
hydroxysuccinimide (NHS), which converts an unstable amine-reactive intermediate formed 
by the EDC reaction into an amine-reactive NHS ester [55,74]. Glutaraldehyde, and 1-
hydroxybenzole (HOBt) with EDC have been used to attach biomolecules to exposed amine 
groups on polymer nanofibers [79,86].  
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 2.3.2.3 Examples of biomolecule surface functionalized nanofibers  
A variety of biomolecules have been attached to polymer nanofibers to increase their 
bioactivities. Many research groups have used the physical absorption method to coat 
nanofibers with nanocrystalline apatites by immersion in simulated body fluid (SBF), which 
is an aqueous solution that contains ions in concentrations similar to those of human body 
plasma [89]. The degree of coating can be controlled by incubation time and SBF solution 
composition [77,78]. Hydroxyapatite coatings stimulate the expression of osteogenic genes 
by osteoblastic cells when compared to uncoated scaffolds [78]. The physical absorption 
method has also been used to coat synthetic nanofibers with biomolecules such as collagen, 
laminin, E-selection, and many others and successful biomolecule incorporation is reflected 
in enhanced cell spreading, viability, attachment, and phenotype preservation [76,90,91]. The 
physical absorption method has the advantage of being a very simple and gentle procedure. 
Modifications preformed by this method limit damage to fragile nanofiber structures and 
biomolecules, but binding can be relatively weak.  
Many biomolecules have been covalently bonded to the surface of polymer nanofiber 
scaffolds as well. Covalent attachment of collagen and laminin to polymer nanofibers 
enhanced the suitability of the nanofibers as neural tissue engineering scaffolds [76,87]. 
Collagen synthesis by esophageal epithelial cells was increased by covalent bonding of 
fibronectin to nanofibers, and covalent attachment of an RGD peptide enhanced the 
attachment and proliferation of fibroblasts [79,88]. When compared to physical absorption, 
covalent bonding provides a more efficient and stable surface attachment of biomolecules. 
The major disadvantages of covalent bonding are more complex procedures and the potential 
use of harsh conditions that may limit the types of biomolecules that can be incorporated. For 
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example, the organic solvents used in some covalent binding procedures may deactivate 
biomolecules such as growth factors.  
Combinational techniques to utilize both covalent bonding and physical absorption 
can also be used to biofunctionalize polymer nanofiber surfaces. The physical absorption of 
hydroxyapatite coatings with SBF can be made more efficient if carboxyl groups are exposed 
by NaOH prior to incubation [77,78]. Growth factors can be bound to polymer nanofibers 
using a combinational technique where molecules such as heparin are covalently bonded to 
act as reservoirs that stabilize, store, and protect growth factors introduced by physical 
absorption [55,82]. This technique allows for strong, stable covalent binding of heparin to the 
nanofiber surface, without exposing the growth factors to harsh conditions that could reduce 
their biofunctionality.  
2.3.3 Bulk biomolecule incorporation  
In addition to surface functionalization, biomolecules can also be incorporated into the bulk 
material of nanofibers during the fabrication process. The three most common methods of 
bulk biomolecule incorporation into polymer nanofibers are direct mixing into a polymer 
solution, co-axial electrospinning, and insertion of biofunctional peptide sequences into 
peptide amphiphile molecules for self assembly. It has been shown that the direct 
incorporation technique can allow for greater amounts of biomolecule incorporation and 
improved bioactivity when compared to surface modification techniques [76]. In addition, 
biomolecules incorporated by this technique are embedded into the bulk material of the fibers 
and can facilitate extended release of biomolecules by diffusion through the nanofibers or 
release by degradation of the nanofibers in the case of biodegradable materials. The release 
kinetics of biomolecules contained in polymer nanofibers commonly involves an initial burst 
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followed by steady extended release.  
2.3.3.1 Mixing biomolecules directly into a polymer solution  
Many biomolecules can be directly incorporated into a polymer solution during fabrication. 
This method of biomolecule incorporation can be employed for nanofiber fabrication 
techniques that utilize a polymer solution such as electrospinning, phase separation, 
templating, drawing, and so on, most notably electrospinning. Biomolecules may be directly 
dissolved in a polymer solution if a common solvent is available [92], dissolved in a miscible 
solvent and incorporated as a suspension [92–94], or dissolved in an immiscible solvent and 
incorporated as an emulsion with agitation [95–97]. When two miscible solvents for a 
particular polymer and biomolecule solution are not available, a multi-component system 
may be used. For example a three component solution containing dichloromethane (DCM), 
methanol, and water was used to incorporate water soluble heparin into DCM soluble PCL 
nanofibers [98]. Heparin was dissolved in water, which is miscible in methanol, which is 
miscible in DCM. Electrospinning of emulsions formed by stirring, vortexing, or sonication 
resulted in beadlike pockets containing an aqueous phase or even a core-shell structure [99–
101]. Inclusion of miscible solvents and emulsions may however disturb the electrospinning 
process and make fiber formation more difficult due to inclusion of multiple phases in the jet 
[95]. Distribution of a biomolecule in a single phase solution was found to be even thoughout 
the nanofiber, while biomolecule distribution was aggregated for a two phase system [92,97]. 
However, even biomolecule distribution has also been observed in nanofibers electrospun 
from miscible solvent suspensions [98]. Reported efficiency of direct biomolecule 
incorporation in electrospun nanofibers varies greatly. This should be expected due to the 
high level of variations in material selection and electrospinning parameters reported in the 
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literature. Heparin electrospun as a miscible suspension had an efficiency of around 100% 
[98], laminin directly blended in organic solvent with PLLA had an efficiency of around 75% 
[76], and nerve growth factor (NGF) electrospun into nanofibers from an emulsion had a 
reported efficiency of just 2.5% [95]. Incorporation of biomolecules can have an effect on the 
morphology of electrospun nanofibers because biomolecule incorporation can change the 
solution properties such as viscosity and charge density [92,93,98]. For example, fiber diam-
eter decreased with increasing loading levels of retinoic acid, while fiber diameter increased 
with increased loading levels of bovine serum albumin (BSA) [92]. Incorporation of 
biomolecules can also have an effect on the mechanical properties of nanofibers because of 
the inclusion of aggregates. Increased loading levels of BSA were observed to decrease the 
ductility of PCL and ethyl ethylene phosphate nanofibers, while the presence of retinoic acid 
increased the strength of the nanofibers independent of the fiber diameter [92]. A variety of 
biomolecules have been directly incorporated into electrospun nanofibers. NGF was mixed 
with BSA as a carrier protein and electrospun from an emulsion with sustained release up to 
3 months after a 20% burst effect and retention of at least some degree of bioactivity [95]. 
Antibiotics have also been incorporated into electrospun polymer nanofibers with sustained 
release and bioactivity retention [93]. DNA has also been successfully incorporated into 
electrospun nanofibers with a sustained release of intact DNA capable to cellular transfection 
and protein encoding [94]. Vitamins were also loaded into electropsun polymer nanofibers 
with expended release [102]. Nanoparticles have also been loaded directly into polymer 
solutions and electrospun as dispersions [103]. A special extruder (Figure 2.11) used to feed 
polymer solution/nanoparticle dispersions into an electrospinning capillary helped to break 
up particle aggregates and maintain a uniform solution composition [103].  
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Figure  2.11:  Deagglomeration of nanoparticles during stages of continuous processing in 
twin screw extrusion electrospinning apparatus (scale bar is 20 µm [103]. 
 
2.3.3.2 Co-axial incorporation (electrospinning)  
An alternative approach to directly mixing biomolecules in an electrospinning solution is to 
use a special co-axial nozzle, which allows the formation of core-shell nanofibers where one 
material makes up a core filament that is surrounded by another material in a concentric 
geometry [104]. Multiple solutions are feed though a special nozzle in a concentric geometry 
to form a two phase liquid electrospun jet where a solution at the center is surrounded by an 
outer solution, forming solid core shell nanofibers upon solvent evaporation. Hollow tube 
nanofibers have also been electrospun using the co-axial technique [105]. Core shell 
nanofibers offer many attractive properties in tissue engineering applications, especially in 
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biomolecule incorporation. Biomolecules incorporated inside of core shell nanofiber are not 
affected by initial burst and they do not require extended contact with any toxic solvents used 
in the formation of the shell materials [106]. The flow rate of each component of the 
nanofiber can be independently controlled to vary the overall diameter of the fibers and the 
core to shell volume ratio. Coaxial electrospinning can also be used to electrospin materials 
that cannot be electrospun using conventional methods. For example, nanofibers were formed 
from poly(glycerol sebacate), a material that cannot be electrospun directly, by encapsulating 
its precursors in a constraining shell material that was removed after curing [107].  
2.3.3.3 Incorporation of biofunctional peptide sequences (self assembly)  
Biofunctional peptide sequences can be directly incorporated into peptide amphiphile 
nanofiber scaffolds. Biofunctional sequences are inserted into peptide amphiphile molecules 
and these biofunctional sequences are presented to cells on the nanofiber surface after self 
assembly. In one example, a peptide sequence called RADA16 was mixed with modified 
RADA16 sequences directly coupled with various bioactive motifs to promote cell adhesion 
and osteogenic functions [108]. Compared to pure RADA16 scaffolds, scaffolds containing 
bioactive motifs increased cell proliferation and markers of osteogenic differentiation. 
Incorporation of a designed chemokine similar to stromal cell-derived factor-1 improved 
cardiac function after myocardial infarction [109], and cell adhesion, differentiation and bone 
marrow homing motifs added to RADA16 sequences improved neural cell survival in 
nanofiber scaffolds [110]. A peptide amphiphile nanofiber scaffold with the incorporation of 
the pentapeptide epitope isolucinelysine-valine-alanine-valine (IKVAV), known to promote 
neurite sprouting and to direct neurite growth was designed as a tissue engineering scaffold 
specifically for neuronal cells [15]. The effect of IKVAV incorporation in the peptide 
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nanofibers was demonstrated by the superior bioactive properties of these scaffolds versus 
controls without the IKVAV sequence. The arrangement of biofunctional peptide sequences 
can have an effect on their bioactivity in nanofibrous scaffolds. RGD peptide sequences 
incorporated into self assembling peptide scaffolds had better cell attachment properties 
when the motif was displayed at a branched site than with linear incorporations of RDG 
because of increased motif availability at the nanofiber surface [111].  
2.4 Cell behavior on polymeric nanofibers  
Cells in their natural in vivo surroundings are exposed to a complex chemical and structural 
environment. The natural extracellular matrix is made up of structural components that are of 
nanoscale dimensions. Major fibrous extracellular molecules such as collagen fibers, elastin 
fibers, keratin fibers, etc. have nano-scale diameters. It is highly important to mimic the 
natural environment when culturing cells in vitro because cell behavior is determined by both 
genetic makeup and the surrounding environmental cues. Cellular behaviors such as 
proliferation, differentiation, morphology, and migration are commonly controlled in culture 
by modulation of the chemical environment. Cells also respond to different morphological 
cues that can be determined by the growth substrate in vitro and in vivo. Four components 
may be involved in the growth, differentiation, functions and morphology of cells on bio-
material surfaces: (1) adsorption of serum components  (2) extracellular matrix components 
secreted by the cell (3) cell adhesion molecules and (4) cytoskeleton mechanics [112]. It has 
been shown that the structural substrate property of surface roughness can cause selective 
protein absorption, and that higher surface roughness increases total protein absorption [113]. 
In this case, increased protein adsorption could be attributed to an increase in surface area for 
rough surfaces and thus could be important in relation to nanotopographical materials 
 34 
 
because these exhibit extremely high surface area. In relation to nanostructure and cell 
interactions, the cytoskeletal mechanics is of importance because cells cultured on substrates 
with nanoscale features can take on different shapes in response to the specific features that 
are encountered.  
Nanotopography can affect cellular behavior through known mechanisms such as the 
regulation of cell shape and surface protein absorption properties, but it is possible that there 
are unknown effects associated with nanotopographies as well. Cells can react to objects as 
small as 5nm [114] and it is possible that nanostructures, especially those with similar 
dimensions to the natural ECM, can influence cell behavior through unknown mechanisms. It 
has been shown that cell behavior can be highly dependent on the substrate that they are 
cultured on, and the understanding of cell substrate interactions with nanostructures could 
provide valuable information that would allow for the design of better tissue engineering 
scaffolds. Nanofibrous scaffolds present nanostructured features, mimic the fibrous 
components of natural tissue, allow three-dimensional configurations, and provide a unique 
mode of presentation of chemical and biological cues to cells. In order to gain a better 
understanding of the effect that nanofibrous architecture has on cell behavior, experimental 
results have been summarized according cell morphology, alignment, attachment, viability, 
ECM production, differentiation, and migration.  
2.4.1 Cell morphology  
Cell morphology can be influenced by the substrate that a cell is attached to. Cells many 
times adopt a different morphology on nanofibrous substrates compared to flat substrates, and 
cell morphology on nanofibrous substrates can be influenced by the fiber diameter. Cell 
morphology is commonly described by the projected area/degree of spreading or the aspect 
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ratio (ratio of the long and short axis). Cell morphology is an important characteristic in tis-
sue engineering scaffold design because of its significance in controlling cell arrangement 
and the translational effects that cell morphology have on other cell functions. 
Cells may adopt a more rounded shape with a smaller projected area when cultured 
on nanofibers as opposed to flat surfaces. Osteoprogenitor cells cultured on electrospun 
polymer fiber meshes with diameters of 140 and 2100 nm displayed significantly smaller 
projected areas than cells cultured on smooth surfaces [115], and fetal bovine chondrocytes 
cultured on nanofibrous scaffolds maintained a round or spindle-like shape in contrast to a 
flat well spread morphology observed on tissue culture plate [116]. Rounded morphologies 
may correspond with lack of organized actin fibers compared to cells with more well spread 
morphologies [116]. Chondrocytes grown on polymer nanofibers (500–900 nm) also adopted 
a rounded shape with a disorganized actin cytoskeleton in contrast to cells grown on 15 µm 
microfibers, which adopted a well spread shape [117]. Because fifteen microns approaches 
the size of a cell, they may react to these fibers in a manner similar to a flat substrate in the 
previous example.  
Cells also may adopt a more elongated shape on nanofibers of certain diameters. 
Osteoprogenitor cells cultured on 140 nm fibers adopted a similar aspect ratio to those on 
smooth surfaces, but cells on 2100 nm fibers had a statistically higher aspect ratio [115]. In 
agreement with this result, dermal fibroblasts had statistically significant increase in aspect 
ratio for fiber diameters of 8640 and 970 nm versus flat controls, but not for fiber diameters 
of 160 and 650 nm [118]. Human umbilical vein endothelial cells also showed enhanced 
elongated cell morphology on larger fibers (1–5 µm) than smaller nanofiber scaffolds (200–
1000 nm and 10–200 nm) [119]. This elongating effect could be due to cells growing along 
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single fibers, as it would be logical that cells would be more likely to grow along single fibers 
in nanofiber meshes with larger diameter fibers.  
2.4.2 Cell alignment  
One of the most important cell morphologies associated with tissue engineering is elongated 
unidirectional cell alignment. Many tissues such as nerve, skeletal and cardiac muscle, 
tendon, ligament, and blood vessels contain cells oriented in a highly aligned arrangement, 
thus it is desirable that scaffolds designed for these tissue types are able to induce aligned cell 
arrangements. It is well documented that cells adopt a linear orientation on aligned substrates 
such as grooves and fibers. Aligned nanofibers arrays can be easily fabricated using the 
electrospinning method [120,121] and many studies have shown that cells align with the 
direction of the fibers in these scaffolds. Primary cardiac ventricular cells and smooth muscle 
cells aligned in the direction of 1.8 µm and 550 nm aligned nanofiber meshes respectively 
[122,123]. Neuron elongation and outgrowth was parallel to the direction of aligned 113 and 
431 nm nanofibers and neuronal stem cells seeded on random and aligned 300 nm and 1.5 
µm nanofibers turned through large angles in order to grow parallel to the fiber alignment 
independent of fiber diameter [57,124]. Human skeletal muscle cells grown on 300 nm 
nanofiber scaffolds aligned on aligned fibers scaffolds in contrast to a random orientation 
adopted on randomly oriented scaffolds [125]. The effect of nanofiber alignment on neurite 
alignment of dorsal root ganglion (DRG) was measured quantitatively for nanofibrous 
scaffolds with different degrees of alignment using Fourier image analysis. Neurite alignment 
corresponded to the degree of fiber alignment as demonstrated by full-width-half max of the 
intensities of the fast Fourier transform images of 38, 69, and 84% (p < 0.0001) for highly 
aligned, intermediate, and randomly oriented samples respectively [126].  
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In addition to the influence on fiber arrangement, cell alignment can have positive 
effects on cell growth within tissue engineering scaffolds. Myotubes formed on aligned 
nanofiber scaffolds were more than twice the length of myotubes grown on randomly 
oriented fibers (p < 0.05) and neurites extending from DRG explants on highly aligned 
scaffolds were 16 and 20% longer than those grown on intermediate and randomly aligned 
scaffolds respectively [125,126].  
2.4.3 Attachment  
When designing tissue engineering scaffolds it is critically important that cells readily attach 
to the constructs. Many studies have confirmed that nanofibrous architectures have cell 
attachment properties superior to flat surfaces. Two factors that may lead to improved cell 
attachment on nanofibers could be the physical entrapment of cells penetrating inside of 
nanofiber meshes or improved focal adhesions. Many more filopia have been observed 
projecting from the edges of cells cultured on small diameter fibers compared to flat surfaces 
[118] and uniform focal adhesion distribution has been observed in cells cultured on 
nanofibers as compared to a distribution around the cell perimeter for cells cultured on flat 
surfaces [118]. An extreme example of physical entrapment was demonstrated when large 
hepatocyte spheroids completely enveloped nanofibers and demonstrated improved adhesion 
to flat controls upon agitation [127].  
Relatively consistent results have been reported on the improved attachment of 
various cell types on nanofibers as opposed to flat surfaces. Fibroblasts, adipose stem cells, 
and smooth muscle cells that were allowed 15 min to 8 h to attach, adhered to nanofibers 
(100–500 nm) at rates 50–150% higher than cells on flat substrate controls [70,123,128]. 
Bone marrow-derived hematopoietic stem cells attached to nanofibrous scaffolds fabricated 
 38 
 
from various materials at levels at least four times that of tissue culture plate at time points 
from 10 to 60 min [91]. After long term cell culture of 10 days, 40% of total hematopoietic 
stem cells grown on polymer nanofiber meshes were adherent after washing, while only 25% 
of total cells stayed on flat substrates [129]. Fiber diameter can have an effect on the cell 
attachment properties of nanofibrous scaffolds, however optimum fiber size seems to vary for 
different types of cells and conditions. The attachment of human mesenchymal stem cells 
was found to be around 40% greater on 1 µm diameter fibers as compared to 500 nm fibers 
[130], but in contrast, attachment of 3T3 fibroblasts on nanofiber scaffolds was greatest on 
425 nm diameter scaffolds and decreased with increasing fiber diameter for 641 and 900 nm 
scaffolds [131]. On a smaller size scale, astrocytes seeded on 60, 100, 120, and 200 nm 
carbon fiber disks attached best to the largest fiber diameter disks [132].  
2.4.4 Viability: survival/proliferation  
Cell survival and proliferation must be well controlled in tissue engineering scaffolds. In 
most cases, maximum survival and proliferation are desired, but in some applications 
reductions in cell survival and proliferation are required. For example, astrocyte proliferation 
at an implant/tissue interface in the central nervous system causes the formation of an 
undesirable glial scar. It is well documented that nanofibrous architecture can have a 
significant effect on the survival and proliferation of cells, however the specific effects may 
vary for different cell types and conditions. Nanofibers have been shown to both increase and 
decrease cell proliferation for various cell types and conditions when compared to flat 
control. Fiber diameter effects on cell proliferation also vary for different cell types and 
conditions.  
Self assembling peptide nanofiber scaffolds were found to improve the viability of 
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transplanted islet cells after 7 days of standard culture and in hypoxia injury model [133]. 
Cell viability as confirmed by MTT assay was increased from 58.6% to 81.0% in standard 
culture and from 29.2% to 60.6% in injury model. Viable fibroblast cell numbers after 8–13 
days of culture were increased up to 3 times on 300–500 nm fibers vs. flat control [128]. It 
was further confirmed by transwell culture that nanofibrous architecture caused cells to 
release soluble factors that could stimulate increased cell numbers. In contrast, hematopoietic 
stem cells cultured on three different types of 500 nm fibers had 10–50% fewer cells than 
those cultured on flat films after 10 days [129], and Schwann cells cultured on five different 
polymer materials for 3–5 days had decreased MTT viabilities on four types of polymer 
fibers (1–4 µm) compared to films and similar viability on one type of nanofiber (130 nm) 
when compared to film [134].  
Specific fiber diameter also has a variable effect on the proliferation of cultured cells. 
3T3 fibroblasts cultured on polymer nanofibers with 6 diameters from 117 to 1051 nm had 
similar cell counts on day 1, but on days 3-7 cell number was greatest on 428 nm scaffolds 
and decreased towards the ends of the range up to 40% for the smallest and largest fiber 
diameters [131]. In contrast, human umbilical vein endothelial cells demonstrated higher 
viability and cell densities on 1000 to 1500 nm fibers as compared to 10–200 nm and 200–
1000 nm fibers [119]. Carbon nanofibers with diameters of 60 and 100 nm resulted in 
osteoblast numbers nearly 3 times that of 125 and 200 nm fibers after 7 days of culture, but 
astrocyte cell counts were up to 66% higher on 125 and 200 nm fibers as compared to 60 and 
100 nm fibers after 5 days of culture [132,135].  
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2.4.5 ECM production  
The goal of many tissue engineering approaches is to provide a framework for the assembly 
of natural ECM secreted by resident cells in vitro or in vivo. For example, biodegradable 
tissue engineering scaffolds are designed to provide initial structural support that is intended 
to be replaced by naturally produced ECM as the original scaffold materials degrade. Thus it 
is important that a well designed tissue engineering scaffold promotes ECM production from 
resident cells. Several studies have shown that nanofibrous architecture can elicit increased 
ECM production from resident cells and that deposited ECM may be more highly organized. 
Chondrocytes seeded on 700 nm nanofiber scaffolds produced more sulfated proteoglycan 
rich, cartilaginous matrix than those seeded on tissue culture plate [116] and chondrocytes 
grown on nanofiber (500–900 nm) meshes showed a nearly 2 fold increase in 
glycosaminoglycan (GAG) production at 28 days as compared to microfiber (15 µm) culture 
[117]. Cartilage ECM markers, such as collagen II and IV, aggrecan, and cartilage 
proteoglycan link protein were also greater in chondrocyte cultures grown on nanofibers than 
microfibers as confirmed by immunostaining [117].  
Fiber diameter and orientation can affect the ECM production of cells residing in 
nanofibrous scaffolds. Calcium production in osteoblasts from 7 to 21 days was significantly 
higher in cells cultured on 60 and 100 nm carbon fibers compared to cells cultured on 125 
and 200 nm fibers [135]. Lee et al. found that human ligament fibroblasts cultured on 650 nm 
nanofibers synthesized significantly more collagen on aligned fibers than on randomly 
oriented fibers as confirmed by collagen assay normalized by DNA content at 3 and 7 days 
[136].  
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In addition to stimulating increased ECM production, nanofibrous structure can also 
result in organized deposition of ECM products. Immunohistochemistry at 7 and 14 days 
revealed that rotator cuff fibroblasts deposited collagen matrix in an aligned orientation on 
aligned nanofiber scaffolds but not on randomly oriented scaffolds [137]. Baker et al. linked 
[138] an increase in scaffold strength after in vitro culture of mesenchymal stem cells 
(MSCs) and meniscal fibrochondrocytes on aligned fiber scaffolds to organized collagen 
arrangement independently of collagen production. Collagen produced by both cell types 
oriented parallel to aligned nanofibers, and despite similar overall collagen content, aligned 
fiber scaffolds showed a >7 MPa increase in modulus over 10 weeks in culture as compared 
to an ~1 MPa increase in modulus for randomly oriented fiber scaffolds.  
2.4.6. Differentiation  
Many tissue engineering strategies require the selective differentiation of stem or progenitor 
cells into a specific lineage. It is well established that various soluble cues can be applied to 
certain cell types to induce them to differentiate to a specific fate. There is also evidence that 
the physical environment can affect cell differentiation. Nanofibrous architecture can have 
strong effects on cell fate versus flat culture surfaces and fiber properties, such as diameter 
and arrangement can affect cell differentiation. The effect of nanofibers on cell differentiation 
can be quite strong, but varies for different cell types and conditions. Nanofibrous 
architecture has also been shown to promote, prevent, and have no effect on differentiation 
when compared to flat surfaces.  
Mouse embryonic fibroblasts cultured in self assembling peptide scaffolds were 
observed to undergo strong osteogenic differentiation after osteogenic induction while cells 
cultured on flat culture plate did not differentiate [139]. Furthermore, mouse embryonic stem 
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cells cultured in nanofibers without osteogenic induction expressed enhanced early stage 
markers of osteoblast differentiation compared to tissue plate culture [139]. Primary cardiac 
ventricular cells cultured on 2 µm diameter fiber scaffolds also shifted to a more mature 
phenotype than those grown on tissue culture plate [122]. In another study, differentiated 
chondrocyte phenotype was maintained on 700 nm nanofiber scaffolds for 21 days of culture 
while chondrocyte cells seeded on flat tissue culture plate de-differentiated [116]. In contrast 
MSCs cultured on 50-1000 nm nanofibers showed no differences in osteogenic phenotype 
markers compared to tissue culture plate after 12 days of osteogenic differentiation induction 
[140].  
Nanofibrous scaffolds have also been observed to prevent differentiation and allow 
for the proliferation and maintenance of a pluripotent niche, which is important in vitro stem 
cell expansion. Hematopoietic stem cells cultured in 529 nm polymer nanofiber meshes for 
10 days mediated a greater percentage of primitive progenitor cells when compared to the flat 
surface [129] and proliferation and self-renewal of pluripotent mouse embryonic stem cells 
were greatly enhanced in nanofibrillar meshes when compared to smooth culture surface 
[141]. While proliferation with self-renewal was allowed to continue in nanofiber 
topography, the cells were observed to maintain their ability to differentiate when exposed to 
differentiation factors [141]. In another study, a small fraction of mouse embryonic stem cells 
appeared to develop into small embryo body like colonies [139]. It was found that the 
frequency of these colonies was remarkably higher in self assembling peptide nanofiber 
cultures than in flat tissue plate culture.  
In addition to possessing the capability to support both stem cell differentiation and 
self renewal, nanofibrous topography can selectively influence differentiation based on fiber 
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diameter and alignment. Differentiation of neural stem cells cultured on aligned and random 
nanofiber meshes with fiber diameters of 300 and 1500 nm was observed to be highly 
dependent on fiber diameter [124]. The quantitative differentiation rates evaluated on the 
basis of shape change were approximately 80% and 40% for 300 and 1500 nm fibers 
respectively. Expression of ligament markers by bone marrow stromal cells was effected by 
both fiber diameter and alignment [142]. While expression of Col-1e1, decorin, and 
tenomodulin in cells cultured on 270 nm fibers was greater than on films, expression of all 
three markers was significantly repressed in cells cultured on 820 and 2300 nm fibers. In 
contrast, expression of the ligament marker Scleraxis increased with increasing fiber diameter 
and fiber alignment. Primary cardiac ventricular cells cultured on aligned fiber scaffolds also 
expressed more markers of a mature phenotype than those grown on randomly oriented fibers 
[122].  
2.4.7 Cell migration  
Cell migration is a critical process in determining the success of tissue regeneration. In 
many designs, tissue scaffolds are populated by cells due to cell migration, either from 
cells seeded on the scaffold surface in vitro or endogenous cell migration in vivo. Tissue 
engineering scaffolds designed with controlled conduction of cell migration are desirable, 
and nanofibrous architecture can have a significant effect on cell migration properties in 
vitro and in vivo.  
Traditional agarose droplet spreading experiment confirmed that nanofibrous 
surface topography can have an effect on the specific migration patterns of adult human 
dermal fibroblasts [118]. Migration and aggregation of hepotocyte cells appeared to be 
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restricted by nanofibrous architecture and this resulted in the formation of smaller more 
uniform aggregates as compared to flat films [127]. MSCs also had reduced migration 
distances on three different ranges of collagen nanofibers (50–200, 200–500, and 500–
1000 nm) that were quantified and found to be 37–56% of those observed on TCPS 
control [140].  
Endogenous cell migration in vivo was increased with the addition of nanofibrous 
architecture. A 3D peptide nanofiber mesh assembled in the in vivo myocardium was able 
to recruit endothelial progenitor cells, smooth muscle cells, and myocyte progentitor cells 
and promote vascularization and tissue regeneration. Implantation of matrigel without 
fibers as control resulted in few numbers of endothelial cells and no myocyte progenitors 
[7]. In this case nanofibrous structure may facilitate cell migration by providing structure 
in 3-dimensional space for them to move along and attach to.  
In addition to the structural roles of nanofibers, they may also elicit functional 
responses in cells to migratory and remodeling behaviors. Nanofibrous structure induced 
fibroblasts to increase production of collagenase that degrades the adhesive collagen 
between the scaffold surface and cell membrane, and this led to the hypothesis that the 
nanofibrous architecture may have been encouraging migratory or remodeling behavior in 
comparison to a smooth surface [128].  
2.4.8 Potential mechanisms of cell–nanostructure interactions  
It is clear that nanofibrous architecture has major effects on modulating a wide variety of 
cell behaviors. It is not surprising that nanofibrous architecture has such an effect on cell 
behavior when considering the differences in local environmental conditions experienced 
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by a cell in a nanofibrous substrate as compared to a flat culture surface. It is theorized 
that nutrient infiltration, surface molecule presentation, and cell shape many be 
mechanisms by which nanofibrous architecture modulate cell behavior. It is intuitive that 
cells in a 3D nanofibrous structure would be able to exchange nutrients and utilize 
receptors throughout their surface, while cells in flat culture conditions are limited to 
nutrient exchange on only one side. By limiting the useable surface area of cells, flat 
culture conditions may also limit their function.  
The surface molecule presentation of nanofibers may be another mechanism by 
which nanofibers modulate cell behavior. Interest in nanofibrous architecture in biology is 
many times credited to mimicking the fibers of the natural ECM, but the more general 
property that has fuelled the study of nanofibers is their extremely high surface area to 
volume ratio. It has been shown that this property results in higher protein absorption and 
more efficient presentation of biomolecules to cells in nanofibrous architectures and that 
this translates to modulation of cell behavior. Leong et al. [143] found that solid 
poly(D,L-lactide) fibers (850 nm) absorbed 16 times as much protein as films, and they 
fabricated porous nanofibers that absorbed 80% more protein than the solid fibers. Cell 
attachment on the three scaffolds increased in agreement with the observed increases in 
protein absorption. Baker et al. [144] found that polystyrene nanofiber scaffolds (200 nm) 
also absorbed 16 fold more serum than the equivalent flask area and hypothesized that 
stromal cell differentiation into smooth muscle cells was inhibited by non-specific serum 
protein absorption. Observed increases in myoblastic mouse cell attachment, proliferation 
and differentiation on fibrous pressed carbon nanotubes as compared to flat pressed 
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graphite were amplified by pre-culture incubation with 50% fetal bovine serum to 
increase the effect of surface protein absorption on cell behavior [145]. It has also been 
shown that biomolecules incorporated into nanofibers are much more efficient at 
modulating cell behavior than flat coated surfaces or soluble factors due to the high sur-
face area to volume ratio of nanofibers. Three dimensional and two dimensional self-
assembling peptide nanofiber meshes incorporating the IKVAV motif of laminin induced 
neural stem cell (NSC) differentiation into neurons at a rate of 35% after 1 day, as 
compared to 15% after 7 days on flat laminin coated substrates [15]. Neuronal differentia-
tion was not increased in non-bioactive fiber meshes with the addition of soluble IKVAV 
and it was hypothesized that improved differentiation rates were caused by an increased 
efficiency in the presentation of the motif to the cells, which was estimated to be 
amplified by 1000 times compared to flat laminin coated surfaces.  
Another pathway for modulation of cell behavior by nanofibrous architecture may 
be through cell shape. One proposed mechanism for the transduction of cell shape 
information into gene expression is by the transmission of mechanic forces directly from 
the actin cytoskeleton to the nucleus [146]. It has been shown that regulation of cell shape 
can influence the differentiation of multipotent human mesenchymal stem cells (hMSCs) 
into adiogenic or osteoblastic fate [147]. Human mesenchymal stem cells allowed to 
flatten and spread expressed osteoblastic markers, such as alkaline phosphatase, while 
constrained cells that remained unspread and rounded expressed adiogenic lipid 
production. While cytoskeletal organization is related to cell shape, the cytoskeleton can 
influence gene expression independently of cell shape. The inhibition of myosin-
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generated cytoskeletal tension in hMSCs caused decreased alkaline phosphatase activity 
and increased lipid production without changing cell shape [147]. In a similar study, 
Spiegelman and Ginty [148] found that differentiation of an adipogenic cell line could be 
inhibited when it was allowed to attach and spread on fibronectin coated surfaces and that 
the inhibitory effect on cell differentiation could be reversed by keeping the cells rounded 
and by chemically disrupting the actin cytoskeleton.  
Nuclear shape has also been measured directly and correlated to gene expression 
and protein synthesis [149,150]. Intermediate values of nuclear distention promoted max-
imum collagen I synthesis in primary osteogenic cells [149]. Two to nine fold increases 
in gene expression above baseline accompanied significant rounding of nuclei in 
mesenchymal stem cells [150].  
Nanofibrous architecture is able to influence a variety of cell behaviors through a 
variety of mechanisms, therefore smart design of nanofibrous components in tissue 
engineering scaffolds can allow for increased control over resident cell behavior and thus 
improved overall function. It is however important to consider that the effect of 
nanofibers on cell behavior varies widely with specific cell types, fiber type and 
environmental conditions. For example, osteoprogenitor cells cultured on electrospun 
polymer fiber meshes exhibited a lower cell density than those on smooth surfaces in the 
absence of osteogenic factors, but when osteogenic factors were added the cell density of 
fiber surfaces was equal to or greater than that on smooth surfaces [115].  
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2.5 Tissue engineering applications of polymer nanofiber scaffolds  
Many different applications for nanofibers in tissue engineering have been explored. 
Because polymer nanofibers can provide three-dimensional architecture, modulate cell 
behavior, and have the potential to deliver biomolecules, they are a good candidate for a 
wide variety of tissue engineering applications. Some of the other properties of polymer 
nanofiber scaffolds lead them to be well suited for more specific applications. For 
example, nanofibers may offer good mechanical properties for load bearing applications, 
directional alignment to tissues with aligned structures, and nanofiber meshes with fine 
pores act as membranes that allow transport of nutrients and waste, but limit cellular 
infiltration. Table 2.2 organizes several references to experiments where polymer 
nanofibers have been used as scaffolds for specific tissue regeneration applications. Each 
of these experiments is related to a specific tissue or application based on (1) The 
incorporation of tissue specific biomolecues (2) eliciting a desirable response from tissue 
specific cells in vitro (3) sharing a similar microstucture or mechanical properties to a 
natural tissue and (4) in vivo applications.  The mechanical integrity of polymer 
nanofibers has lead to a vast amount of research for bone tissue engineering scaffolds. 
Many of these studies concentrated on the functionalization of nanofibers with bone 
specific biomolecules such as hydroxyapatite. It has been demonstrated that nanofibrous 
scaffolds can support osteogenic differentiation in vitro and promote in vivo bone growth 
into nanofibrous scaffolds in subcutaneous and bone defect models. The mechanical 
properties of nanofibrous structures also make them an attractive scaffold for use in 
cartilage tissue engineering where chondrocytic function and differentiation has been 
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demonstrated in nanofibrous scaffolds. Polymer nanofibers are a suitable material choice 
for vascular grafts because of their tensile strength and directional guidance properties. 
Polymer nanofiber vascular grafts have been tested in vitro under static and pulsatile 
conditions and in vivo. In skeletal muscle, tendon, and ligament tissue engineering, the 
tensile strength and directional alignment of polymer nanofibers are also attractive 
properties. Nerve tissue engineering benefits from the directional guidance offered by 
aligned nanofibers as well. Polymer nanofiber scaffolds can improve the viability, 
growth, alignment, and differentiation of neural cells in vitro and they have been applied 
to injuries in the peripheral and central nervous system to promote regeneration in vivo. 
Many in vivo studies have been conducted using nanofiber scaffolds in wound healing 
applications, including clinical trials [151]. Nanofiber scaffolds can provide structure for 
the ingrowth of cells around a wound site and provide a barrier to outside infection.  
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Table 2.2:   Nanofibrous scaffolds for tissue engineering applications.
 
2.6 Cell incorporation into nanofibrous electrospun scaffolds  
The success of a tissue engineering scaffold is determined by its ability to incorporate 
desired cell types and to promote the desired functionality of the incorporated cells. 
Despite great promise and widespread investigation there have been few clinically 
relevant successes for nanofibers as tissue engineering scaffolds. One of the main reasons 
for this limited success is the difficulty of incorporating cells into electrospun nanofibrous 
scaffolds. Electrospinning is the most versatile and widely studied method of nanofibrous 
scaffold fabrication, but it still remains a major challenge to fabricate electrospun 
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scaffolds with antiquate cell incorporation or permeability. Cells can be easily incor-
porated into self assembling peptide nanofiber scaffolds, which is one of the major 
reasons for the success of this technique. There are however some major limitations to 
the self assembling peptide method such as, complex procedures, and limited control over 
fiber material, size, and arrangement. In contrast, the electrospinning technique is a very 
simple and versatile process that allows the fabrication of nanofibers from many types of 
materials and offers control over fiber size and arrangement. A feasible and practical 
method of quickly advancing the field of nanofibrous tissue engineering scaffolds is 
through the development of better methods to incorporate cells into electrospun scaffolds. 
Several creative approaches have been explored to address this major challenge in 
polymer nanofiber scaffold fabrication. Cell incorporation into nanofibrous scaffolds may 
be achieved in two ways: (1) Cell incorporation inside of the scaffold during fabrication 
(2) Migration of cells into the scaffold in vitro or by host tissue cells after in vivo 
implantation. Some of the strategies for improving cell incorporation into electrospun 
nanofiber scaffolds include cell incorporation during fabrication, physically assisted 
seeding methods and the design of cell permeable scaffolds using composite techniques, 
layer by layer assembly, and incorporation of sacrificial materials.  
2.6.1 Cell incorporation during fabrication  
Several techniques for direct incorporation of cells into electrospun nanofiber scaffolds 
have been developed. Cell nanofiber constructs were fabricated by directly pipetting cell 
suspension into an electrospun nanofiber scaffold during collection. Nanofibers were 
electrospun onto a charged ring on the surface of culture media and intermittent pipetting 
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of cells during the fabrication process resulted in nanofibrous constructs with uniform cell 
incorporation [101]. No significant toxicity was caused by residual solvent left on the 
electrospun nanofibers. A similar approach incorporated cells into an electrospun 
nanofiber scaffold by electrospraying a cell containing solution onto a grounded target 
while nanofibers were simultaneously electrospun onto the same target [209]. Cells 
integrated into the nanofiber constructs and no significant decrease in cell viability from 
the fabrication process was apparent. Fibroblast and adipose-derived adult stem cells 
were directly added into an aqueous PVA solution and electrospun to form nanofibers 
that encapsulated the cells [210]. Fibroblasts incorporated into PVA nanofibers retained 
viability, proliferation, and function.  
2.6.2 Cell population by migration  
When cells are not directly incorporated into a nanofiber scaffold, the scaffold may be 
populated by cells that migrate into the interior of the scaffold from the outer surface. The 
extent of cell migration into nanofiber scaffolds can be affected by both the architecture 
of the scaffolds and the biological or chemical cues incorporated into the scaffold.  
2.6.2.1 Perfusion  
Cells infiltration into nanofibrous scaffolds can be enhanced by physical forces, such 
vacuum, flow perfusion, or centrifuge [172,211]. These types of techniques can be 
utilized to increase the speed at which cells infiltrate nanofibrous scaffolds during in vitro 
seeding. Flow perfusion speeds up cell infiltration by moving cells with hydrodynamic 
forces and increases nutrient transport improving cell viability deeper inside the scaffolds 
[211].  
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2.6.2.2 Scaffold permeability  
In order for cell migration into a nanofibrous scaffold to occur there must be adequate 
void space for cells to occupy and move around. In the case of randomly aligned electro-
spun mats, pore size is generally related to fiber diameter, where scaffolds fabricated 
from larger fibers have larger pores and thus greater permeability to cell infiltration [212]. 
Pham et al. [211] fabricated electrospun microfiber scaffolds with fiber diameters ranging 
from 2 to 10 µm. The pore size of these scaffolds increased with increasing fiber diameter 
from a value of around 10 µm for 2 µm diameter fibers, to around 40 µm for 10 µm 
diameter fibers. In contrast, overall porosity ranged from around 85–89% with the 
greatest porosity in smaller diameter fiber scaffolds. Cell infiltration into 5 µm diameter 
nanofiber scaffolds was severely limited by the inclusion of a thin layer of electrospun 
600 nm fiber on its surface under both static and flow perfusion culture conditions [211]. 
Migration of human venous myofibroblasts into nanofiber scaffolds with diameters 
ranging from 3.4 to 12.1 µm increased with fiber diameter during 3 days of culture [213]. 
Even the relatively large 3.4 µm diameter fiber significantly impeded cell migration when 
compared to the 12.1 µm fiber scaffolds. Optimal pore size may be dependent on the 
specific cell type or application, but the minimum pore size necessary for infiltration must 
not be significantly smaller than that of the migrating cells. Small diameter nanofibers can 
be desirable because of the effects that fiber diameter has on cell behaviors as discussed 
in section 2.4, but pore size requirements limit the use of small diameter nanofibers in 
tissue engineering scaffolds. The tradeoff between scaffold porosity and fiber diameter in 
electrospun scaffolds is a limiting factor of this technology in tissue engineering.  
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2.6.2.3 Strategies to increase cell permeability  
Several strategies have been developed to fabricate nanofiber scaffolds that combine both 
small diameter nanofibers and adequate permeability for cell infiltration. Several groups 
have fabricated composite fiber scaffolds that combine microfibers for large pore size and 
structural stability and nanofibers for improved cell interactions and increased area for 
attachment. A starch based scaffold made by fiber bonding with 160 µm microfibers was 
electrospun with 400 nm nanofibers that allowed endothelial cells to span the spaces 
between microfibers, migrate, and organize into capillary-like structures while maintain-
ing structural integrity and a porosity of 70% [214,215]. A composite scaffold made from 
direct polymer melt deposition of microfibers that included electrospun PCL/collagen 
nanofibers showed improved cell adhesion and proliferation [216]. Multilayered 
micro/nanofiber structures have also been fabricated by modifying electrospinning 
conditions to include layers of 5 µm and 600 nm fibers [211]. Nanofibers with diameters 
of 400–500 nm were even directly electrospun onto 30 µm microfibers, which were 
subsequently formed into a highly porous scaffold containing nanofibers [217].  
Another method to produce nanofiber scaffolds with improved cell infiltration 
properties is by addition of large pores within a nanofibrous structure. One hundred 
micron holes etched into 500 nm fiber scaffolds by UV lithography allowed the migration 
of smooth muscle cells into the scaffolds [218]. Porogen leaching has also been used as a 
method of fabricating structures with large interconnected pores within a nanofibrous 
network. Silk fibroin electrospun nanofiber scaffolds were soaked in a salt containing 
solution and lyophilized to create a porous structure. This process formed 600–900 µm 
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pores in a scaffolds with fiber diameters of 400 nm, in contrast to an initial pore size of 
1–2 µm [219]. Salt particles have also been incorporated into nanofiber meshes by 
mechanical addition of solid salt particles directly to an electrospun jet during fabrication 
[164]. Salt particles were deposited in intervals during electrospinning to form a layered 
structure containing regions of salt particles. Cell infiltration of depths up to 4 mm was 
reported in these scaffolds after 3 weeks of in vitro culture.  
Similar techniques have utilized other types of sacrificial materials to create an 
evenly distributed enhanced porous structure within electrospun nanofibrous scaffolds. 
Ice crystals were introduced to nanofiber scaffolds during fabrication by cooling a 
collecting mandrel to –30 
◦
C while electrospinning at room temperature [220]. Ice 
crystals simultaneously deposited on the mandrel during electrospinning and were 
distributed throughout the mesh. Freeze drying resulted in a nanofiber mesh with pores 
around 100 times larger than in control meshes and pore size changed with the level of 
humidity. Larger pore size resulted in nanofiber meshes that allowed cell penetration up 
to 50 µm, while control meshes allowed only surface cell growth. A similar technique 
involves simultaneously electrospinning water soluble sacrificial fibers into a nanofibrous 
scaffolds to create void space after sacrificial fiber dissolution. In randomly oriented PCL 
nanofiber (diameter ~1 µm) scaffolds, the depth of cell penetration after 7 days was 
increased from 48 to 114 µm with the addition of soluble gelatin nanofibers (diameter 
~1µm) [7]. Cell penetration into PCL scaffolds containing water soluble PEO fibers 
increased with increasing percentage of PEO fibers [144]. In contrast, it has also been 
reported that nanofiber meshes with sacrificial PEO and gelatin fibers offered very limited 
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improvement versus control meshes in an infiltration experiment due to the collapse of 
the structure after sacrificial fiber leaching [221].  
Cell permeable materials can be added as a filler material within a nanofibrous 
scaffold to add space for cell penetration. Ekaputra et al. fabricated a hybrid fibrous 
PCL/Col mesh with regions of hydrogel matrix by simultaneously electrospinning 
nanofibers and electrospraying hydrogel onto a collection mandrel [221]. The depth of 
cell infiltration into nanofiber meshes containing electrosprayed hydrogel was increased 
from around 60 to 225 µm when compared to control after 10 days of culture. Composite 
films containing a protein matrix and nanofibers were fabricated by adding fixed 
nanofiber arrays to an aqueous gelatin solution [12]. After gelatination, the gelatin matrix 
provided structural support to fragile aligned nanofiber arrays with significant void space 
between individual fibers.  
Porous 3D nanofibrous networks have been fabricated by suspending electrospun 
nanofibers in liquids. A unique method of dispersing hydrophobic nanofibers in aqueous 
solutions was developed that utilized the attachment of lipase onto the surface of 
electrospun polystyrene nanofibers [222]. Alcohol pretreatment of the surface modified 
fibers caused the tightly aggregated nanofibers to be dispersed into a loosely entangled 
structure with greatly increased volume, and this dispersed geometry remained when the 
fibers were immersed DI water as long as the fibers remained hydrated throughout the 
washing step. Silk fibroin nanofibers collected directly in a methanol bath formed a three 
dimensional structure that was retained after hydration and freeze drying [223]. Cells 
were able to penetrate into the porous structure of these scaffolds, while control scaffolds 
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collected on a rotating mandrel did not allow cell penetration. Three dimensional 
networks of PCL nanofiber yarns were fabricated as suspensions in water by 
electrospinning into a novel dynamic flow collecting system [224]. These nanofiber yarn 
networks also retained their porous microstructure after freeze drying. It is hypothesized 
that these loosely dispersed nanofibers would allow improved cell penetration.  
2.6.2.4 Layer by layer assembly of pre-seeded nanofiber sheets  
Three-dimensional nanofibrous constructs with uniform cell distributions have been 
fabricated with layer-by-layer stacking of thin cell containing nanofibrous sheets. A 
cylinder with an 8 mm diameter and a height of 3 mm was constructed by stacking thirty 
100 µm thick cell seeded nanofiber disks, and nourished with a perfusion bioreactor 
[225]. Thin sheets of nanofibers with a thickness of 10 µm were collected on a wire ring 
with a diameter of about 15 mm and seeded with cardiomyocytes [226]. Individual layers 
adhered immediately when these thin cell-nanofiber sheets were stacked, and constructs 
of up to 5 layers were formed without incidence of core ischemia. Multilayer cell-
nanofiber structures have also been formed by stacking additional layers of cell 
containing fiber sheets every few days during cell culture [184].  
2.7 Concluding remarks  
Many damaged or degenerated tissues cannot be treated by conventional methods. Tissue 
engineering presents a promising alternative to regenerate damaged and degenerated 
tissues by guiding the formation of new healthy tissue. An ideal matrix for promoting the 
formation of such tissue requires a supporting structure for cell attachment within three 
dimensions as well as adequate void space for cell infiltration and vascularization. 
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Polymer nanofibers are an ideal material for assembling structures that address both of 
these requirements. In addition polymer nanofibers posses many other advantages as 
tissue engineering scaffolds, such as versatility for biofunctionalization, and the 
promotion of specific desired cell behaviors that are elicited by the nanofibrous 
architecture. Despite a variety of techniques employed to fabricate polymer nanofibers 
and to assemble them into structures, no optimal method has emerged that combines the 
potential advantages of polymer nanofibers and a truly 3-dimensional structure. The 
future clinical success of polymer nanofiber tissue engineering scaffolds will depend on 
whether new techniques are developed that allow for the fabrication of polymer nanofiber 
scaffolds with control over structural arrangement, material composition, and 
biofunctionalization, while maintaining reasonable cost and yield.  
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CHAPTER 3  
3.  EFFECTS OF ELECTROSPINNING PARAMETERS ON THE NANOFIBER 
DIAMETER AND LENGTH 
3.1 Introduction 
The fabrication of polymer nanofibers by electrospinning has received much attention in 
recent years. Polymer nanofibers exhibit several properties that make them favorable for 
many applications. Nanofibers have a very large surface area to volume ratio, flexibility in 
surface functionalities, and mechanical properties superior to larger fibers [1–3]. Some 
potential applications for nanofibers include: tissue engineering scaffolds, filtration devices, 
sensors, materials development, and electronic applications [2–13].  
In a typical electrospinning process, fibers are drawn from a solution or melt through 
a blunt needle by electrostatic forces. Electrospun nanofibers are most commonly collected as 
randomly oriented or parallel-aligned mats. Randomly oriented fiber mats result when a 
simple static collecting surface is used, and parallel-aligned mats have been collected by 
several methods [1]. Parallel aligned fiber mats are most commonly collected with a rotating 
mandrel used as the collecting device. Nanofibers can also be collected across an air gap 
between two parallel plates in a linear orientation [14]. The electric field produced between 
two parallel plates causes fibers to align perpendicular to the plates and stretch across them. 
Because individual nanofibers can be collected by this method, it expands the potential 
applications of electrospinning. Once collected these fibers may be further processed to form 
structures suitable for specific applications. When exploring the types of structures that could 
potentially be developed, it may be of importance to have some idea of the maximum length 
of polymer fibers that is achievable by the parallel plate technique. Li et al. collected poly 
(vinal pyrrolidone) nanofibers across two conductive silicone strips up to several centimeters 
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in length and Teo and Ramakrishna collected PCL nanofibers across two thin steel blades at 
lengths up to 10 cm [14,15].  
We theorized that longer fibers could be collected with a larger collecting device and 
that the maximum fiber length collected with this device would be affected by the 
electrospinning parameters. The characteristics of electrospun fibers are determined by many 
different parameters such as solution composition, polymer solution feed rate, applied 
voltage, and drop height. The maximum length of fibers that can be collected by the parallel 
plate method should be affected by these parameters and by the geometry and material 
characteristics of the collecting device. Optimization of these parameters could lead to the 
production of longer continuous fibers of a desired length and diameter. In this study the 
effect of these parameters on length and diameter is measured in order to gain an 
understanding of the factors that influence fiber diameter, uniformity, and maximum fiber 
length.  
3.2 Materials and methods  
Fibers were electrospun from polymer solutions containing 8, 11, 14, 17, and 20% w/v PCL 
(Mn 80,000, Sigma) and 0.06% w/v NaCl. Solution shear viscosities were approximately 
0.12, 0.22, 0.45, 0.56, and 0.82 Pa respectively as measured with a TA Instruments AR100 
rheometer. A 7:3 mixture of dichloromethane (DCM, Alfa Aesar) and methanol (Fisher 
Scientific) respectively was used as the solvent. To prepare polymer solutions, 6 mg of NaCl 
was dissolved in 3 ml of methanol and the resulting solution was added to 7 ml of DCM. The 
desired amount of PCL was then added to obtain the appropriate concentrations. A second 
14% PCL solution was mixed without the addition of NaCl. The PCL solutions were 
transferred to 5 ml syringes and connected to a 30, 23, or 21 gauge blunt tipped needle with 
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polyethylene tubing. The needle tip was connected to a high voltage power source (Gamma 
High Voltage ES40P-10W) operating at 10, 15 or 20 kV, and polymer solution was feed into 
the needle at a rate of 0.010, 0.017, or 0.025 ml/min by a syringe pump (Medex inc. 
Medfusion 2010i). Two identical grounded aluminum plates were used as the collecting 
device. Three different sizes of plates were used. Dimensions were 30.5×7.5×0.7, 15×4×0.35, 
and 7.5×2×0.15 cm for large, medium, and small plates respectively. The plates were placed 
flat with an orientation that made their heights 7.5, 4, or 2 cm and arranged to be parallel 
along the longest dimension with a gap between them. The electrospinning setup is shown in 
Figure 3.1.  
 
Figure  3.1:   Experimental setup for electrospinning across two parallel plates. 
 
The air gap between the two plates was set at a distance estimated to be close to the 
maximum fiber length and the needle tip was kept at a height equal to the distance between 
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the parallel plates. The gap between the plates and the drop height of the needle tip were 
adjusted in 2.5 cm increments to determine the maximum distance at which polymer fibers 
could be collected across the parallel plates. It has been previously shown that fiber collection 
rate decreases with increasing gap distance and constrains the maximum length at which 
fibers can be collected [15], therefore extending the length between the plates in increments 
allows an estimate of the maximum fiber length. Criteria used in making this determination 
were: (1) Polymer fibers stretched across the gap with each end attached to one of the parallel 
plates (2) Polymer fibers could be collected at an estimated amount of at least 50 fibers during 
a 2 min period (3) Polymer fiber collection at that distance was repeatable at least twice 
consecutively.  
In group one, polymer concentration was varied with plate size set at 30.5×7.5×0.7 
cm and NaCl concentration set at 0.06%. In group two, plate size was varied with polymer 
concentration set at 14% and NaCl concentration set at 0.06%. In group three, NaCl 
concentration was varied with polymer concentration set at 14% and plate size set at 
30.5×7.5×0.7. Data was collected for all values in each group for all possible combinations of 
10, 15, and 20 kV and 0.010, 0.017, and 0.025 ml/min.  
Polymer fibers deposited across the parallel plates were adhered to an electron 
microscope stub moved through the air gap perpendicular to the fibers. Fibers contacting the 
stub stuck to its surface and were pulled off of the parallel plates. The samples were sputter 
coated with gold at a thickness of 50–70 nm using a Cressington 108 AUTO sputtercoater 
with a current of 30 mA for 2 min. Images of the samples were taken at 10,000 times 
magnification using a scanning election microscope (SEM, Hitachi TM-1000). The diameters 
of individual fibers were measured using Image-Pro Plus 4.0 and averaged for each group 
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using 17 to 40 measurements per group. Standard deviation % was calculated as the standard 
deviation of measured fiber diameters for one set of parameters divided by the average fiber 
diameter for that set of parameter. For this experiment, standard deviation % was used as a 
measure of the uniformity of the collected fibers. The presence of beaded fibers was 
quantified by measuring the ratio of the maximum to minimum diameter along the length of 
randomly selected fiber segments from 10,000 X SEM images. At least 65 fiber segments 
were averaged for 14% PCL solutions with and without NaCl added.  
The effects of five different parameters were investigated: PCL %, plate size, NaCl 
concentration, voltage, and feed rate. The effects of polymer concentration, plate size, and 
NaCl concentration were analyzed within their groups and the effects of voltage and feed rate 
were analyzed using all of the data points. The Kruskal–Wallis test was used to determine 
whether the properties of maximum fiber length, resultant fiber diameter, or uniformity 
(standard deviation %) were affected by polymer concentration, plate size, NaCl 
concentration, voltage, or feed rate. The Holm's test was used to further investigate the 
relationships within the groups that had differences of Kruskal–Wallis significance.  
Because of the instabilities in the jet, there was a random factor associated with 
fiber collection. The rate of fiber collection and the repeatability of fiber collection for a 
specific electrospinning setup were associated with the probability that fibers were being 
ejected in a direction that allowed them to collect in the desired location. The maximum fiber 
length was determined from the distance when the probability of fiber collection across the 
gap was too low to easily collect samples for analysis based of repeatability (two times 
consecutively) and rate of collection (estimated minimum of 50 fibers in a 2 min period). A 
P-value of <0.01 was selected to determine significance because of the variability involved 
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with random fluctuations in the electrospinning jet, and because of the error associated with 
human observation.  
3.3 Results  
Continuous fibers were successfully collected across the parallel aluminum plates for most 
groups. PCL nanofibers with an average diameter of less than 500 nm were collected at 
lengths up to 42.5 cm, and PCL nanofibers with an average diameter of less than 1 µm were 
collected at lengths up to 50 cm. Collected fibers tended to be oriented perpendicular or near 
perpendicular to the plates. Fibers were also observed to collect on nearby structures that 
were not part of the collecting device.  
Fibers were successfully collected across the parallel plates for all parameter 
combinations except for at 8% PCL, 0.025 ml/min, and 20 kV; 20% PCL, 10 ml/min, and 15 
kV; and all three flow rates in combination with 20% PCL and 20 kV. It appeared from 
observation that collection was impeded in the 8% PCL, 0.025 ml/min, and 20 kV group 
because of rapid deposition of unoriented fibers that collided with and broke the fibers 
collecting across the parallel plates. In the other four groups that failed to collect, fiber 
formation appeared to be impeded by solution properties.  
Fiber collection is limited by a number of different factors. In some cases fibers 
extending across the plates were pulled down off the collecting plates. It was hypothesized 
that this was due to the electrostatic attraction to the surrounding objects because of the high 
acceleration observed. In several cases fiber collection proceeded from the bottom up, as 
electrostatic repulsion from other fibers were able to hold up new fibers on top. Fibers were 
also observed to fall off the plates because of collisions with other fibers. At some distances 
fibers were not observed stretching across the plates at all. Data points from the variable 
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polymer concentration and plate size groups are plotted in Figure 3.2. Voltage for each data 
point can be obtained from the legend, but differences in feed rate are not represented.  
 
Figure 3.2:  Fiber length, diameter, and uniformity versus polymer concentration and plate size. 
3.3.1 Feed rate  
Feed rate was not found to have a significant effect on maximum fiber length, diameter or 
uniformity over all parameter variations. Once the feed rate is sufficient for forming fibers, 
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higher feed rate only provides more polymer solution than needed, since it was observed that 
the amount of excess polymer solution formed at the needle tip increased with increasing 
feed rate (Table 3.1).  
3.3.2 Polymer concentration  
Maximum fiber length and fiber diameter increased with increasing polymer concentration at 
significant levels with plate size (30.5×7.5×0.7 cm) and NaCl concentration (0.06%) fixed 
and variable voltage and feed rate. Significant variation between 8% and 17%, 11% and 17%, 
and 11% and 20% PCL concentration groups for fiber length was identified by Holm's test. 
Holm's test also identified significant variation between 11% and 14%, 11% and 17%, and 
11% and 20% PCL concentration groups for fiber diameter. Uniformity was observed to 
decrease with increasing polymer concentration, but not at the required level of significance. 
Fiber formation was sometimes impeded by the high viscosity of the solution at very high 
polymer concentration (20%) (Table 3.1).  
3.3.3 Voltage 
Fiber length and diameter decreased with increasing voltage over all data points, but only 
fiber diameter decreased at the desired level of significance. Uniformity of the fibers formed 
increased with increasing voltage at significant levels. Subsequent analysis of individual 
groups by Holm's test resulted in significant differences between the 10 kV and 15 kV and 10 
kV and 20 kV groups for both fiber diameter and fiber uniformity (Table 3.1). 
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3.3.4 NaCl 
Addition of salts to the polymer solution increases the conductivity of the solution and the 
surface charge density of the solution jet. Previously, addition of salts to polymer solutions 
reduced bead defects and decreased fiber diameter when a rotating drum was used as the 
collecting device [16]. Removal of NaCl from the polymer solution in this experiment did not 
result in any significant differences in maximum fiber length, diameter, or uniformity for the 
two NaCl concentration groups with polymer concentration (14%) and plate size fixed 
(30.5×7.5×0.7). There was however some observed decrease in fiber diameter with 
increasing NaCl concentration and fibers with beads were observed only when NaCl was not 
present in the polymer solution. The presence of beaded fibers due to lack of NaCl was 
quantified by the ratio of the maximum to minimum diameter of fiber segments in 10,000 
times SEM images. The mean diameter ratio for fibers spun with and without NaCl added 
was 1.16 and 1.66 respectively (p<0.01). Beaded fibers electrospun from 14% PCL 
solution with no NaCl added are compared to fibers electrospun with 0.06% NaCl in solution 
in Figure 3.3 (Table 3.1). 
 
Figure 3.3:  Fibers electrospun from 14% PCL solution feed at 10 ml/min and 10 kV applied voltage 
with (A) and without 0.06% w/v NaCl (B). 
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3.3.5 Plate size 
A significant increase was observed for maximum fiber length and fiber diameter for 
variations in plate size with PCL concentration (14%) and NaCl content (0.06%) fixed. 
Analysis of individual groups by Holm's test resulted in significant differences in the small 
and large, and medium and large plates for fiber length and the medium and large plates for 
fiber diameter (Table 3.1). 
Table 3.1:  Effect of electrospinning parameters on length, diameter, and uniformity of the resultant 
fibers 
 
3.3.6 Diameter 
Maximum fiber length was compared to fiber diameter (Figure 3.4) to determine if fiber 
diameter had a limiting relationship on maximum fiber length. There appeared to be some 
correlation between maximum fiber length and fiber diameter, but this correlation was 
determined weak by observation. 
Feed rate comparison Kruskal P‐Value PCL % Comparison Kruskal P‐Value
Length 0.9 Length 0.00005
Diameter 0.6 Diameter 0.00002
Standard Dev 0.7 Standard Dev 0.03
NaCl concentration Kruskal P‐Value Voltage Kruskal P‐Value
Length 0.8 Length 0.01
Diameter 0.1 Diameter 0.003
Standard Dev 0.8 Standard Dev 0.00008
Plate size Kruskal P‐Value
Length 0.00007
Diameter 0.003
Standard Dev 0.743
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Figure 3.4:  Fiber diameter versus maximum fiber length. 
3.4 Discussion  
The data would suggest that of the variables investigated, polymer concentration, applied 
voltage, and plate size had significant effects on the characteristics of fibers collected by the 
parallel plate method. The most interesting aspect of this experiment is the question of what 
the maximum length of PCL nanofibers is under optimum experimental conditions. In 
analyzing this question it is important to consider whether the limiting factor for maximum 
fiber length is the formation of continuous correctly oriented fibers or the adhesion of those 
fibers to the plates without fracture. It has previously been reported that under certain 
conditions fibers extended across two parallel plates, but broke under their own weight [14].  
The data suggests that the electrical properties of the jet and the electric field have an 
effect on both fiber length and fiber diameter as indicated by the observed effect of polymer 
concentration and applied voltage on maximum fiber length. The forces acting on the fibers 
after contact with the plate are: adhesion to the plates, the weight of the fiber, electrostatic 
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attraction to the plates, electrostatic attraction to the ground, electrostatic repulsion from 
other collected fibers, and collisions with other fibers. A diagram of these forces is illustrated 
in Figure 3.5.  
 
Figure 3.5:  Forces acting on a single nanofiber electrospun across two parallel plates. 
 
Fiber diameter is a variable that reflects all of the forces acting on the fiber after 
contacting the plate, therefore if plate adherence or fiber strength were major factors in 
limiting maximum fiber length then it could be expected that fiber diameter would be 
strongly related to fiber length. 
 The data shows some trend of increasing maximum fiber length with increasing fiber 
diameter, but the wide range of diameters for each fiber length suggests a weak correlation of 
maximum fiber length and fiber diameter. This would tend to discount the theory that plate 
adhesion or fiber strength has a strong limiting effect on the maximum fiber length for PCL, a 
relatively elastic material, across two parallel plates at the distances investigated.  
The data suggests that it would be possible to extend the maximum length by 
increasing the polymer solution concentration or increasing the size of the plates. Polymer 
solution concentration can only be increased to a certain extent before the viscosity impedes 
jet formation, but the plate size can be increased without limit to any reasonable size. It is 
hypothesized that increasing the plate size can increase maximum fiber length to an 
undetermined value when using the parallel plate method, and it may be of future interest to 
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determine how long electrospun nanofibers can be made by this method under optimum 
conditions. Nanofibers are a very promising material, but the fabrication of the long 
continuous individual nanofibers that are required for many applications remains a challenge. 
Fabrication of increasingly longer nanofibers collected by the parallel plate method using 
increasingly larger plates will expand the potential uses of electrospinning fabrication to 
applications that require longer continuous nanofibers. 
3.5 Conclusions  
This experiment showed that continuous individual PCL nanofibers with diameters in the 
range of approximately 350 nm to 1 µm could be collected at lengths of 35 to 50 cm, and that 
polymer concentration, voltage, and plate size had significant effects on maximum fiber 
length, fiber diameter, and fiber uniformity. Fibers of this length could potentially be used as 
single fibers or further assembled into structures for many applications. For practical 
applications it will be desirable to obtain high quality fibers of a desired length and diameter, 
with a high degree of uniformity in diameter. It has been shown that all of these parameters 
can be controlled by changing the electrospinning conditions. It may be of interest to produce 
relatively long nanofibers for certain applications and it was shown that fiber length could be 
increased by increasing the PCL concentration in solution and the plate size. Because plate 
size can be increased without disrupting the electrospinning process, it is hypothesized that 
plates larger than those used in this experiment could be used to collect significantly longer 
PCL fibers up to an unknown maximum length. Parallel plate electrospinning could be used 
to create devices suitable for many different applications and by understanding how to create 
longer continuous fibers with controlled properties we can expand the versatility of this 
technique.  
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CHAPTER 4  
4.  FABRICATION OF LOOSE NANOFIBER ARRAYS FROM AN 
ELECTROSPINNING JET 
4.1 Introduction 
The fabrication of nanofibers using the electrospinning technique has generated a great 
amount of attention and research in recent years. Nanofibers have favorable geometric 
properties and superior mechanical properties when compared to larger fibers [1-2]. The 
surface area to volume ratio of a 500 nm diameter fiber is 8 million m2/m3 and 1000 times 
higher than that of a 500 um diameter fiber. The percentage of functional groups exposed on 
the surface of a polymer nanofiber is approximately three orders of magnitude greater than 
the percentage of functional groups on the surface of a microfiber [3].  A high percentage of 
surface area may result in improved cell-substrate interactions such as attachment, 
proliferation, and differentiation [4-7], increased sensor sensitivity [8], and improved filter 
efficiency. The potential of nanofibers in strong lightweight composites and fabrics is 
highlighted by experimental mechanical testing that shows that the Young’s modulus of 
polymer fibers can be increased up to three times by reducing the diameter of the fibers [2].  
Polymer nanofibers can be easily fabricated by electrospinning. Typically a polymer 
solution or melt is feed through a blunt needle tip that is connected to a high voltage power 
source. A thin liquid jet is ejected from the needle tip toward a grounded target as 
electrostatic forces overcome the surface tension forces in the needle.  The jet thins and dries 
or cools as it travels toward the grounded target resulting in small diameter solid fibers.  
Electrospinning is a simple low cost method of producing polymer nanofibers. It is also a 
favorable technique for constructing biological scaffolds because drugs and biomolecules can 
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be incorporated into electrospun fibers for sustained release, while maintaining their 
functionality [9-11].   
However, current technologies for fabricating structures from electrospun nanofibers 
are limited.  Electrospun nanofibers have been fabricated using several methods of collection, 
such as flat surfaces, rotating mandrels, and parallel plates [2, 12-13].  Randomly oriented 
meshes collected on flat surfaces have been used to fabricate tissue engineering scaffolds and 
filtration devices, but their application is limited because only a random orientation is 
possible with this technique and because pore size is dependent on the fiber diameter [14].  
Linearly aligned nanofiber scaffolds can be collected on a rotating mandrel, but only tubular 
structures, or segments cut from them, with a dense aligned or randomly oriented mesh are 
collected by this method. One major challenge with nanofiber fabrication is that nanofibers 
generated using electrospinning are not completely dry once they reach the collecting 
substrate.  Due to the fact that nanofibers are formed from polymer solutions or polymer 
melts and that nanofibers are formed at relatively high speeds, there is not enough time to dry 
the fibers before they contact with each other. Therefore, all of the nanofibers are prone to 
stick to one another and form dense mats. This dense mat structure can cause a lot of 
problems in real life applications. For example, in tissue engineering applications, cells may 
only grow on the surface of the dense mat and be unable to penetrate inside the nanofiber 
scaffolds, which greatly limits the tissue formation process. Another challenge in nanofiber 
fabrication is the difficulties in the fabrication of ordered structures and a lack of continuous 
steady state fiber fabrication techniques for industrial scale up. In current electrospun 
nanofiber fabrication, the collection rates are not uniform and continuous due to charge 
buildup and shielding effects of deposited fibers, which repulse the deposition of subsequent 
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fibers.  
In order to address the limitations of current electrospun nanofiber fabrication, a 
novel parallel mobile track based collecting technology was developed to allow continuous 
uniform aligned loose nanofiber collection. The electric field generated by two parallel 
conductive tracks causes charged nanofibers to deposit perpendicular to the tracks with one 
end fixed to the upper edge of each track, based on the similar principle demonstrated 
previously by Li et al [12]. Due to the incorporation of automation in these parallel 
conducting tracks, newly formed nanofibers are continuously pulled away from the collecting 
edge. There are three distinct advantages to this method: (1) Individual fibers are allowed 
enough time to dry on the mobile tracks before contacting other fibers in the final structure, 
thus reducing the chance of adhesion between adjacent fibers and even opening the door to 
electrospinning structures from slow evaporating solutions and high temperature melts.  (2) 
Charge does not build up across the track as it does with the static parallel plate technique so 
fibers can be collected continuously, uniformly, and indefinitely.  (3) Static loose nanofiber 
arrays on the tracks can be assembled into a structure during and after electrospinning.  
Complex structures that cannot be directly collected from the rapidly whipping 
electrospinning jet may be fabricated from the continuous supply of stabilized individual 
fibers.   
In this work, two designs were developed to continuously collect fibers using mobile 
tracks.  The first design uses tracks moving in the same direction as the jet to pull fibers 
down away from the collecting area and the second design used tracks moving in the 
direction normal to the jet to pull fibers sideways away from the collecting area.  Figures 
4.1A and D schematically show the motion of the tracks relative to the electrospinning nozzle 
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for each design. 
The application of this technology was demonstrated in the fabrication of: (1) large 
area aligned nanofiber mats with controllable fiber density and unlimited thickness; (2) ultra-
thin membranes with a highly controllable pore size that is dependent on fabrication 
parameters and not fiber diameter (3) Complex 3-dimensional structures with controlled fiber 
packing density. 
 
Figure 4.1:  Schematics of track motion relative to an electrospinning jet (A&D), CAD drawings (B&E) 
and photographs (C&F) of two different types of mobile track based nanofiber collecting devices. 
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4.2. Materials and methods 
4.2.1 Design of the Collecting Device 
Two different devices were constructed to demonstrate the potential of utilizing automated 
mobile tracks to collect nanofibers from an electrospinning jet and assemble them into 
structures.  Figure 4.1 contains a schematic (B and E) and a photograph (C and F) of both of 
the fabricated devices.  All raw materials for constructing the devices were obtained from 
Smallparts (Miramar, FL) and McMaster-Carr (Atlanta, GA) unless otherwise specified.  The 
frames of the devices were constructed from medical grade polycarbonate. Stainless steel 
rods were inserted into bearings and connected to Animatics SmartMotors (4-40C; Animatics 
Corporation. Santa Clara, CA) that controlled the movement of the mobile tracks. Two 
separate motors were used to turn each of the tracks synchronically at a controlled speed.  
The motion of the motors was controlled using Animatics SmartMotor Data Logger software.  
The tracks on the devices consisted of an inner layer made from a latex sheet, a center layer 
of double sided tape and an outer layer of aluminum foil.  The tension applied to the tracks 
could be adjusted by increasing their length. 
4.2.2 Electrospinning  
Polycaprolactone (PCL Mn=80,000, Sigma, St Louis, MO), polyurethane (PU, Tecoflex SG-
80A, Noveon, Cleveland, OH), Poly(L-lactide) (L-PLA Boehringer Ingelheim, L2095), 
P(DL-lactide) (DL-PLA LACTEL, B6014-1), P(DL-lactide-co-glycolide) (DL-PLG 85:15 
LACTEL 85DG065), and a degradable PU (PU-D, synthesized in our lab) based on lysine 
diisocyanate (LDI, Kyowa Hakko Koygo Co., Ltd, Tokyo, Japan) and polycaprolactone diol 
(PCL-diol, Sigma) were electrospun from polymer solvent solutions.  Tecoflex SG-80A was 
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dissolved in hexafluoro-2-propanol (HFIP, Oakwood, West Columbia, SC) at 5-8 wt/v% and 
degradable PU was dissolved in dichloromethane:dimethylformamide (3:1) (DCM:DMF, 
Sigma) at concentrations of 13-17 wt/v%.  PCL was dissolved in DCM:Methonal (7:3; 
Sigma) at concentrations of 5-15% and in DCM:DMF (3:1) at concentrations of 13-18%.  L-
PLA was dissolved in HFIP at 7 wt/v% and DL-PLA was dissolved in HFIP at 35 wt/v%.  
DL-PLG was dissolved in 3:1 DCM:DMF at 30 wt/v%. Polymer solution was feed by a 
syringe pump (Medfusion 2010i; Medex Inc.) at adjustable feed rates of 0.008- 0.025 ml/min 
through 1/16” polyethylene tubing into a 30, 23, or 21g blunt tipped needle.  A voltage of 8-
20kV was applied to the needle tip with a high voltage power supply (Gamma High Voltage 
ES40P-10W).  The needle tip was held at 5-20 cm above the level of the collecting device.  
The tracks of the collecting devices were run at speeds of 0 to 0.05 m/s.   
4.2.3 Fiber Collection Rate Measurement 
Two parallel strips of Scanning Electron Microscope (SEM) tape were placed on SEM stubs 
and aligned fiber arrays were collected for 1, 2.5, 5, or 7.5 minutes in an orientation 
perpendicular to the tape.  Samples were analyzed using SEM. Fibers per unit length in the 
direction perpendicular to fiber alignment was counted using ImagePro Plus 4.0. Six 
measurements were averaged for each of three trials per collection time.   
4.2.4 Pore size of crisscrossed mats  
Squares of SEM tape were placed on SEM stubs.  The inner dimensions of the squares were 
8x8 mm. Fiber arrays were collected for 10s, 20s, 30s, 1 min, 2.5 min, or 5 min.  Four layers 
of fiber arrays were collected for each collection time and transferred to the SEM stubs.  The 
stub was rotated 90 between each layer to make a crisscross pattern.  Samples were analyzed 
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using SEM and the space between crisscrossed fibers was measured using ImagePro Plus 4.0.  
Approximately 40 spaces were measured for each of three trials per collection time.    
4.2.5 Scanning Electron Microscopy 
Samples were sputter coated with gold at a thickness of 50-70 nm using a Cressington 108 
AUTO sputter-coater with a current of 30 mA for 2 minutes. Images of the samples were 
taken at 500 to 10,000 times magnification using a scanning election microscope (SEM, 
Hitachi TM-1000).   
4.2.6 Light microscopy 
Light microscope images were taken using a Nikon Eclipse TE2000-S microscope with a Q-
Imaging Micropublisher 3.3 RTV camera with Q-Capture software, or with a Zeiss Imager  
M2 microscope and AxioCam MRm with AxioVs40 software. 
4.2.6 Laser Confocal Microscopy 
In order to visualize the nanofibers in laser confocal fluorescent microscope, DiO 
(Invitrogen) was added to polymer solution at a concentration of 0.03mg/ml.  A Leica 
confocal microscope (TCS SP5 AOBS) was used to visualize the nanofiber scaffolds. 
4.2.7 Image Processing 
ImagePro Plus 4.0 (Media Cybernetics, L.P.) was used to analyze images of nanofibers taken 
using SEM. Fiber diameter, number of fibers per unit length, and the space between 
crisscrossed fibers were all analyzed with ImagePro Plus. 
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4.2.8 In Vitro Cell Culture 
To demonstrate the 3-dimensional  cell growth and penetration of cells into the 3D nanofiber 
arrays, human osteoblast cells, human neural stem cells, and mouse myoblasts were cultured 
on aligned loose 3D nanofiber arrays (fabricated using design shown in Figure 4.1D-F) for 5 
days with appropriate cell culture medium for each cell types. For all cell types, media was 
filled just above the level of the nanofiber arrays and cells were seeded by dripping cell 
suspension above the area of the scaffolds.  
4.2.9 Immunocytochemistry and Histology 
All cells were fixed in 4% paraformaldehyde. Some samples were directly stained using 
standard immunocytochemistry procedures. Some specimens were embedded in O.C.T. 
compound and sectioned at 20um thickness along the nanofiber direction. Some sections 
were stained with hemotoxilin and eosin and coversliped. Some sections were processed for 
immunocytochemistry staining. Osteoblasts were stained with AlexaFluor 488 Phalloidin 
(Invitrogen) for the actin filament inside the cells. C2C12 cells were immunostained against 
skeletal muscle heavy chain myosin and neurospheres were immunostained against BIII-
tubulin. Aligned polymer nanofibers were visualized by confocal microscopy using 
reflection, and 4'-6-Diamidino-2-phenylindole (DAPI, Invitrogen) stained for the cell nuclei. 
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4.3. Results 
4.3.1 Fiber collection 
PCL, PU, PU-D, PLA, P(DL)GA, and P(DL)A nanofibers were successfully collected using 
the described mobile track devices. Nanofibers were collected using a number of different 
electrospinning parameters and the diameter and length of these fibers could be predictably 
adjusted. Individual fiber length was equal to the distance between the tracks of the collecting 
devices.  The distance between tracks was adjusted to collect fibers of all polymer types to 
different length.  Solution properties and electrospinning parameters were adjusted to 
predictably fabricate 8 cm long PCL fiber arrays with diameters of 250, 500, and 1000 nm. 
Fiber collection rate was affected by the specific electrospinning parameters selected.  When 
fibers were collected across the parallel tracks in the static state, electrostatic repulsive forces 
on the deposited fibers resisted further collection. Limitation of accumulation at the 
collection area was readily overcome with track motion and this allowed continuous 
collection of aligned loose nanofiber arrays. At very low track speeds, the collected fibers 
stayed in the collecting area longer, which resulted in an observed repulsive force.  This 
repulsive force caused large amounts of electrospun fibers to move away from the collecting 
area and accumulate elsewhere on the surface of the device or in the area surrounding the 
device.  Fibers were continuously collected with track velocities of up to 0.05 m/s.  It was not 
attempted to increase the track velocities further. 
Fibers arrays were collected for 1, 2.5, 5 and 7.5 minutes (with electrospinning 
parameters and track speed fixed) to confirm continuous and uniform nanofiber collection.  
The results (Figure 4.2) of this experiment suggest a continuous linear collection rate.  Fiber 
arrays were continuously collected for attempted time periods of up to eight hours.  
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Figure 4.2:  Nanofiber delivery rate of a mobile track device (shown in Figure 1D-F) with motion 
parallel to the direction of an electrospinning jet.  
4.3.2 Collection of aligned nanofiber structures 
Unidirectional aligned nanofiber arrays were easily assembled by placing a polycarbonate 
rectangular rack in between the two tracks of the device. The rack was held in place by 
holders placed on the collecting device. A very small space (~0.25cm ) was left between the 
edge of the rack and the wall of the collecting device to allow the mobile track to pass in 
between.  Shear forces generated on the fibers as the track moved past the rack easily cut the 
fibers off, leaving the fibers deposited perpendicularly across the rack. A PCL nanofiber 
array collected across such a rack is displayed in Figure 4.3.  
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Figure 4.3:  SEM image of an aligned nanofiber array collected using a mobile track device (shown in 
Figure 1D-F) with motion in the direction of an electrospinning jet.   
4.3.3 Thin membranes with controlled porosity 
Ultra thin perpendicularly crisscrossed nanofiber sheets (Figure 4.4A) were assembled by 
rotating a collecting rack in 90 increments at the bottom of the device. The pore size of these 
mats was dependent on fiber density and not fiber diameter.  Collection time determined fiber 
density and thus the average area between crisscrossed fibers.  Four layers of perpendicular 
fiber arrays were collected for 10 seconds to 5 minutes per layer and the average pore size 
was measured (Figure 4.4B&C). The average area between crisscrossed fibers decreased with 
increasing collection time as displayed in Figure 4.4A.  It appeared that pore size was related 
to collection time by a power law as would be expected.   
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Figure 4.4:  Crisscross patterned nanofiber membranes: (A) Plot of average pore size versus fiber layer 
collection time. SEM images of thin sheet/membranes with four layers collected for (B) one and (C) five 
minute each. 
4.3.4 Fabrication of 3-dimensional aligned structures with controlled fiber packing density 
A 3-dimensional volume of aligned nanofibers (Figure 4.5A, light reflection allows 
visualization of the small diameter (~600 nm) nanofibers with the naked eye) is naturally 
created as fibers travel down the tracks of the device described in Figures 4.1A-C. The fiber 
density of this volume is related to the track speed.  In addition, a layer-by-layer approach 
was utilized to fabricate three-dimensional structures with controlled fiber density across a 
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rack at the bottom of the device when spacers were placed intermittently between layers of 
collected fibers.  Nanofibers could be collected for uniform time intervals and spacers of 
different thickness could be placed in between nanofiber layers.  For example, an aligned 
loose nanofiber structure of 10 mm thickness and 5cm in width can be readily fabricated 
when approximately two hundred 50μm spacers are used to separate 200 nanofiber arrays 
collected for 20 seconds per layer. Figure 4.5B is such a structure labeled with DiO and 
visualized by confocal microscopy. Another such structure was immersed in aqueous solution 
and analyzed by confocal microscopy. The fibers in the stacked array structure remained 
separated from neighboring fibers and intact after contact with water demonstrating the 
potential of these 3-dimensional arrays as components for composite assembly.  
 
Figure 4.5:  (A) Image of parallel nanofibers suspended throughout the interior space of a mobile track 
device (shown in Figure 1D-F) with track motion parallel to the direction of an electrospinning jet 
during collection. (B) Confocal images of a three-dimensional loose nanofiber array fabricated using 
mobile track collecting device and layer spacers.  
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4.3.5 Tissue engineering constructs 
The potential of this technology in 3-dimensional tissue growth was demonstrated by seeding 
different types of cells on the surface of the fabricated loose aligned nanofiber arrays (Figure 
4.6). When human neural stem cells were seeded on the nanofiber array under neural 
differentiation condition, 3-dimensional aligned neurites sprouted from human neural stem 
cells aligned with the nanofibers and grew inside the nanofiber arrays to form 3D nerve fibers 
(Figure 4.6A&E). When human osteoblasts were seeded on the nanofiber arrays, cytoskeletal 
actin filaments inside the cells are highly aligned along the loose nanofibers and formed 3-
dimensional tissue structure. When mouse myoblasts were seeded on the nanofiber arrays 
under myo-differentiation condition, myotubes were formed on both sides of loose nanofiber 
array even though myoblasts were seeded only on one side, which also proved the ability of 
cells to migrate through the loose nanofiber array (Figure 4.6C&F).  Myoblasts cultured on 
thick loose non-adherent aligned nanofiber array were able to penetrate deep into the fiber 
mats after just one week in culture, and after 3 weeks of culture myoblasts populated the 
entire thickness of nanofiber array and formed skeletal muscle like tissue (Horizontal sections 
along the nanofiber direction, Figures 4.6D&H). It is hypothesized that loose nanofiber 
arrays (i.e., without fiber-fiber adhesions) allowed for good cell penetration throughout the 
nanofiber bundles.  
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Figure 4.6:  Three-dimensional cell-nanofiber structure formed after seeding cells on the surface of the 
nanofiber arrays and grown for 5 days: Human neural stem cells(A and E), human osteoblasts(B and 
F), and 21 days: mouse myoblasts(C and G). A horizontal section of an aligned loose nanofiber array 
seeded with myoblast shows good penetration of cells and form skeletal muscle like tissue structure after 
3 weeks in culture stained with H&E and taken in bright field (D) and DIC mode (H). Scale bar= 50um     
4.4 Discussion 
Nanofiber structures are commonly obtained from an electrospinning jet using a flat plate, 
rotating collection device, or parallel plate collector. While each of these techniques is 
different, they are all limited in the kinds of nanofiber structures that can be fabricated 
because all utilize nanofiber assembly directly from an unstable highly charged 
electrospinning jet. A novel technology was developed that allows for an intermediate step in 
between the stabilization of nanofibers from the electrospinning jet and the assembly of 
nanofibers into a structure.   
The two described collecting devices demonstrated the potential of this technology to 
maintain continuous and uniform collection of aligned nanofibers for an indefinite time 
period. Unlike most methods of fiber collection, this technology allows for a consistent 
electrical field. Charge build up and electrical shielding by deposited fibers cause variations 
in the electric field when previous available collection methods are employed. Variations in 
D
GFE
A
H
CB
 108 
 
the electrical field can affect the rate of collection as well as limit it. The described devices 
demonstrated fiber collection rates that were uniform and indefinitely continuous (verified 
continuous collection tested up to 8 hours).  
The continuously collected fiber arrays are maintained as individual fibers until 
further post-processing assembly, thus providing additional time for evaporation of residual 
solvent or cooling of melts before the individual fibers contact one another. This results in the 
elimination of any unwanted fiber-fiber adhesions in the final assemblies and may even open 
the door for electrospun nanofiber structure assembly using slow-evaporating solutions and 
high temperature melts. Control over evaporation/cooling time will also allow greater 
versatility in a variety of applications. One example is that this novel technology may also 
allow for direct live cell loading within the nanofiber arrays during the fabrication/assembly 
process since this technology allows extra time for solvent evaporation or cooling, where 
toxic solvents and high temperatures can damage cells. 
Several structures were assembled from nanofiber arrays collected by automated 
tracks in order to demonstrate the potential of this method. Easily fabricated ultra-thin 
nanofiber mats with controllable pore size could have potential use as filtration devices or 
guidance tissue regeneration (GTR) membranes. Importantly the pore size of these ultra thin 
structures was not dependent on the fiber diameter as is seen in conventional randomly 
oriented nanofiber meshes. Independent control over pore size and fiber diameter allows for 
the assembly of structures with both optimized fiber diameter and optimized pore size. Ultra 
thin crisscrossed mats have been previously fabricated from static parallel electrodes [12, 15], 
but fabrication with incorporation of automated tracks offers advantages in maximum overall 
mat area, minimum pore size, uniformity, and practicality in the manufacturing process.      
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 Fabricated aligned loose nanofiber arrays allow many different types of cells to 
attach, grow, and penetrate inside the 3-dimensional arrays. As shown in Figure 4.6A and 
4.6E, nerve fibers sprout from neural stem cells and form aligned nerve fiber bundles along 
the loose nanofiber arrays. The same is true for osteoblasts and myoblasts, where thick 
aligned loose nanofiber arrays allow good cell penetration deep into the scaffolds. It is 
hypothesized that cell penetration was facilitated because this fabrication procedure addresses 
some of the problems that may be encountered when conventional rotating mandrel or 
parallel plate collectors are used in nanofiber collection. The rotating mandrel method 
requires high rotation speeds that generate tangential velocities of several meters per seconds 
[13]. This results in a tightly wound structure that contributes to poor cell penetration 
properties. The static parallel plate method utilizes a gentler nanofiber collection process, but 
a thick aligned nanofiber scaffold cannot be fabricated by this method alone because of 
charge resistance and shielding caused by previously deposited fibers [16]. In addition, the 
rotating mandrel, the static parallel plate method, and all other collecting methods developed 
before this method have inherent problems of fiber to fiber adhesions due to incomplete 
drying or cooling of fibers that are in contact with one another soon after formation. Fiber to 
fiber adhesions can limit cell penetration into nanofibrous structures.  
This automatic dynamic collecting device allows fabrication of 3-dimensional aligned 
nanofiber structures that could not be possible using previous methods. The applicability of 
electrospun nanofiber structures is limited by the difficulty in fabricating ordered 3-
dimensional structures. It was demonstrated that this technology is capable of fabricating 
large volume 3-dimensional aligned fiber arrays with controllable uniform packing density. 
Fiber alignment with large volume and uniform spacing among individual nanofibers make 
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those structures unique to this system of fabrication.  The ability of these 3-dimensional fiber 
arrays to maintain their structure in liquid highlights a potential for composite fabrication and 
tissue regeneration.  
The most substantial impact of this technology may come not from the types of 
structures that can be assembled, but the practicality for industrial scale up. Most nanofiber 
structures are assembled directly from the electrospinning jet and are thus restricted by the 
unstable jet, which experiences violent whipping motions and high electrical charges.  
Difficulties involved in predictably controlling this jet seriously limit the possibility of 
assembling complex nanofiber structures with electrospun nanofibers. Other potential 
problems facing conventional electrospinning for industrial scale up include non-
uniform/limited fiber collection rates and clogging, spitting, and increased unpredictability 
during the beginning of each electrospinning collection cycle. The presented technologies 
demonstrated continuously delivered individual nanofibers in stable aligned arrays, where 
after they can be post-processed into more complex structures by mechanical methods.  
Delivery of continuous stable nanofiber arrays on automated tracks in a highly controllable 
fashion opens the door for countless innovative ways to assemble complex nanofiber 
structures that may not be feasible by available techniques. 
The exceptional versatility of this technology was demonstrated by the successful 
fabrication and operation of two fiber collecting devices. Continuous aligned nanofiber arrays 
were collected for a variety of materials with controlled fiber diameter and length. The 
simplicity of this system makes it conducive for combination with other electrospinning 
techniques such as; addition of auxiliary electrodes, magnetic fields, and alternating currents; 
and mechanical assembly techniques such as rapid prototyping technologies [17-19].    
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4.5 Conclusions 
A novel technology for collecting nanofibers using parallel automated tracks was developed.  
Parallel tracks were moved in two different planes to collect nanofibers and deliver them for 
assembly into various structures.  A uniform electric field is maintained because movement 
of fibers away from the collecting area alleviates repulsive charge accumulation.  Steady state 
indefinitely continuous delivery of immobilized nanofiber arrays by motorized tracks was 
verified. The described method also allows an indefinite amount of extra time for individual 
fibers to dry or cool before contacting other fibers in the final structure. Thus, potential fiber-
fiber adhesions due to incomplete drying or cooling can be eliminated.  It is hypothesized that 
nanofiber arrays collected and distributed with motorized collecting tracks could be 
assembled into complex ordered structures that cannot be practically fabricated using other 
current methods. This novel method of fiber collection adds an intermediate step that outputs 
stable aligned fiber arrays collected from the violent highly charged electrospinning jet.  
Fixation and organization of the fibers permits feasible post processing of electrospun 
nanofibers into complex structures by mechanical means. Several structures were fabricated 
to demonstrate the potential of this technology. 1) Thick aligned loose nanofiber array with 
good cell penetration properties due to the assembly techniques. 2) Three dimensional 
aligned fiber arrays with uniform fiber packing densities and theoretically unlimited width 
and depth. And 3) Ultrathin crisscrossed meshes fabricated with independent control of both 
nanofiber diameter and pore size. All these structures are difficult to fabricate using other 
current collecting techniques due to the unpredictable electrospinning jet. With a mobile 
parallel track based nanofiber fabrication technology, it is very practical for scale up with a 
variety of automated mechanical assembly methods for the fabrication of nanofiber 
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containing structures that are not feasible with current methods.  
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CHAPTER 5  
5.  FABRICATION OF NANOFIBER REINFORCED PROTEIN STRUCTURES 
FOR TISSUE ENGINEERING 
 
5.1. Introduction  
Many tissue engineering strategies involve the use of scaffolds that support cell attachment, 
survival and proliferation, and formation of tissue-like structures. Natural extracellular 
matrices (ECMs), such as collagen, gelatin, laminin and fibronectin, promote cell attachment, 
survival, and growth. However, without extra-cross-linking, these materials are structurally 
very weak after in vitro processing, which greatly limits their potential use for guiding tissue 
regeneration [1]. In addition, ECMs without appropriate alignment may not offer directional 
guidance to attached cells. On the other hand, degradable electrospun nanofibers support cell 
attachment, and provide excellent directional guidance to the attached cell [2–5]. Like ECMs, 
individual degradable nanofibers are also very fragile and difficult to handle unless a 
relatively dense mat or dense bundle of nanofibers is formed. However, densely packed 
nanofibers provide a barrier for cell penetration inside the nanofiber bundles, especially in the 
case of aligned nanofibers, and thus preventing the use of 3D structures of aligned nanofibers 
as effective tissue engineering scaffolds. Interestingly, a combination of ECMs and loose 
degradable nanofiber arrays may help to address the weakness of each component as a 
scaffold. Nanofibers can offer directional cues to the ECMs, and also provide extra structural 
integrity with nanofiber reinforcement. ECMs can act as a substrate to immobilize individual 
nanofibers and serve as spacers among nanofibers, thus creating nanofiber arrays with loose 
nanofiber packing that also provides adequate structural integrity. Since ECMs may degrade 
very fast in the body, the resulting spaces will allow cells to populate into the space among 
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the nanofibers. To this end, degradable loose nanofibers were embedded in protein matrix in 
an attempt to fabricate a composite scaffold with improved properties; such as improved 
strength, guidance, spacing among nanofibers, etc. The goal of this study was to design a 
method of fabricating hybrid protein structures by combining degradable nanofibers and 
protein matrices. The model system tested was the electospun PCL nanofibers embedded into 
gelatin thin films and the properties of these hybrid structures were evaluated with 
mechanical testing and in vitro cell culture.  
5.2. Materials and methods  
5.2.1. Electrospinning  
Polycaprolactone (PCL, Mn =80,000, Sigma, St. Louis, MO) was dissolved in 
dichloromethane and dimethylformamide (3:1) (DCM: DMF, Sigma) at a concentration of 
18%wt/v. A hydrophobic cyanine dye, 1,1′-dioctadecyl-3,3,3′3′-tetramethylindocarbocyanine 
perchlorate (DiI, Invitrogen, Carlsbad, CA, USA), was added to the polymer solution at 
concentrations of 0.025 mg/ml to label the fabricated nanofibers. Polymer solution was feed 
by syringe pump (Medfusion 2010i; Smiths Medial Inc., Carlsbad, CA, USA) at a rate of 
0.015 ml/min through a 23 G blunt tipped needle. A voltage of 8 KV was applied to the 
needle tip with a high voltage power supply (ES40P-10 W, Gamma High Voltage Research, 
Ormond Beach, FL, USA). The needle tip was held at 10 cm above a custom built collecting 
device designed in our lab to collect large loose arrays of parallel nanofibers across a 
rectangular rack [6]. This device utilized parallel mobile tracks that pulled electrostatically 
aligned electrospun fiber arrays into a secondary collection area at a vertical speed of 16.9 
mm/s.  
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5.2.2. Composite film fabrication  
Parallel electrospun nanofibers were collected continuously across a rectangular rack (Figure 
5.1A) for 3 or 6 min. This fiber array was then transferred to a two-piece polycarbonate frame 
that was held together with screws (Figure 5.1B and C). Composite films were fabricated 
with two different fiber orientations: unidirectional straight fibers (Figure 5.2 A, C, and E) 
and bi-directional/criss-crossed fibers (Figure 5.2B, D, and F). During the fabrication of 
unidirectional composites, nanofibers were collected for 6 min first and transferred to a  
 
Figure:  5.1 Hybrid film fabrication: (A) PCL nanofibers on collecting rack (B) nanofiber array is 
transferred to smaller frame (C) nanofiber array inside of frame (D) nanofiber array is wetted in gelatin 
solution (E) nanofiber array is removed from gelatin solution and (F) dried hybrid film. 
 
polycarbonate frame. For fabrication of bi-directional composites, nanofibers were collected 
twice for 3 min at two different directions and then transferred to the polycarbonate frame. 
The frames holding the nanofiber arrays were then coated in a 1 wt.% gelatin aqueous 
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solution (Bovine skin type B, Sigma, St. Louis, MO, USA) and allowed drying. Some of the 
composite films were cross-linked with 1-Ethyl-3-(3-dimethylaminopropyl) carbodimide 
(EDC, TCI America). All the films were sterilized with 75% ethanol. 
5.2.3. Visualization  
All SEM images were taken at 1000 to 5000 times magnification using a scanning electron 
microscope (SEM, Hitachi TM-1000). Samples were not sputter coated. In order to visualize 
the embedded fibers, the composite film edges were selected for taking pictures. All  
 
Figure 5.2:  Hybrid gelatin/PCL nanofiber membranes: (A) Schematic of unidirectional aligned 
nanofiber reinforced protein membrane. (B) Schematic of criss-cross nanofiber reinforced protein 
membrane. (C) Fluorescent image of gelatin/PCL membrane. PCL fibers dyed with DiI in a 
unidirectional pattern. (D) Fluorescent image of gelatin/PCL membrane. PCL fibers dyed with DiI in a 
bi-directional pattern. (E) SEM image of gelatin/PCL membrane. PCL fibers are in a unidirectional 
pattern and (F) PCL fibers are in a bi-directional pattern. 
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fluorescent and light microscope images were taken using a Nikon Eclipse TE2000-S 
microscope with an EXFO X-cite 120 fluorescence illumination system, and a Q-Imaging 
Micropublisher 3.3 RTV camera with Q-Capture software. ImagePro Plus 4.0 (Media 
Cybernetics Inc., Bethesda, MD, USA) was used to measure the average thickness of 
composite film samples using SEM images of the cross sections.  
5.2.4. Mechanical testing  
Mechanical properties of the hybrid PCL nanofiber reinforced gelatin films were 
characterized using both biaxial tensile testing and uniaxial tensile testing. Biaxial tensile 
testing was performed using a BioTester5000 Biaxial Test System (CellScale division of 
Waterloo Instruments Inc., Waterloo, Ontario, Canada) to examine the mechanical properties 
of the membrane samples in two directions. In brief, gelatin/PCL nanofiber based thin film (5 
mm×5 mm) was attached with 20 tungsten finger grips (300 μm diameter, five on each side) 
and stretched in the nanofiber direction or perpendicular to the nanofiber direction in dry 
condition (Figure 5.3A). Each set of five finger grips was attached to an actuator, and load 
cells measured the force along the two pulling axes. The load cell used was 2500mN. The 
samples were sequentially tested with 3% strain, 5% stain and 7% strain and each stain rate 
was done in 20s. Uniaxial tensile testing was performed in a Shimadzu EZ Graph tensile 
tester (Nakagyo-ku, Kyoto, Japan) with Trapezium 2.32 software for data acquisition to 
examine the strength and stiffness of the thin films. SEM tape was adhered to both ends of 
20mm×5mm rectangular strips of composite film and these were attached to the tensile 
tester's grips leaving an initial length of 10 mm of sample between the grips prior to 
elongation. The purpose of the tape was to limit stress concentrations on the thin films and to 
prevent slippage from the grips. A total of 20 samples were fabricated for mechanical testing, 
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with 5 samples for each of 4 groups: (1) Unidirectional (2) Bidirectional (3) 
Unidirectional+EDC and (4) Bi-directional+EDC. Strips were cut from the samples in the 
direction of the aligned fibers (90°) and perpendicular to the direction of the aligned fibers  
(180°). Strips cut from each sample were tensile tested in both directions under both wet and 
dry conditions. Under wet conditions the samples were secured in the grips of the tensile  
 
Figure 5.3:  Biaxial tensile testing on hybrid gelatin membrane embedded with PCL degradable 
nanofiber arrays. (A) Example of a gelatin/PCL membrane mounted in the biaxial tester. (B) Gelatin 
membrane embedded with criss-crossed PCL fibers were tested at 3% strain, 5% strain and 7% strain 
condition. (C) Gelatin membrane embedded with unidirectional aligned PCL fibers were tested at 3% 
strain, 5% strain and 7% strain condition. 
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tester and then hydrated. The elastic modulus, maximum stress, and elongation were 
measured from the stress strain curves. Statistical analysis was done using SPSS 15.0 
software (SPSS Inc. Chicago, Illinois, USA). All p-values (p) were calculated using the 
Mann–Whitney test.  
5.2.5. In vitro cell culture study  
Circular pieces of unidirectional and bi-directional EDC cross-linked hybrid film with a 
diameter of 19mm were cut and placed at the bottom of 12 well cell culture plates. Half-inch 
sections of polycarbonate rod (Outer Diameter: 19mm, Inner Diameter: 13mm) were place on 
top of the films to hold them down. Sample wells were sterilized with 75% ethanol and 
80,000 3T3 fibroblast cells were seeded on each sample and allowed to incubate for 3 days. 
Cells were fixed in 4% paraformaldehyde and stained with AlexaFluor 488 Phalloidin 
(Invitrogen) for the actin filament inside the cells and 4′-6-Diamidino-2-phenylindole (DAPI, 
Invitrogen) for the cell nuclei.  
5.3. Results  
5.3.1. Hybrid film fabrication  
Thin gelatin/PCL degradable nanofiber hybrid films were fabricated using the techniques 
described above. The surface tension of the gelatin solution caused the formation of a thin 
film over both unidirectional and bi-directional nanofiber arrays. A thin hybrid film remained 
intact after drying. Fluorescent and SEM microscopy confirmed that the nanofibers remained 
embedded in the gelatin films in their original configurations (Figure 5.2C–F). The average 
thickness of the films was 2.73um with a standard deviation of 0.28. It was estimated from 
previously collected data that PCL fibers were approximately 585nm in diameter and 
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collected at a rate of approximately 0.05 fibers/um/min (data not shown), therefore the 
estimated volume fraction of PCL nanofibers embedded in the composite films was around 
3% v/v. The volume fraction and the size of the nanofibers can be readily adjusted by 
controlling the nanofiber fabrication conditions and collecting time. Fabricated films 
demonstrated the strength and structural integrity for manipulation into complex shapes.  
5.3.2. Mechanical testing  
Results for biaxial testing in dry conditions can be observed in Figure 5.3A. Hybrid 
membranes reinforced with PCL nanofibers in crisscross pattern possessed similar 
mechanical properties in both 90
o 
and 180
o 
directions (Figure 5.3B). In contrast, membranes 
with PCL nanofibers in a unidirectional pattern had significant differences in strength in 
different directions (Figure 5.3C).  
Uniaxial tensile testing was done in the 90° and 180° planes under both wet and dry 
conditions for samples that were uncrosslinked and cross-linked with EDC. The elastic 
modulus and failure strength for each set of conditions is displayed in Figure 5.4. Fiber 
orientation had significant effects on the strength of composite films for unidirectional 
samples with and without EDC in the dry and hydrated state. The elastic modulus of 
unidirectional hybrid films were 392% (p =0.05), 231% (p =0.02), and 164% (p =0.03) higher 
in the direction of the aligned fibers for hydrated, hydrated+EDC, and dry films respectively. 
The failure strength of unidirectional hybrid films were 1265% (p=0.05), 437% (p=0.03), and 
212% (p=0.02) higher in the direction of the aligned fibers for hydrated, hydrated+EDC, and 
dry films respectively. Composite films cross-linked with EDC were stronger than films 
without EDC cross-linking over all fiber orientations (p< 0.05). The elastic modulus of cross-
linked films were 36% (p=0.02) higher in the dehydrated state, and 306% (p< 0.01) higher 
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when hydrated. The failure strength of cross-linked films were 86% (p< 0.01) higher in the 
dehydrated state, and 139% (p=0.01) higher when hydrated.  
 
Figure 5.4:  Elastic modulus of samples tested under (A) dry and (B) wet conditions and failure stress of 
samples tested under (C) dry and (D) wet conditions: U=unidirectional sample, B=bi-directional sample, 
90=force applied in the direction of aligned fibers, 180=force applied perpendicular to aligned fibers, 
EDC=cross-linked sample. 
5.3.3. In vitro cell culture study  
PCL nanofiber/gelatin hybrid thin films maintained their integrity under cell culture 
conditions and promoted the attachment of 3T3 fibroblast cells. Since the membrane is very 
thin, cells were able to sense the embedded PCL nanofibers. Fibroblast cells on composite 
films containing bi-directional nanofibers adopted a somewhat random orientation, although 
it appeared that some cells may have oriented in the criss-crossed pattern of the fibers (Figure 
5.5A). Fibroblast cells on composite films containing unidirectional nanofibers however, 
clearly elongated in the direction of the aligned nanofibers (Figure 5.5B).  
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Figure 5.5:  3T3 fibroblasts grown on gelatin/PCL nanofiber composites with (A) bi-directional and (B) 
unidirectional fiber orientations. 
5.4. Discussion  
Extracellular matrix proteins, such as collagen, gelatin, laminin, fibronectin, etc. have 
favorable properties as tissue engineering scaffolds. Because most of these materials are 
naturally found in the body, they promote cell attachment, survival and growth and are fully 
biodegradable. The concern about the immunogenicity can be overcome by using human 
recombinant ECM molecules. Unfortunately natural ECMs are mechanically weak after in 
vitro manipulation, which limits their practicality as tissue engineering scaffolds. Structural 
weakness not only limits these proteins as coating materials or applications in non-load 
bearing environment, but it also makes them very difficult to handle and manipulate in the 
fabrication, processing, and implantation steps.  
Degradable polymer nanofibers exhibit many properties that make it an excellent 
substrate to add to protein matrices to construct hybrid structures with improved structural 
properties. Nanofibers mimic the size and structure of the natural guidance cues and therefore 
provide physical guidance for tissue regeneration, which is critical for regenerating aligned 
tissues such as nerve, tendon/ligament, or muscle tissue. Nanofibers can provide mechanical 
strength due to their high surface area to volume ratio and act as a barrier to crack 
 125 
 
propagation because of their long continuous length.  
The combination of polymer nanofibers with gelatin in a hybrid membrane expands 
the versatility of both of these promising materials or structures. The addition of as low as 
3% v/v PCL nanofibers improved the strength of gelatin film in the direction of unidirectional 
aligned fibers when compared to the strength in the direction perpendicular to the fibers, 
especially for hydrated samples. It could be hypothesized that addition of a greater 
percentage of nanofibers could strengthen protein matrices much further. And furthermore, 
chemical modification of the nanofiber surface to promote the covalent bonding between 
nanofibers and protein matrix will further improve the mechanical properties of the 
composite structures. These hybrid structures also address one of the greatest limitations of 
nanofibers as a scaffolding material. Nanofibers are very difficult to handle, process and 
implant into the body, and in addition, the tendency of forming dense nanofiber mats greatly 
limits cell population inside the nanofiber structure. The protein matrix in hybrid structures 
allows the fabrication of scaffolds containing loose nanofiber arrays with sufficient space for 
cell growth inside the nanofiber bundles, which can provide directional guidance without 
obstructing cell penetration.  
The fabrication techniques used to manufacture these composite films is readily 
adaptable for scale up and use in a Good Manufacturing Practices (GMP) fabrication facility 
for human tissue regeneration applications. Because the films were fabricated in atmospheric 
conditions there is no need to remove them from any substrate and they can be easily handled 
and manipulated. Complex two and three-dimensional structures assembled from dry 
composite films become gelatinous scaffolds once again upon rehydration, and thus this 
material may be a versatile tool in the fabrication of tissue engineering scaffolds.  
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5.5. Conclusions  
A method for fabricating nanofiber and protein hybrid thin membranes was developed. 
Hybrid membranes could be fabricated with a relatively consistent thickness between 2 and 
4um. The hybrid films were structurally robust enough for handling and manipulation into 
complex structures. Hybrid membranes could be fabricated with unidirectional and bi-
directional embedded fibers, and cross-linking with EDC strengthened the films significantly. 
Increased strength of films in the direction of unidirectional nanofibers suggests that an 
embedded volume fraction of PCL nanofibers as low as 3% can improve the mechanical 
properties of gelatin significantly. In vitro culture of fibroblasts confirmed that these 
composite films supported cell attachment, survival, and growth, and that embedded 
nanofibers could provide directional guidance to cells growing on the hybrid membranes. It 
was shown that nanofibers and protein matrices can be easily combined into a composite 
structure that has improved properties as a tissue engineering scaffold when compared to 
either component alone. This versatile technique can be used to develop tissue scaffolds that 
are biodegradable and biocompatible; promote cell attachment, survival, and growth; provide 
directional guidance; and possess the structural stability required for practical handling. 
Studies in progress are evaluating direct cell loading into the hybrid membrane and the use of 
nanofiber reinforced protein structures for engineering blood vessel, skeletal muscle, 
tendon/ligament and nervous tissue.  
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CHAPTER 6 
6.  A NOVEL FABRICATION TECHNOLOGY FOR CREATING NANOFIBER 
COMPOSITES THAT MIMIC THE MICROSTRUCTURE AND MECHANICAL 
PROPERITES OF NATURAL BLOOD VESSELS 
6.1 Introduction 
Cardiovascular disease causes more fatalities in the United States than any other disease [1].  
Highly diseased coronary artery and peripheral vessels must be repaired or replaced to restore 
healthy blood flow patterns.  Current treatments for occluded vessels are limited by low 
patency rates in small diameter (<6 mm) vessels and in addition, the use of autologous grafts 
is limited by the lack of adequate donor tissue in many patients [2,3]. There exists a great 
need for a small diameter synthetic vascular graft with improved long-term patency. Failure 
of synthetic grafts is brought about by one of three primary mechanisms: thrombosis due to 
the lack of an adequate endothelium; restenosis brought about by inflammatory responses and 
compliance mismatch; and infection [4].  An engineered vascular graft must be made from 
biocompatible materials with a lumen that promotes strong endothelial cell attachment and 
with mechanical properties that closely match those of natural tissue.  
The technology to fabricate blood compatible vascular grafts through the use of  
biocompatible materials and surface modification of the graft is well established.  The other 
critical factor for achieving graft patency is that the mechanical properties match with natural 
vessels. The property of ‘compliance’ is commonly used when comparing the mechanical 
properties of vessel grafts to natural vascular tissue. Compliance describes how the 
mechanical properties of a vessel or graft change depending on the internal hemodynamic 
pressure (and thus distention).  It is reported that compliance mismatch between vessel grafts 
and surrounding the vasculature causes intimal hyperplasia or aneurysm and that poor vessel 
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graft patency may be the result of turbulent flow brought about by compliance mismatch 
[5,6]. Hemodynamic flow variations arise due to the compliance mismatch of vascular grafts 
[7] and cause areas of both increased shear stress, which damages the endothelium, and 
decreased shear stress [8], which leads areas of stagnation, pooling of chemokine factors [9], 
and increased platelet interactions and oscillatory forces [10]. It is therefore paramount that 
the structure of such a graft be designed to replicate the mechanical properties of the native 
artery as closely as possible to maximize patency [11]. Mechanical property mismatches can 
also cause increased stress concentrations at the anastomosis of a graft and the surrounding 
vasculature. Stress concentrations can bring about remodeling that leads to intimal thickening 
and eventual graft failure.  
Natural blood vessels are composite structures with complex mechanical properties, 
and mimicking these properties may be the most challenging aspect of designing a synthetic 
vascular graft.  Blood vessels do not exhibit a linear stress-strain curve in the circumferential 
direction. Instead they exhibit a non-linear ‘J-shaped’ stress-strain curve, which has a 
relatively elastic region at low values of vessel distension (less than 140-160% of initial 
radius) that transitions into a relatively stiff region as distension increases [11-14] (Figure 
6.1). This type of dual stress-strain behavior is a necessity in the vascular system because of 
physiological requirements. Blood vessels must be elastic in order to provide pulse 
smoothing and capacitance, but they must also have the stiffness required to provide a stable 
geometry over a wide variety of pressures.   
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Figure 6.1:  Schematics of stress-strain profile of natural blood vessels (purple curve), collagen fibers 
remaining (blue curve; Trypsin was used to digest elastin from natural blood vessel), and elastin fibers 
remaining (red curve; Formic-acid was used to digest collagen from natural blood vessel) (Modified 
from  [13]) 
Several studies have shown that the collagen and elastin fiber components of blood 
vessels are associated with the two regions of the J-shaped stress-strain curve (Figure 6.1) 
[13, 15].  In the natural blood vessel, collagen fibers have a wavy or helical orientation at 
mean physiological pressure [16] (Figure 6.2a,b,c). Because these bundles of collagen fibers 
do not appear to be taut at lower values of vessel distention, they may offer little resistance to 
expansion until the vessel wall is distended enough to fully straighten them [17]. This 
mechanism would allow the mechanical properties of the blood vessel to exhibit elastin 
dominated elastic behavior at low levels of vessel distention and collagen dominated stiff 
behavior at high levels of vessel distention as seen in the J-shaped stress-strain curve.  At low 
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levels of pressure and thus distension, the highly elastic elastin fibers dominate the vessels 
mechanical properties. As pressure and thus distension increase, progressive recruitment of 
relatively inelastic collagen fibers bring about collagen dominated vessel mechanical 
properties. The geometry of the fibrous microstructure in blood vessels could be the 
mechanism that allows collagen to provide stiffness at high levels of distention without 
compromising elasticity at low levels of distention. Therefore, we hypothesize that a fibrous 
graft with components designed to mimic the mechanical properties and microstructure of 
elastin and collagen fibers in natural vessels will exhibit bulk mechanical properties similar 
to natural blood vessels. 
 
Figure 6.2:  Schematic (A) and fluorescent (B) images of collagen fiber microstructure in natural 
vessels. SEM (C) and fluorescent (D) images of straight/PU – wavy/PCL nanofiber composites.  PU 
fibers are dyed red with DiI and PCL fibers are dyed green with DiO.   
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The suitability of polymer nanofibers as a vascular implant material has been 
previously investigated.  A wide range of polymer materials are available and the properties 
of polymers can be specifically tailored for applications to a certain extent. Because of this, a 
material based on polymer fibers offers great flexibility for optimization throughout the 
design process. Some types of polymers such as polyurethane (PU), polycaprolactone (PCL), 
and poly(DL-lactide-co-glycolide) (PLGA) have shown excellent biocompatibility when used 
as implants [18-20]. Polymer nanofibers have several properties that make them excellent 
scaffolding structures when compared to larger polymer fibers. Because of their small size, 
nanofibers are recognized by cells, which align in the direction of aligned nanofibers [19, 
21]. Polymer nanofibers have also been shown to support cell attachment [22, 23]. In 
addition, drugs and proteins that can be directly incorporated into electrospun nanofibers and 
retain bioactivity and exhibit extended release kinetics [24-26]. Several groups have 
fabricated tubular vascular grafts from electrospun nanofibers, but these materials did not 
closely match the mechanical properties of natural blood vessel tissue [18, 27].   
The goal of this study was to develop a technology to fabricate a polymer composite 
graft, with similar compliance to natural vessels, by mimicking the mechanical properties and 
microstructure of the elastin and collagen fibers found in native tissue.  
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6.2 Materials and Methods 
6.2.1 Electrospinning  
Polycaprolactone (PCL Mn=80,000, Sigma, St Luois, MO), polyurethane (PU, Tecoflex SG-
80A, Noveon, Cleveland, OH), Poly(L-lactide) (PLLA, L2095,  Boehringer Ingelheim, 
Ingelheim Germany),and  P(DL-lactide-co-glycolide) (PLGA 85:15, LACTEL, Cupertino, 
CA) were electrospun from polymer solvent solutions.  PU was dissolved in hexafluoro-2-
propanol (HFIP, Oakwood, West Columbia, SC) at 8% wt/v and PLLA was dissolved in 
HFIP at 7% wt/v. PCL was dissolved in dichloromethane:dimethylformamide (3:1) 
(DCM:DMF, Sigma) at a concentrations of 18% wt/v and PLGA was dissolved in 3:1 
DCM:DMF at 30% wt/v. Polymer solution was feed by a syringe pump (Medfusion 2010i; 
Smiths Medial Inc., Carlsbad, CA, USA) at feed rates of 0.015 ml/min for PU and PLLA, and 
0.10ml/min for PLGA and PCL, through 1/16” polyethylene tubing into a 23g blunt tipped 
needle (Smallparts, Miramar, FL).  A voltage of 8kV was applied to the needle tip with a 
high voltage power supply (ES40P-10W, Gamma High Voltage Research, Ormond Beach, 
FL).  The needle tip was held at 10 cm above a custom build collecting device. In cases 
where nanofibers were stained, DiI or DiO (, Invitrogen, Carlsbad, CA) was added to the 
polymer solution at a concentration of 0.025 mg/ml. 
6.2.2 Composite fiber mat assembly   
Two fabrication processes with the same principle were used to fabricate the vascular grafts. 
In one method, custom build device designed in our laboratory [28] was used to collect 9 cm 
long parallel-aligned nanofibers and deposit them across an adjustable rectangular rack.  This 
device utilized two parallel mobile tracks to collect aligned fiber arrays and pull them down 
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to a secondary collecting area at a vertical speed of 10mm/second.  Composite fiber mats 
were constructed using a stepwise procedure (Figure 6.3). First a layer of elastic PU fibers 
was collected across the adjustable rack at a length and then elastic PU fibers were stretched.  
Stiffer polymer fibers (PCL, PLA, or DL-PLG) were then deposited on top of the PU fibers 
and the rack was relaxed back to its original width. This process could be repeated for 
multilayer mats.  
In the second method, a rotating mandrel was used to collect aligned elastic PU 
fibers. Mandrel diameter was increased to stretch the PU fibers and stiffer aligned polymer 
fibers (PCL, PLA, or DL-PLG) were then deposited on top of the PU fibers.  The diameter 
was then relaxed back to its original width.  This second method could also be repeated for 
multilayer mats 
In order to investigate the effect of the ‘compression’ distance (ΔD in Figure 6.3) of 
the stiff fibers, PCL fibers were collected, by the method described above on top of a layer of 
4 cm PU fibers that were stretched to a distance of  6.25, 5.25, or 4cm before relaxation back 
to 4cm (ΔD = 2.25, 1.25, 0 respectively from Figure 6.3). A theoretical schematic of the 
effect of ‘compression’ distance on composite mat microstructure is shown in Figure 6.3 (a-
c).   
 135 
 
 
Figure 6.3:  Fabrication of straight-elastic/wavy-stiff nanofiber composites. Elastic fibers (PU in red) 
were collected either (A) across a rack or (B) around a mandrel (1) and stretched distance ∆D (2).  Stiff 
fibers (PCL in green) were collected on top of elastic PU fibers (3) and pulled into a wavy orientation by 
elastic PU fibers upon relaxation back to their original length (4).  A schematic of PCL fiber orientation 
for composites with increasing D is shown in figures a-c.   
In order to investigate the effect of the ratio of elastic to stiff fibers, PU-PCL 
composite fiber mats with varied PU and PCL collection times were fabricated.  Three 
groups of composite mats were fabricated with PU:PCL collection times of 15:5, 10:10, and 
5:15 minutes, where an estimated 3000 PCL fibers (diameter = 600nm) or 600 PU fibers 
(diameter = 1200nm) were collected in a 5 minute time period.   
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6.2.3 Mechanical Testing  
To prepare the samples for mechanical testing, the first fabrication method was used. 
Samples of composite mat were mounted in 1x1cm sections on rectangular paper frames.  
Samples were clamped into a Bose 3220 tensile testing machine with a 22N load cell with the 
aligned PU fibers in the direction of the applied force.  Prior to testing, the two sides of the 
paper frame were carefully cut, so that they did not offer any resistance, and the load was 
zeroed. Samples were pulled at 0.05mm/second and data was collected at a rate of 13 points 
per second. Stress-strain curves were calculated from the force displacement data recorded by 
Bose WinTest software. For stress calculations, the cross sectional area of each sample was 
determined by multiplying the estimated number of fibers in the sample by the estimated 
cross-sectional area of each fiber.  In order to estimate the number of fibers per sample, PU 
and PCL fibers were collected for 5 minutes under the exact conditions used in composite 
mat fabrication. The resulting aligned fiber array was transferred onto an electron microscope 
stub and the average fiber diameter and the rate of fiber collection (fibers/um/min) was 
determined using Image Pro Plus 4.0.   
After the stress-strain data was calculated, a one hundred point moving average was 
applied to smooth the curve.  Elastic moduli were calculated using points from linear regions 
of the stress-strain curve.  A one hundred point moving average of the first and second 
derivative were also calculated and plotted. The local maximum of the second derivative in 
the region of the ‘elastic to stiff’ transition point was used as a quantitative representation of 
the location of the transition region.  The stress-strain curve of straight fiber composites 
immediately exhibited stiff behavior and was therefore given a quantitative value of zero for 
the ‘elastic to stiff’ transition point.   
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6.2.4 Microscopy 
All samples imaged using scanning electron microscopy (SEM) were sputter coated with 
gold at a thickness of 50-70 nm using a Cressington 108 AUTO sputter-coater with a current 
of 30 mA for 2 minutes. Images of the samples were taken at 500 to 10,000 times 
magnification using an SEM (Hitachi TM-1000). Fluorescent and light microscope images 
were taken using a Nikon Eclipse TE2000-S microscope with an EXFO X-cite 120 
fluorescence illumination system, and a Q-Imaging Micropublisher 3.3 RTV camera with Q-
Capture software.   
6.2.5 Cell culture 
Rat Smooth Muscle Cells (ATCC# CRL-1444) and adult rat aortic endothelial cells (RAEC, 
passage 6–8; Cell Applications, San Diego, CA) were cultured on bare culture plate or on 
coated or uncoated glass slides using 12 well culture dishes. Glass slides were coated with 
PU film, PCL film, or PU/PCL nanofiber composite.  Alamar blue (Serotec) assay was used 
to determine cell viability and proliferation at days 1, 2, 4, and 7 using an absorbance plate 
reader (Spectra max 384 Plus, Molecular Devices). At day 7, cells were fixed in 4% 
paraformaldehyde and stained with AlexaFluor 488 or 543 Phalloidin (Invitrogen) for the 
actin filament inside the cells and 4'-6-Diamidino-2-phenylindole (DAPI, Invitrogen) for the 
cell nuclei. 
6.2.6 Statistical Analysis 
Statistical analysis was performed using SPSS 15.0 version software. The Kruskal Wallis test 
was used to compare mechanical properties obtained from the stress-strain curves using 5 
samples per group.  Students-t-test was used for analysis of Alamar blue metabolic assay.    
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6.3 Results 
6.3.1 Composite mat microstructure 
With our novel fabrication technology, elastic polyurethane (PU) fibers were used as model 
structure to mimic elastin fibers which remained straight and aligned, while polycaprolactone 
(PCL) fibers were used to mimic collagen fibers adopted a wavy aligned orientation.  Figure 
6.2 (C and D) shows the straight-wavy aligned microstructure of a PU-PCL composite mat.  
It was confirmed by fluorescent microscopy that the elastic PU fibers in red remained straight 
while PCL fibers in green adopted a wavy orientation.  
6.3.2 Mechanical behavior  
6.3.2.1 Stress-strain curve 
Composite grafts with a straight-wavy microstructure adopted a J-shaped stress-strain 
behavior, while composite grafts without wavy microstructure did not (Figures 6.4, 6.6a).  
 
Figure 6.4:  Normalized stress-strain curves of PU/PCL composites and native aorta tissue  
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Straight-wavy composite graft displayed an initial region with a low elastic modulus that  
transitioned into a secondary region of high elastic modulus, while control straight fiber 
composites graft displayed an initial high slope region that transitioned into a low slope 
region. Stress-strain curves of straight-wavy and control straight fiber composites plotted 
against native aorta tissue (Figure 6.4) confirm that straight-wavy fiber composites display 
mechanical behavior similar to natural blood vessel tissue. Stress values for the three curves 
in Figure 6.4 were normalized by dividing all values of stress by the maximum stress.  
Normalization allows comparison of the shapes of the stress-strain curves, independent of the 
stress differences. It was confirmed that the location of the elastic-to-stiff region on the 
stress-strain curve for straight/wavy composites corresponded with the straightening of the 
stiff PCL fibers (Figure 6.5).  
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Figure 6.5:  A PU-PCL composite fiber mat stretched to a strain of: 0, 0.1, 0.2, 0.3, 0.4, 0.5, and then 
relaxed to 0.3, 0.1, and 0 (A-I respectively) 
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6.3.2.2 Transition point location shift 
PU-PCL composite fiber grafts that were fabricated with different degrees of rack extension 
(ΔD from Figure 6.3) resulted in composite fiber mats with different degrees of PCL 
‘compression’.  PCL fibers were collected on top of PU fibers with extension of ΔD=56%, 
31%, and 0%, and they were pulled into a wavy orientation by the elastic PU fibers upon 
relaxation back to ΔD=0. The average ‘elastic to stiff’ transition point on the stress-strain 
curve was 0.38, 0.17, and 0 (σ = 0.05, 0.06, 0 respectively) for the extension of ΔD=56%, 
31%, and 0% respectively.  It was found that the transition point was significantly shifted to 
the right of the stress-strain curve according to the degree of PCL compression (p<.01) 
(Figure 6.6a).  
6.3.2.3 Curve shape  
PU-PCL composite fiber mats were fabricated with different material composition ratios.  
The stress-strain curves of three groups with PU:PCL collection times of 15:5, 10:10, and 
5:15 were compared. The shape of the curve was quantitatively calculated as the ratio of the 
slope of the initial and secondary linear regions of the stress-strain curve.  The ratio of these 
two elastic modulus were 3.2, 6.5, and 8.8 MPa  (σ = 0.9, 1.7, 2.4 MPa respectively) for 
PU:PCL collection times of 15:5, 10:10, and 5:15 min respectively.  The difference in elastic 
modulus ratio according to PU:PCL collection times was significant (p<.01) and its relation 
to curve shape is displayed in (Figure 6.6b). 
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Figure 6.6:  Stress-strain curves for PU-PCL composites with (A) varied PU expansion rate (∆D in 
Figure 2) and (B) varied PU to PCL fiber ratios 
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6.3.2.4 Cyclic Loading  
It is essential that any material used as a vascular graft is able to maintain its integrity under 
cyclic loading. It was determined that the stress-strain curve of electrospun PU fibers 
fabricated by our protocol are weakened after the first cycle and then maintain a consistent 
stress-strain behavior for subsequent cycles. A stress-strain curve of a straight PU-PCL 
composite was tested under cyclic loading and it was found that the stress-strain curve had 
some weakening in the elastic region after the first cycle, and consistent mechanical behavior 
for subsequent cycles (Figure 6.7). Visual inspection confirmed that the unique 
microstructure of these composite grafts returned to its initial state after loading and 
subsequent relaxation (Figure 6.5).        
 
Figure 6.7:  Straight-PU/Wavy/PCL composite fiber mat loaded from 0 to 60% strain at 0.05mm/s. 
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6.3.3 In vitro   
Cell viability and proliferation were analyzed using the Alamar Blue metabolic assay. The 
metabolic activity of smooth muscle cells and endothelial cells grown on PU-PCL fiber 
composite graft was compared to that of cells grown on PU film, PCL film, and glass on days 
1, 2, 4, and 7 of culture.  Endothelial cells (ECs) and smooth muscle cells (SMCs) grown on 
fiber mats had higher metabolic scores than cells grown on PU-PCL films for all time points, 
but the increase reached significance only in endothelial cell culture on day 7 (p<0.05).  Both 
smooth muscle cells and endothelial cells adopted an aligned morphology in the direction of 
the aligned PU fibers when grown on composite fiber mats, but not on the films. (Figure 6.8 
a,b,c & d).  
 
Figure 6.8:  SMCs (A,B) and endothelial cells (C,D) cultured on PU-PCL fiber composites (A,D) and 
PCL films (B,E).  The alamar blue metabolic score of SMCs versus cells cultured on well plate control 
are displayed in C, and the alamar blue metabolic scores of endothelial cells versus no cell control wells 
are displayed in D. 
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6.4 Discussion 
According to 2008 estimates of the American Heart Association, the US health care system 
will incur over $448.5 billion in costs for treatment and management of cardiovascular 
disease [29]. Treatment for the most severe cases requires mechanical repair or replacement 
of diseased vessels.  Stenting, the most common repair strategy, is an adequate short term 
solution in some cases, but faces may limitations such as restenosis, platelet activation, and 
vessel wall damage [30, 31]. While stenting comprises 70-90% of revascularization 
procedures, restensosis rates of 20-30% are still seen up to 6 months after surgery in small 
diameter (<5mm) vessels [32, 33]. The gold standard replacement strategy, autologous vein 
transplant, also faces severe limitations. Venous tissue is structurally different from arterial 
tissue and this is reflected in mechanical properties mismatches that lead to restenosis. In 
addition, healthy vein tissue in diseased subjects is often unavailable, especially in repeated 
procedures, and there is morbidity and cost associated with the harvesting procedure.  While 
synthetic grafts are currently available, these grafts do not match the compliance of natural 
vessels and they are less effective that vein transplants. The patency of rates of 
polytetrafluorethyle (ePTFE) or Dacron grafts when used for infrapopliteal arterial 
reconstruction are 20-30% at 4-5 years [34].    
 An ideal synthetic graft must be biocompatible, promote the formation of a strongly 
attached endothelial layer, and match the mechanical properties of the connecting vessel 
tissue.  In this attempt to develop an ideal graft for blood vessel replacement, we primarily 
focused on matching the mechanical properties of the natural vessel in this work because it is 
the most challenging requirement.  Our strategy was to mimic the mechanical properties and 
microstructure of the elastin and collagen structural components of natural blood vessels with 
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a polymer nanofiber composite.  Using this strategy we were able to create materials that 
exhibited the J-shaped stress-strain curve characteristic of the natural blood vessel.  In the 
future study, we will further improve the chemistry of the graft for improved in vitro and in 
vivo outcome of the vascular grafts. 
 While the main focus of this study was to develop a novel technology to fabricate a 
graft that is more mechanically compliant with vascular tissue, this method of fabrication has 
biological advantages as well.  Because of their geometrical similarities to the natural fibers 
of the ECM, electrospun polymer nanofibers provide excellent substrates for strong 
endothelial cell attachment in the lumen of vascular grafts and SMCs grown on the nanofiber 
scaffolds adopted an aligned morphology similar to that seen in natural blood vessels.  The 
electrospinning method of fabrication also allows direct incorporation of drugs, proteins, and 
growth factors for slow release.   
 While mechanical testing results for this graft are very promising, the stresses 
experienced by an actual vessel implant are much more rigorous. Further testing will be 
required in the future to confirm whether or not this material is suitable as a vascular graft for 
long term implantation, but preliminary tests were promising.  Most of the mechanical data 
collected was for dry samples, but straight-wavy composites that were hydrated did retain the 
same J-shaped stress-strain behavior.  In addition it was determined that the straight/wavy 
microstructure and the mechanical behaviors associated with that microstructure remained 
consistent over multiple loading cycles.  While this material still must be tested under in vivo 
physiological conditions, experimental evidence leads us to believe that it could withstand 
such conditions. 
The greatest advantage of this method of fabrication is its versatility.  The mechanical 
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properties of straight/wavy fiber composite materials can be modified by several methods to 
allow fine-tuning of mechanical properties. Fine-tuning may be accomplished by changing 
the material components of the composites or by changing their structure.   
While most of these experiments were conducted using PU:PCL composite 
structures, this fabrication technology is by no means limited to any specific material.  
Preliminary data has shown that PU:PLGA and PU:PLLA composite nanofiber mats 
fabricated using the same procedure also adopted a straight-wavy microstructure and a J-
shaped stress-strain profile.  It is hypothesized that any material that can be electrospun could 
be incorporated into a straight-wavy composite material using this fabrication method. For 
instance, this fabrication method could be used to make both a degradable and a non-
degradable vascular graft by changing the polymer materials used as the straight/elastic and 
wavy/stiff fibers. The mechanical properties of individual fibers can even be modified 
without changing material types.  Electrospinning parameters can be modified to change the 
diameter and microstructure of individual fibers and thus their mechanical properties.  
 The mechanical properties of these straight-wavy fiber composite materials can also 
be modified without changing the material of its components.   It was demonstrated that the 
location of the elastic-to-stiff region of the stress-strain curve is shifted when the degree of 
“waviness” of stiff fibers is modified.  It was also demonstrated that the shape of the stress-
strain curve of composites changes when the ratio of straight/elastic to stiff/wavy fibers is 
modified.   
In summary, the mechanical properties of these fibrous composite materials can be 
fine tuned by: 1) the modification of individual fiber components, such as material selection 
and fiber microstructure (i.e. diameter, porosity…), and 2) the modification of composite 
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microstructure, such as the degree of stiff fiber “wavyness” and the ratio of fiber components.  
All of these versatilities allow great flexibility for designing straight-wavy electrospun 
nanofiber composites with fine tuned mechanical properties.  In addition, while a two-
component system was used in the examples presented, there is certainly no limit to the 
number of different components that may be used in the design of these composite grafts.   
Such versatility allows great potential for fabrication of nanofiber composite materials that 
closely match the mechanical properties of any vessel in the body.   
Because this material can be assembled as very thin (a few microns) mechanically 
stable sheets, it is well suited for use as a component in tissue engineering strategies for 
vascular grafts. Several tissue engineered vascular grafts have been developed with 
promising results [1,4, 35].  Many of these strategies incorporate long term bioreactor culture 
to impart mechanical integrity. Thin nanofibrous composite sheets with optimized 
mechanical properties could offer additional mechanical strength and very quick cell 
alignment from this onset of graft fabrication.   
6.5 Conclusions 
Treatment of cardiovascular disease is currently limited by a lack of adequate vessel repair 
and replacement strategies. One of the likely mechanisms for failure of current vascular 
implants is the mismatch of mechanical properties when compared to natural tissue.  
Nanofibrous composite materials were fabricated that mimicked the microstructure and 
mechanical properties of the elastin and collagen fiber components of natural vessels.  
Mechanical testing confirmed that these composite materials demonstrated a J-shaped stress-
strain behavior similar to natural blood vessels. The versatility for fine-tuning the mechanical 
properties of such a composite was demonstrated by altering the arrangement and ratio of the 
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elastic and stiff fiber components in composite scaffolds. The feasibility of these grafts for 
use as vascular implants was demonstrated by confirmation of endothelial and SMC 
attachment, survival, and alignment on composite materials. In addition it was confirmed that 
the mechanical properties and microstructure of composite materials maintained their 
integrity after cyclic loading and in both dry and hydrated state.  An ideal synthetic graft 
must be biocompatible, allow for the formation of a strongly attached endothelial layer, and 
match the mechanical properties of the natural surrounding vasculature. These composite 
grafts address all three key requirements. The straight/elastic-stiff/wavy nanofibrous 
microstructure of these composite materials matched the mechanical properties of natural 
blood vessels and allowed for the strong attachment and alignment of endothelial and smooth 
muscle cells.  The versatilities of these composite scaffolds allow for fine-tuning of 
mechanical properties that cannot be achieved with a single material structure.  Vascular 
grafts with improved patency could be fabricated by incorporation of a straight/elastic-
wavy/stiff nanofibrous microstructure that allows close matching of mechanical properties to 
that of surrounding vessel segments.   
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CHAPTER 7 
7.  VASCULAR GRAFTS ASSEMBLED FROM BIOMIMETIC NANOFIBROUS 
COMPOSITES THAT MATCH THE MICROSTRUCTURE AND COMPLIANCE OF 
NATURAL BLOOD VESSELS 
7.1 Introduction   
Cardiovascular disease is the cause of more deaths than any other disease in Western 
societies, and costs our health care systems hundreds of billions of dollars each year [1]. 
Diseased blood vessels in the coronary and peripheral vascular system must be repaired or 
replaced with the goal of reestablishing normal blood flow patterns. While blood vessel 
replacement with synthetic grafts may be an ideal treatment in some cases, current synthetic 
grafts are not effective as small diameter (<6 mm) vessels replacements due to very low 
patency rates. For example, the patency of rates of polytetrafluorethyle (ePTFE) or Dacron 
grafts when used for infrapopliteal arterial reconstruction are 20-30% at 4-5 years [2].    
A better synthetic vascular graft for small diameter vessel replacement is clearly a need.  
 It is hypothesized that a vascular graft may fail due to three primary mechanisms: 
(1)Thrombosis due to  activation of the coagulation cascade by the graft. (2) Restenosis 
brought about by compliance mismatch or inflammatory response, and (3) infection [3].   Our 
goal is to develop a method to fabricate vascular grafts with optimized, highly tunable 
mechanical properties to address the issue of failure by compliance mismatch. The term 
‘compliance’ is commonly used when the mechanical properties of a vascular graft are 
compared to that of its neighboring natural vascular. Compliance (C=ΔVolume/ΔPressure) 
describes the relationship of vessel distention to the internal pressure and is related to the 
circumferential elasticity of the vessel wall. Compliance mismatch may result in 
hemodynamic blood flow disturbances and stress concentrations at the anatomosis of a 
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vascular graft as shown in Figure 7.1 [4]. Hemodynamic flow variations can result in areas of 
increased shear stress, which may damage the endothelium, and decreased shear stress [5], 
which may lead to areas of stagnation, chemokine pooling [6], and increased platelet 
interactions and oscillatory forces [7]. Stress concentrations can bring about tissue 
remodeling that results in intimal thickening, which eventually leads to graft failure. It has 
been reported that turbulent flow caused by compliance mismatch may bring about intimal 
hyperplasia or aneurysm and result in poor graft patency [8-9].  
 
Figure 7.1: Schematic of non-compliant vascular grafts.  (A) Grafts with compliance greater than 
neighboring vessels undergo a greater degree of expansion due to internal blood pressure, and (B) grafts 
with compliance lower than neighboring vessels undergo less expansion. In both case, geometric 
inconsistencies result in blood flow turbulence and stress concentrations at the anatomosis.  
 Designing a vascular graft with compliance that matches that of the natural vascular 
is difficult because the compliance of natural blood vessels is not uniform, and varies with 
the degree of wall distension. The vascular system must be elastic to provide capacitance and 
pulse smoothing to blood flow, but must also offer stability over a wide range of pressures. In 
order to address both of these needs, blood vessels are relatively elastic at low levels of 
vessel distention (less than around 140-160% of initial diameter), but and their stiffness 
increases rapidly at vessel distention above that value. The mechanical profile of the vascular 
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wall adopts a J-shaped curve that reflects this behavior as shown in Figure 6.1. It has been 
hypothesized that this J-shaped mechanical behavior is due to the contributions of the 
relatively elastic elastin fibers and much stiffer collagen fiber components of vascular wall. 
Roach and Burton [10] provided evidence to support this theory when they compared the 
mechanical properties of a vessel wall that had its elastic fiber component digested by trypsin 
to a vessel wall that had its collagen fiber component digested by formic acid. It was found 
that the sample containing elastic fibers had a mechanical profile similar to a control vessel 
as low levels of vessel distention, and that the sample containing collagen fiber had a 
mechanical profile similar to a control vessel at higher levels of distention (Figure 6.1). The 
mechanism that allows collagen to contribute to the strength of the vessel in such a way may 
be explained by the microstructural arrangement of collagen in the vessel wall. Collagen 
fibers in the natural blood vessel exhibit a wavy or helical orientation at mean physiological 
pressure [11]. Because these collagen fiber bundles do not appear to be taut at low levels of 
vessel distention, they may not contribute much to resisting expansion until the vessel wall is 
distended enough to where they are fully straightened [12]. It can be hypothesized that elastin 
fibers dominate the mechanical behavior of the vessel at low pressures and thus distention, 
and that as pressure and distention increases progressive recruitment of collagen fibers 
dominate the mechanical behavior and result in increasing stiffness.   
 We previously showed that the J-shaped mechanical behavior of blood vessels could 
be mimicked with a two component nanofiber structure where one component was relatively 
elastic and the other relatively stiff compared to one another and where the stiffer component 
exhibited a waved orientation [13]. It was our goal to use this novel concept to fabricate an 
implantable vascular graft that retained this optimized mechanical behavior, similar to natural 
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blood vessels, both in vitro and in vivo, and both before implantation and after implanted or 
retrieval. 
7.2 Materials and Methods 
7.2.1 Electrospinning 
Wavy nondegradable nylon 6 (Arcos, New Jersey, USA) nanofibers and straight 
nondegradable medical grade aliphatic polyether polyurethane (PU, Tecoflex SG-80A, 
Noveon, Cleveland, OH) nanofibers were electrospun from their polymer solvent solutions.  
Nylon was dissolved in hexafluoro-2-propanol (HFIP, Oakwood, West Columbia, SC) at 
30% wt/v and PU was dissolved in HFIP at 12% wt/v.  Polymer solutions were doped with 
poly(ethylene glycol) (PEG, M.W. 400, Arcos, New Jersey, USA), amine terminated 
polypropylene glycol-block-PEG (PEG-NH2, Sigma 14527), or gelatin (Fisher S80023-1, 
Rochester, NY). Doping concentrations used were 1 & 10%(w/w) vs. PU and 2% vs. nylon, 3 
& 30% vs. PU and 7% vs. nylon, and 5 & 20% vs. PU and 10% vs. nylon respectively.  
Aligned PU fibers were electrospun using low concentration doping agent solutions and 
randomly aligned PU fibers were electrospun using high doping agent solutions. Polymer 
solutions were feed by a syringe pump (Medfusion 2010i; Smiths Medial Inc., Carlsbad, 
CA,USA) at a feed rate of 0.025 ml/min through 1/16” polyethylene tubing into a 21g blunt 
tipped needle (Smallparts, Miramar, FL). A voltage of 8-12kV was applied to the needle tip 
with a high voltage power supply (ES40P-10W, Gamma High Voltage Research, Ormond 
Beach, FL). The needle tip was held at 10 cm above a custom build collecting device [14]. 
7.2.2 Biomimetic vascular graft fabrication 
Biomimetic vascular grafts with wavy and straight nanofiber structures were made using a 
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custom build device designed in our laboratory [14] and detailed methods were described in 
Chapter 6.  
7.2.3 Heparin immobilization 
A 0.05M MES buffer was prepared with a pH of 5.6 and warmed to 37ºC. Heparin (Sigma, 
H4784), N-Hydroxysuccinimide (NHS, Sigma 130672), and 1-Ethyl-3-(3-
dimethylaminopropyl) carbodimide (EDC, TCI America), were added to the buffer solution 
at 0.2%, 0.12%, and 0.2% respectively and incubated for 10 minutes to activate heparin. 
Samples were added to the solution and incubated for 4 hours then removed and washed in 
water 5 times over 24 hrs.   
7.2.4 Mechanical testing 
Mechanical tests were performed using a BioTester5000 Biaxial Test System (CellScale 
division of Waterloo Instruments Inc., Waterloo, Ontario, Canada) with a 10N load cell (ring 
samples ~1mm in length for data shown in Figure 7.6) and a Shimadzu EZ Graph tensile 
tester (Nakagyo-ku, Kyoto, Japan) with a 50N load cell (ring samples ~2.5 mm in length all 
other data). All mechanical testing was performed in PBS warmed to 37 ºC. Circumferential 
strength was evaluated by inserting two rods through the lumen of small ring samples of 
grafts or explant tissue followed by tensile displacement to failure. Force data was halved to 
reflect the wall strength of a single piece of vessel. Fatigue testing was performed by 
straining rings to around 200% diameter at 250um intervals for 100 cycles.  
7.2.5 Surgical Implantation 
Female New Zealand white rabbits at least 8 months old were anaesthetized and shaved. An 
incision was made and the right carotid artery was exposed. Heparin was administered 
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intravenously at 10U/kg prior to surgery. Distal and proximal ends of a section of vessel were 
clamped to prevent blood flow through the vessel. End to end procedure was used for the 
vessel replacement surgery, the section of vessel was clamped to prevent blood flow and the 
vessel was cut between the clamps. The graft was sutured end to end directly the cut ends of 
the vessel using interrupted 6-0 prolene sutures. In all cases blood flow through the graft was 
confirmed by flushing the graft by tweezers and observation of graft re-expansion. A total of 
8 rabbits were treated (5 bimimetic microstructure, 3 control).   
7.2.6 Histology 
Rabbits were sacrificed at 3 months after graft implantation. Grafts were cut out with 
portions of the distal and proximal vessel. The tissue was trimmed and a segment was cut 
from either end that included the anastomosis and approximately 1mm of the graft and or 
tissue on each end. The remaining portion of the graft was cut into rings approximately 1mm 
in length. Samples for histology were fixed in 4% paraformaldehyde overnight and 
embedded in paraffin. Serial sections were stained with hematoxylin and eosin for general 
microstructure, modified Masson trichrome stain for extracellular matrix, and immunostained 
with anti α-smooth muscle actin (Sigma, A5228) to identify smooth muscle cells. SEM 
images were taken with a scanning electron microscope (SEM, Hitachi TM-1000). Samples 
were not sputter coated.  
7.2.7 X-ray photoelectron spectroscopy (XPS) 
Samples were fabricated from solutions doped with PEG, PEG-NH2, and gelatin as described 
above. Three groups were analyzed using XPS: (1) Complete EDC heparinization reaction 
(2) Control EDC reaction without heparin added (3) Control washed with water only. XPS 
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measurements were carried out on the Kratos AXIS Ultra DLD XPS system equipped with a 
hemispherical energy analyzer and a monochromatic Al Kα source.  
7.3 Results 
7.3.1 Graft morphology   
Tubular vascular grafts with similar dimensions to the explanted rabbit carotid artery were 
assembled using the fabrication methods described above and displayed in Figure 7.2A-C. 
Biomimetic grafts maintained a straight-wavy biomimetic nanofiber microstructure within 
the tubular grafts (Figure 7.2D). For control grafts, all fibers remained straight (Figure 7.2E).  
Biomimetic grafts appeared to have thicker walls and greater porosity when compared to 
control grafts.  
 
Figure 7.2:  Gross morphology of rings cut from (A) tubular nanofiber graft with biomimetic 
microstructure, (B) tubular nanofiber graft with control microstructure, and (C) rabbit carotid artery 
explant. SEM images of nanofibrous microstructure of (D) tubular nanofiber graft with biomimetic 
microstructure (E) tubular nanofiber graft with control microstructure 
B
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7.3.2 Grafts mechanical properties 
Biomimetic and control grafts were cut into ring sections and circumferentially strained by 
pins inserted into the lumen of the rings. Biomimetic grafts displayed a J-shaped mechanical 
profile characteristic of natural vascular tissue, while control grafts did not (Figure 7.3A). 
Graft mechanical properties could be optimized by varying (1) the ratio of PU to nylon fibers, 
(2)the total amount of nanofibers, and (3)fiber sheet width reduction (D in Figure 6.3).  
7.3.2.1 Optimizing grafts mechanical properties 
Because fiber deposition is steady state with our collecting device, the ratio of PU to nylon 
fibers could be modified by changing the collection times for each polymer type.  
 
Figure 7.3: Force vs. increase in diameter of ring samples strained by a tensile testing machine: (A) 
Mechanical profiles of an optimized biomimetic nanofiber graft, control nanofiber graft, and rabbit 
carotid artery explants. (B) Length reductions of 0%, 20%, and 29% during fabrication caused different 
degrees of nylon fiber “wavyness” and thus required greater level of strain to reach the mechanical 
profile transition point.  
The overall strength of tubular grafts can be increased by increasing the total amount of 
nanofibers in the structure. All grafts presented contained both PU and nylon nanofibers were 
electrospun for 45 total minutes each. The amount of fibers of each type appeared to be 
similar. These values were selected in an attempt to optimize grafts to mimic the 
circumferential mechanical profile of the rabbit carotid artery. Many grafts were evaluated 
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and screened in selecting these two parameters (data not shown).  
The location of the transition point in the J-shaped mechanical profile, which 
represents the value of strain at which the strength of the graft rapidly increases, could be 
predictably moved by modifying the fiber sheet width reduction distance (D in Figure 6.3). 
Fiber sheet width reductions after nylon nanofiber deposition resulted in buckling of the 
nylon fibers and caused them to adopt a wavy orientation. As the width reduction increased, 
the “wavyness” of the nylon fibers increased, resulting in a shift of the mechanical profile 
transition point to higher values of strain. Grafts with several different values of  D (Figure 
6.3) were evaluated in an attempt to optimize grafts to mimic the circumferential mechanical 
profile of the rabbit carotid artery. A graft that closely matched the mechanical properties of a 
rabbit carotid artery explants was fabricated using a protocol where nylon fibers in these 
sheets buckled to conform to a 20% reduction in length (Figure 7.3A). The circumferential 
strength of optimized grafts was tested under cyclic loading conditions in order to evaluate 
the fatigue strength of the grafts. A ring sample was strained to approximately 200% initial 
diameter for 100 hundred cycles while immersed in PBS at 37ºC to simulate physiological 
conditions. The maximum force reached for each cycle remained unchanged throughout the 
duration of the test, indicating that grafts are able to withstand cyclic strains without 
permanent deformation or reduction in strength. Optimized grafts were evaluated in vivo in a 
rabbit carotid artery model.   
7.3.3 Heparin attachment 
Heparin attachment to nanofiber scaffolds was analyzed using XPS (Figure 7.4). Nanofibers 
grafts electrospun from solutions blended with PEG, PEG-NH2, and gelatin were analyzed. 
Heparin attachment was confirmed by peaks in an XPS spectrum at around and 164eV for 
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S2p and 228eV for S2s. These two peaks correspond to the –OSO3 and –NSO3 moieties in 
heparin. Three groups were used: (1) Sampled heparinized with EDC reaction, (2) control 
samples where EDC reaction was performed without the presence of heparin, and (3) control 
washed in distilled water. For all three groups, group 3 had negligible peaks at 164eV for S2p 
and 228eV for S2s. Group 2 had a small peak at 164eV for S2p and 228eV for S2s and group 
1 had pronounced peaks at 164eV and 228eV. Within group1, grafts containing gelatin and 
PEG-NH2 with free amine functional groups available for covalent heparin binding had more 
pronounced peaks than grafts containing PEG without free amine groups. Results indicate 
that heparin is present in all grafts subject to the heparinization surface functionalization 
reaction. A small portion of the S2p and S2s signals detected appears to be due to the EDC 
reaction, which would indicate that some of the MES buffer remained within the scaffolds. It 
also appeared that a portion of the heparin incorporated into the scaffolds was due to physical 
absorption as indicated by the S2p and S2s peaks in grafts blend with PEG that contained no 
functional groups capable to covalently attaching to heparin in the EDC reaction. 
 
Figure 7.4:  XPS analysis of grafts blended with gelatin, PEG-NH2, or PEG surface functionalized with 
heparin via EDC crosslinking reaction. (A) Comparison of spectra for gelatin blended grafts that were 
heparinized with EDC crosslinking reaction, underwent EDC crosslinking reaction without the presence 
of heparin, or left untreated. (B) Comparison of spectra for gelatin, PEG-NH2, and PEG grafts that 
were heparinized with EDC crosslinking reaction.  
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7.3.4 In vivo testing  
A preliminary in vivo study was conducted to evaluate the potential of such grafts as vascular 
replacement grafts. Eight grafts were implanted into the carotid artery of rabbits (5 
biomimetic & 3 control) (Figure 7.5A). Grafts preformed very well during surgical 
implantation. No stretching or tearing was evident during rigorous surgical manipulation, 
sutures held tight without tearing, and blood leakage though the grafts was not apparent. 
Blood flow though the grafts after implantation was confirmed. Grafts were removed after 3 
months in vivo. Grafts remained similar in appearance to pre-implantation from the outside 
and in ring cross sections. Explanted biomimetic and control grafts are shown in (Figure 
7.5B-E).  
 
Figure 7.5:  Pictures of: (A) Implanted graft. (B) Biomimetic and (D) control grafts removed after 3 
months in vivo. Ring segments cut from explanted (C) biomimetic and (E) controls grafts. Sections taken 
from explanted biomimetic grafts stained with (F) H&E, (G) modified Masson’s, and (H) anti-smooth 
muscle actin. Scale bars are 2mm (B&D), 1mm (C&E), 500um (F), and 50um (G&H)  
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Histology confirmed that biomimetic grafts maintained their ‘wavy’ microstructure, 
while control grafts contained all straight fibers. Infiltration of cells as well as ECM 
deposition within the grafts was also confirmed (Figure 7.5F-H). Modified Masson trichrome 
stain for extracellular matrix identified collagen disposition (light blue, Figure 7.5G) within 
the grafts and immunostaining for α-actin smooth muscle antibodies positively identified 
smooth muscle cell infiltration (brown, Figure 7.5H) deep within the microstructure of the 
grafts. Histology confirmed that grafts remained open at their center. A ring was cut from the 
center of the biomimetic and control grafts and mechanically tested to confirm whether 
optimized mechanical properties could be maintained throughout long term in vivo 
implantation. Results of this test confirmed that biomimetic graft did maintain a J-shaped 
mechanical profile, while control grafts did not (Figure 7.6).    
 
Figure 7.6:  Force vs. % initial diameter plotted for ring samples of native rabbit carotid artery and 
biomimetic and control grafts explanted after 3 months in vivo. 
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7.4 Discussion 
The goal of this study was to investigate the feasibility of designing a highly compliant 
vascular graft using a two component hybrid electrospun nanofiber material with biomimetic 
microstructure. Previous we developed hybrid nanofiber structures with a relatively elastic 
component in a straight aligned orientation and a relatively stiff component in a ‘waved’ 
aligned orientation. These composite nanofiber grafts adopted a two phase ‘J-shaped’ 
mechanical profile that is similar to that observed in several natural tissues. It was 
demonstrated that biomimetic mechanical properties corresponded to the precisely designed 
microstructure of the hybrid sheets.  
There is an obvious need for a better vascular graft because current options for small 
diameter vessel replacement demonstrate unacceptably low patency rates [2]. Vascular graft 
design is a complex process because of several modes of failure that led to several sets of 
requirements. It is generally accepted that vascular grafts may fail due any of three 
mechanisms: (1) Thrombosis due to activation of the coagulation cascade by the graft. (2) 
Restenosis brought about by compliance mismatch or inflammatory response, and (3) 
infection. Therefore, a vascular graft must be made with non-thrombogenic properties, 
promote rapid and complete endothelialization, match the mechanical properties of natural 
vessels, be biocompatible, and be implanted under sterile conditions.  A major difficulty in 
vascular graft design is that several of these properties are not related to one another, and 
therefore it is hard to design a single material that fits all of those needs. It was our goal to 
show that the mechanical properties of a vascular graft can be optimized for a wide variety of 
different materials by using precise microstructural arrangement. Thus, materials with 
excellent bioactivity and non-thrombogenicy that are non-compliant may be used to design a 
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compliant vascular graft. The ratio of mechanical strength of elastin digested blood vessel 
tissue vs. collagen digested tissue is around 30:1 (Figure 6.1). It can be hypothesized that a 
hybrid nanofibrous vascular graft where the ratio of the strength of the elastic straight fiber 
component and the stiff wavy fiber component is around 30:1 would mimic natural vessel 
behavior. We would hypothesize that any two materials with an elastic modulus ratio from 
around 10:1 to 100:1 could be arranged in a composite with an overall 30:1 ratio by 
modifying the total number and diameter of the nanofiber of each type. We expect that 
compliant vascular grafts may be fabricated from a very wide range of polymer materials 
using this method because many polymers can be easily electrospun into nanofibers.  
 In this study we used polyurethane as a relatively elastic material and nylon as a 
relatively stiff material. These materials are not known to be especially non-thrombogenic or 
bioactive, and in addition, the polyether based polyurethane may not be ideal for long term 
implantation due to potential for stress cracking [15]. However these materials were selected 
based on availability, cost, and very slow biodegradability properties, as model materials 
with which to test the mechanical performance of biomimetic fibrous grafts. Our goal was to 
show that two materials with such mechanical properties could be used to fabricate a durable 
vascular graft with highly tunable compliance that could withstand surgical implantation and 
retain its structural and mechanical properties long term in vivo.  
 It was demonstrated that tubular vascular grafts could be fabricated with geometry 
and mechanical properties that were remarkably similar to that of natural blood vessels. The 
mechanical profile of these grafts could be predictably tuned by modifying the precise 
orientation of nanofiber microstructure. Durable grafts were able to withstand surgical 
implantation, and blood flow though the grafts was confirmed without leakage. Grafts 
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removed after 3 months in vivo demonstrated smooth muscle cell infiltration and collagen 
production deep within the graft walls. Nanofiber microstructure and biomimetic mechanical 
properties appeared to be maintained in after long term in vivo implantation. It was our hope 
to show that the mechanical properties of an electrospun hybrid biomimetic vascular graft 
could be optimized by modulating microstructure, that such a graft would be durable enough 
for surgical implantation, and that mechanical properties would not change during long term 
in vivo implantation. Microstructure and mechanical properties appeared to be unaffected by 
long term implantation. Overall the results of this study demonstrate the potential of this 
technology for the design of a compliant vascular graft.  
7.5 Conclusions 
A method of fabricating hybrid nanofiber sheets with biomimetic microstructure and 
mechanical properties was previously designed. It was our hypothesis that a compliant 
vascular graft could be fabricated with wavy and straight nanofiber morphology to best 
mimic the mechanical properties of natural blood vessels. Evaluation of grafts in vivo 
demonstrated that these grafts were durable enough for surgical implantation and were able 
to retain their desirable mechanical properties during long term in vivo implantation. The 
results of this preliminary study demonstrates the potential of this technology in vascular 
graft fabrication. The versatility of this technology in allowing for highly compliant graft 
fabrication from materials with a wide range of mechanical properties highlights its potential 
in small diameter vascular graft applications.  
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CHAPTER 8 
8.  ENGINEERING SKELETAL MUSCLE TISSUE WITH MYOBLAST CELL 
SEEDED ALIGNED NANOFIBER SHEETS 
8.1 Introduction 
Failure of adult skeletal muscle tissue to regenerate often occurs after traumatic injury, tumor 
ablation, congenital disorders, and other myopathies [1]. Currently, the standard treatment for 
radical muscle tissue loss is transfer from donor sites.  However, this practice often results in 
significant donor site morbidity and loss of function [1]. Recently, tissue engineering 
approaches have been developed that show much promise in generating functional skeletal 
muscle tissues for transplantation that may replace conventional donor site transplantation.  
In addition to transplantation, engineering skeletal muscle tissues provide useful models for 
the study of skeletal muscle development and drug screening that may replace the use of 
animals [2].    
Traditional tissue engineering approaches to skeletal muscle involve seeding 
myoblasts onto biodegradable, biocompatible scaffolds, followed by differentiation induction 
before in vivo implantation.  Since native muscle tissue is characterized by aligned, multi-
nucleated myotubes that are ideal for producing uniaxial contractile forces, many approaches 
have focused on generating these aligned myotubes in vitro. Successful approaches include 
seeding cells onto aligned electrospun nanofibers [3-5] and seeding cells onto micropatterned 
surfaces [6]. Skeletal muscle cell progenitor cell lines, such as C2C12 myoblasts and 
explanted skeletal muscle cells cultured on aligned electrospun nanofibers exhibited 
significantly greater alignment and myotube formation compared to cells cultured on 
randomly aligned fibers [3, 7]. Myotube contractility also appeared to be increased on 
aligned nanofibers as indicated by correctly arranged sarcomeric contractile machinery [7].  
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In order to utilize the advantages of aligned nanofibers in skeletal muscle tissue 
engineering, scaffolds must be designed in a way that is practical for functional muscle 
transplantation procedures. One promising approach is cell sheet engineering. The potential 
applications of cell sheet substrates for tissue engineering include thin sheet applications as 
well as other applications where thicker substrates are fabricated from stacks of cell sheets 
[8]. Aligned electrospun nanofibers were used to fabricate aligned cell sheets with uniaxial 
cell alignment useful in skeletal muscle engineering [9]. Because cell sheets do not include a 
biomaterial component they are not limited by biocompatibility issues and hindrance to cell-
cell contact and mass transport that may be associated with scaffolds. However, 
disadvantages of this approach include relatively long cultures times required for sheet 
formation, mechanical and structural weakness, and difficulty in manipulating individual 
sheets. Tight adhesions are required for layer-by-layer stacking of cell sheets, and their 
tendency to fold and contract make this difficult. We developed an alternative approach to 
aligned cell sheet tissue engineering that retains some of the advantages of cell sheets, while 
also addressing some of its weakness. It was our hypothesis that free suspended ultra thin 
nanofiber sheets could be used to culture confluent aligned skeletal muscle cell sheets. The 
nanofiber component improves the mechanical properties of the substrate, and because these 
scaffolds are inherently fixed at their edges they are much easier to manipulate for three 
dimensional structure assemblies. However, a very low fiber density allows for retention of 
cell-cell contacts and mass transport advantages associated with conventional cell sheet tissue 
engineering.  
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8.2 Materials and Methods 
8.2.1 Electrospinning 
Polycaprolactone (PCL, Mn~80,000, Sigma, St. Louis, MO) was dissolved in 
dichloromethane and dimethylformamide (3:1) (DCM:DMF, Sigma) at a concentration of 
17% wt/v. Polymer solution was feed by syringe pump (Medfusion 2010i; Smiths Medial 
Inc., Carlsbad, CA, USA) at a rate of 0.025 ml/min through a 21 G blunt tipped needle. A 
voltage of 9 KV was applied to the needle tip with a high voltage power supply (ES40P-
10W, Gamma High Voltage Research, Ormond Beach, FL, USA). Nanofibers were collected 
using a custom built collecting device designed in our lab [10]. The device utilized 
electrostatic forces to deposit aligned nanofibers across the air gap between two parallel 
plates as described by Li et al [11]. However static parallel plates were replaced by 
conductive mobile tracks, which continuously distribute and assemble the aligned fiber arrays 
into mats with controllable fiber density. The needle tip was held at 10cm above this device 
during electrospinning, while the parallel mobile tracks pulled electrostatically aligned 
electrospun fiber arrays into a secondary collection area at a vertical speed of 21 mm/s. Ultra 
thin aligned fiber mats were assembled on a rectangular rack simultaneous to fiber collection 
and fiber density varied with collection times from 5 to 30 minutes. Ultra-thin aligned PCL 
nanofiber sheets were fixed to thin 25mm inner diameter stainless steel rings (Bokers, 
Minneapolis, MN) with medical silicon (NuSil) for in vitro cell culture. Aligned nanofiber 
mats with variable density were fabricated by modifying the collection time.  
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8.2.2 Cell culture 
C2C12 myoblasts were cultured in T-75 flasks to near confluence in DMEM media with 10% 
fetal bovine serum (FBS). Aligned nanofiber scaffolds were sterilized in 6 well plates in 75% 
ethanol for 30 minutes, washed twice with PBS, and covered with media. Cells were 
trypsonized and resuspended in media at approximately 1 million cells per ml. 
Approximately 0.5ml of cell suspension was dripped evenly over each scaffold. Cells were 
dripped directly onto the tissue culture plate surface for controls that contained no scaffolds. 
Scaffolds were incubated in DMEM media supplemented with FBS for 5 days. After 5 days 
some scaffolds were incubated in DMEM with 10% horse serum (HS) to induce 
differentiation into myobtubes. Media was changed every 48 hours.  
 Nanofiber/fibrin gel composite thin films were fabricated using a procedure similar to 
one previous developed in our laboratory [12]. However, our new modified method, shown in 
Figure 8.1, allowed for direct cell incorporation during film fabrication. Fibrinogen (Bovine, 
MP Biomedicals 154165) was dissolved in PBS at a concentration of 15mg/ml and vacuum 
filtered with grade 417 filter paper to remove particulate, and a 0.22µm filter for sterilization. 
Thrombin (Bovine, MP Biomedicals 154163) was dissolved in DMEM culture media and 
sterile filtered with a 0.45µm syringe filter. Myoblast cells were suspended in fibrin and 
thrombin solutions at concentrations of approximately 500,000 cells/ml. An aligned 
nanofiber sheet was immersed in each solution and removed to form a thin liquid film. The 
fibrinogen and thrombin liquid films were then combined and allowed to polymerize into a 
fibrin gel film. Some fibrin scaffolds were incubated in media supplemented with tranexamic 
acid (trans-4-aminomethyl-cyclohexane-1-carboxylic acid, t-AMCA) at a concentration of 
160ug/ml to inhibit fibrinolysis [13]. 
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Figure 8:  Aligned nanofiber-fibrin film composite fabrication. (A) Mounted nanofiber arrays are 
immersed in (B) fibrinogen (yellow) and thrombin (red) solutions containing suspended cells (blue). (C) 
Removal from the liquid results in the formation of a thin uniform liquid film over the nanofiber array. 
(D) Fibrinogen and thrombin films are sandwiched together to and allowed to mix. (E) Polymerization 
reaction results in crosslinked fibrin film with embedded nanofibers and cells.  
8.2.3 Three-dimensional structure fabrication 
Two dimensional aligned nanofiber/cell sheets were used to assemble 3-dimensional tissue 
engineering scaffolds. Two different methods where developed to demonstrate the potential 
of these structures as assembly blocks for engineering 3D tissues. Several layers were stacked 
layer-by-layer to form thick discs from the single layer sheets (Figure 8.2F). Up to 15 single 
layer nanofiber/cell sheets were stacked on top of one another on a supporting ring with a 
15mm inner diameter. Four posts extending vertically from the face of the ring served to hold 
the layers in place. A second ring with holes cut to match the post locations was placed on 
top of the construct to sandwich the nanofiber/cell sheets together and secure them. 
Constructs were cultured for 5 days to allow cell layers to adhere to one another.   
A B C D E
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Figure 8.2: Aligned nanofiber-cell sheets were cut (yellow dotted line) in a pattern shown in A-D to 
promote self assembly into a tubular structure and bound together using sutures (E). A crosssection of 
this scaffold stained with H&E is shown in H. Aligned nanofiber-cell sheets were stacked on a secondary 
support ring (F) to form thick multilayered tissue constructs. The cross section of a 6 layered tissue 
construct (G) demonstrates cell alignment.  Scale bar is 50µm. 
 
Three dimensional aligned nanofiber/cell structures were also fabricated from the 
nanofiber/cell sheets using a novel technique. When ultra thin aligned myoblast/nanofiber 
sheets were cut according to the method shown in Figure 8.2A-E, they demonstrated a natural 
tendency to self assemble into bundled structures. Surface tension from the media covering 
the sheet and mechanical tensions within the nanofiber resulted in an oval shaped hole when 
sheets were cut along the direction parallel to nanofiber/cellular alignment (Figure 8.2A). The 
sheet was then cut in the direction perpendicular of nanofiber/cell alignment starting at the 
ends of this hole resulting in spontaneous folding of a portion of the sheet over itself (Figure 
8.2B-D). After most of the sheet had been cut away, a thin tubular structure attached at both 
ends to its metal ring support remained. Tubular scaffolds were tied off on each end with 6-0 
sutures and cut from their ring supports (Figure 8.2E). Larger scaffolds were fabricated by 
bundling up to 8 filaments together.  
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Thick nanofiber/fibrin gel composites containing cells were fabricated by layer-by-
layer stacking as well. One fibrin composite film was fabricated, placed on a glass cover slip 
and allowed 2 minutes to polymerize. The following layer was added immediately after 
fibrinogen and thrombin combination to promote adhesion between layers. Fibrin layers were 
cut away from their steel support rings after polymerization. In contrast to layer-by-layer 
fabrication methods utilized for cell-nanofiber stacks, no support ring was necessary because 
layers adhered well to each other due to fibrin polymerization.  
8.2.3 In vivo implantation 
Mice were anesthetized  and an incision was made along the spine to expose the 
paravertebral muscle. An incision was made along the paravertebral muscle of approximately 
15mm in length and 2mm in depth. Nanofiber bundles with or without cells were placed in 
the incision and sutured at both ends so that they remained taut. The muscular and skin 
incisions were then closed. Mice were sacrificed and the grafts were removed with 
surrounding tissue for histological evaluation. Explanted grafts were embedded in OCT 
compound and cyrosectioned at 5-30um.    
8.2.4 Histology/Immunohistochemistry 
Cells were fixed in 4% paraformaldahyde for 45minutes or 2.5% glutaraldehyde overnight. 
Fixed specimens were stained with AlexaFluor 488 Phalloidin (Invitrogen) for the actin 
filament inside the cells, 4′-6-Diamidino-2-phenylindole (DAPI, Invitrogen) for the cell 
nuclei, and immunostained with anti-skeletal myosin heavy chain antibody (Sigma, M4276)  
for differentiated myotubes. Explants were immediately embedded in OCT compound, 
cyrosectioned, fixed in 4% parafomaldahyde for 1 minute, washed in PBS and stained using 
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hematoxylin and eosin (H&E). 
8.2.5 Microscopy/Image processing 
Fluorescent and microscope images were taken using a Nikon Eclipse TE2000-S microscope 
with an EXFO X-cite 120 fluorescence illumination system, and a Q-Imaging Micropublisher 
3.3 RTV camera with Q-Capture software and a Leica confocal microscope (TCS SP5 
AOBS). Scanning electron microscrope (SEM) images were taken at 1,000 to 6,000 times 
magnification using an Hitachi TM-1000 SEM. ImagePro Plus 4.0 (Media Cybernetics, L.P.) 
was used to analyze SEM images of nanofibers and florescent images of cells to measure 
fiber diameter, alignment and density, and cellular alignment, density, and myotube 
dimensions respectively.  
8.2.6 Statistical Analysis 
Kruskal–Wallis test was used as an initial test for differences within a sample set. For sample 
sets with a Kruskal–Wallis p-value (ρ) < 0.05 the Mann–Whitney test was used to evaluate 
differences between groups using ρ < 0.05. All statistical analysis was done using SPSS 
software. 
8.3 Results  
8.3.1 Nanofiber sheets 
8.3.1.1Fiber density  
PCL nanofibers scaffolds were made up of free suspended aligned fiber arrays with an 
average fiber diameter of around 750nm.  The average standard deviation of the fiber angle 
was 4º +/- 0.5 ºand the degree of fiber alignment was not affected by fiber density. Aligned 
nanofiber scaffolds with variable fiber densities were fabricated and seeded with C2C12 cells 
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to investigate the cell response to scaffolds of different fiber densities. Cells were seeded on 
scaffolds with aligned fiber densities of 0.1, 0.25, 0.35, 0.5, 0.85, and 1.1 fibers per µm 
length (measured in the direction perpendicular to fiber alignment) and fixed at 1, 3 & 7 days. 
Several parameters were evaluated quantitatively. Percent cell confluence was evaluated as 
the ratio of the area of actin staining to the overall area, and cellular alignment was evaluated 
as the standard deviation of the angular direction of the long axis of the actin cytoskeleton. 
Representative images and graphs of percent confluence and cell alignment for all groups are 
shown in Figure 8.3. 
It was found that cells aligned well in the direction of the nanofiber substrates. The 
standard deviation of the direction of cell elongation was between 2-8º for various fiber 
densities and days in culture. Statistically significant differences in cell alignment for 
different fiber densities were not present, but there was a marked increase in cell alignment as 
fiber density increased.  
Aligned cells were able to proliferate and form nearly confluent monolayers on 
aligned nanofiber sheets. After three days in culture, a systematic increase in the percentage 
of area occupied by cells was apparent as fiber density was increased from 0.1 fibers/µm to 
0.5 fibers/µm. At 3 and 7 days the average percentage area coverage for all groups where 
fiber density was 0.5 fibers/µm or greater was above 95%. It was apparent from images taken 
on a confocal microscope that myotubes were present on both sides of the nanofiber sheets 
despite single side seeding (Figure 8.4). This would indicate that cells were able to migrate 
through the nanofiber sheets. It is estimated that an aligned nanofiber sheets with 0.5 
fibers/µm had a porosity of more than 60%. Statistically significant differences in percent 
area coverage (ρ < 0.05) were present for 1.1 fibers/µm versus all groups except for 0.85 
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fibers/µm (ρ =.827).   
 
Figure 8.3:  SEM images of aligned PCL nanofiber sheets with fiber densities of (A) 0.1 fibers/um, (B) 
0.35 fibers/um, and (C) 0.85 fibers/um. C2C12 cells cultured on these fiber sheets are shown in 
fluorescent images in (D-F) respectively. Quantitative measurements of (G) % confluence and and cell 
alignment (H) are graphed for fiber densities from 0.1 – 1.1 fibers/um.  
8.3.1.2 Myotube formation  on nanofiber sheets  
Myotube formation by C2C12 cells on aligned PCL nanofiber sheets versus tissue culture 
plate (TCP) was evaluated. Cells were seeded and allowed to proliferate to confluence for 5 
days in proliferation media (DMEM supplemented with FBS). After 5 days some samples 
were incubated in differentiation media (DMEM supplemented with horse serum, HS).  
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Figure 8.4:   Myotube formation on aligned nanofiber sheets: (A) top view of fluorescent image & (B) 
3D reconstruction. 
C2C12 myotube formation was evaluated for four groups where different substrates and 
medias were used: (1) Nanofiber sheets/differentiation media (HS), (2)nanofiber 
sheets/proliferation media (FBS), (3)TCP/HS, and (4)TCP/FBS. Myotube formation was 
evaluated by: (1) Number of myotubes per unit area (2) myotube length, and  (3) myotube 
alignment. Quantitative results and representative fluorescent images are displayed in Figure 
8.5. Myotube formation was analyzed from 1 to 21 days after culture media was switched. 
Both average myotube density and average myotube length were considerably greater for 
TCP when compared to nanofiber substrates. However, C2C12 cells seeded on TCP formed 
confluent sheets that eventually detached from the substrate surface. Cells incubated in 
differentiation media on TCP peeled off after 5-7 days and cells remaining in proliferation 
media peeled off of TCP surfaces after 16-20 days in culture. All samples cultured on PCL 
nanofiber grafts remained adhered for the duration of the experiment. In addition, all samples 
cultured on nanofibers for in vivo implantation remained adhered for cultures times up to 7 
weeks. Local myotube alignment on TCP was quite good, but clusters of aligned myotubes 
were very randomly aligned over large areas. As expected, myotubes grown on aligned 
A B
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nanofibers were much better aligned than those cultured on TCP. However, myotube 
alignment on nanofiber scaffolds showed a considerable systematic decrease from days 1-7 
after which alignment values leveled off or decreased. In conjunction with the decrease in 
alignment, myotube density and average length showed tends of systematic increase from 
days 1-7 followed by leveling off after day 7. Analysis of all parameters revealed little 
difference between cells cultured in proliferation medium and differentiation medium.  
8.3.2 Fibrin gel nanofiber composites  
A thin fibrin film with embedded aligned nanofibers was formed due to polymerization of 
fibrinogen and thrombin liquid film combination. Cells were observed embedded throughout 
the composite films in a uniform distribution. Cells began to align in the direction of the 
nanofibers after only one hour of incubation. After one day, cells were observed to align and 
elongate along the embedded nanofibers. Cell proliferation resulted in aligned cell sheets at 
nearly full confluence by day 7. Fluorescent images of cell morphology at various time points 
are shown in Figure 8.6. Fibrin gel degradation in culture media supplemented with t-AMCA 
was investigated for films incubated with and without cells. Fibrin gel fibrils could be 
observed within the films using fluorescent confocal microscopy in samples fixed in 
glutaraldehyde.  In films without cells, fibrin gel matrix was observed in all time points from 
1-7 days. However, it appeared that the fibrin may have degraded with time as the thickness 
and organization of the matrix appeared to decrease between 5 hours to 7 days incubation. 
Images of films incubated with cells appeared to degrade much faster. A substantial fibrin 
matrix was observed at 1 hr after incubation. After 1 day in culture, fibrin matrix could still 
be identified, but large areas that contained no fibrin matrix were present.  On days 3 and 7, 
fibrin matrix could not be identified in fluorescent images. Identification was difficult 
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because of large areas covered by cells, but holes containing no cells or fibrin matrix were 
present. Images taken at various time points are shown in (Figure 8.6). 
 
Figure 8.5:  Myotube (A) density, (B) average length, and (C) alignment for C2C12 cell cultured on 
aligned PCL nanofibers in proliferation & differentiation and cultured on TCP in FBS & horse serum 
for 1-21 days. Representative fluorescent images of C2C12 cells cultured in FBS for 14 days on (D) 
nanofibers  and (E) TCP stained for skeletal myosin heavy chain. Scale bar=500µm.  
8.3.3 Three-dimensional structure fabrication 
Mulitlayer cell-nanofiber constructs up to 15 layers were fabricated using layer-by-layer 
assembly. Scaffold layers appeared to be well adhered to one another as confirmed by  
manipulation of the scaffolds and observation of crossectional histological images. The cross 
section of a six layer scaffold is shown in Figure 8.2G. Fibers and cells appeared to remain 
well aligned thought the thickness of the constructs and cell survival was demonstrated 
throughout its thickness.  
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Figure 8.6:  Fluorescent images of aligned nanofiber-fibrin film composites with (A-D & I-L) and 
without (E-H) embedded C2C12 myoblast cells. Images A-D are stained green for actin filament and 
blue for nuclei. PCL nanofibers, fibrin gel microstructure, and cell bodies are fluoresced due to 
glutaraldehyde fixation in images E-L.  
Cell nanofiber 3D bundles assembled from single aligned nanofiber-cell sheets had 
an oval shaped cross section with a diameter of around 150µm. The overall lengths of these 
constructs were up to 20mm. The cross section of such a construct is shown in Figure 8.2H. 
 Multilayer fibrin composite scaffolds also demonstrated cell survival throughout their 
thickness. Scaffold layers appeared to be well adhered to each other as confirmed by 
manipulation of the scaffolds and observation of crossectional histological images.  
8.3.4 In vivo  
Bundled scaffolds were successfully implanted inside the paravertebral muscle of a mouse 
(Figure 8.7A). Scaffolds remained taut at all time points due to sutures holding the ends in 
tension. Scaffolds were removed with the surrounding tissue, sectioned and analyzed after 1 
to 14 days. A cross section of one of these samples removed after 5 days is shown in Figure 
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8.7B. It is apparent the implanted cells were able to retain a well aligned microstructure 
during in vivo implantation.  
 
Figure 8.7:  (A) Tubular aligned nanofiber-cell constructs were implanted in the paravertebral muscle 
on the back of a mouse. (B) The aligned microstructure of grafts is visualized after removal with 
sectioning and H&E staining. 
8.4 Discussion  
Favorable cell response to aligned nanofibrous substrates demonstrates the potential of 
aligned nanofibers in the regeneration of damaged or degenerated aligned tissues.  However, 
most investigations of  cell interactions with aligned nanofibrous  are conducted on relatively 
thick, densely packed aligned nanofiber mats, or on aligned nanofibers that are attached to 
stiff flat substrates. Constructs containing aligned nanofibers that are practical for functional 
tissue engineering applications must be developed to expand the versatility of this 
technology.   
 We previously developed a method to fabricate free suspended ultra thin aligned 
nanofiber sheets with precisely controlled fiber packing density and we hypothesized that 
these structures could have advantages as tissue engineering scaffolds. Ultra thin nanofiber 
sheets were able to support practically confluent cell sheets that demonstrated uniaxial 
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alignment. Cell sheets with greater than 95% confluence were grown on aligned PCL 
nanofiber sheets with fiber densities as low as 0.5 fibers per microns or 60% porosity. 
Myotube formation on the bottom side of nanofiber sheets that were not seeded with cells 
indicates that cells were able to migrate though the scaffolds. We hypothesize that because of 
low fiber densities, these scaffold will share advantages of traditional cell sheet technology 
such as a lack of hindrance to cell-cell contacts and mass transport. In addition, these 
scaffolds may be superior to cell sheets for structure assembly due to their improved 
mechanical properties and the fact that these scaffolds are inherently fixed at their edges, and 
thus easier to handle and manipulate.  
 Single aligned nanofiber cell sheets were evaluated for potential in skeletal muscle 
tissue engineering.  Scaffold seeded with C2C12 cells were able to support the formation of 
well aligned myotubes, although a marked decrease in myotube alignment was observed with 
increasing time in culture. We hypothesis that the effect of the nanofibrous topography on 
cells is reduced as cell density increases. Cells may have reduced contact to the fibers due to 
crowding, or may even grow on top of one another. Myotube density and average length 
were both lower on aligned PCL scaffolds compared to TCP. However, cell layers 
spontaneously detached from TCP after 5-20 days. In contrast, cell layers did not detach from 
nanofiber scaffolds in long term culture up to 7 weeks. We hypothesize that decreased 
myotube density and average length demonstrated on aligned nanofiber scaffolds was due 
either to a lower bioactivity in PCL compared to TCP or to restrictions on cell proliferation 
and migration that may have been caused by the microstructure or mechanical properties of 
the substrates. Fibrin gel-nanofiber thin film composites offered an alternative method of 
aligned cell sheet fabrication. This method allowed one step cell incorporation directly during 
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fabrication. These composites materials may be ideal for tissue engineering applications 
because they allow ample space for vascular ingrowth. This technique is very promising, but 
fibrin may not be an ideal material for the matrix component due to rapid degradation that 
was observed.   
 The potential of aligned nanofiber cell sheets and matrix-nanofiber composites as 
building blocks for functional tissue engineering scaffolds was demonstrated with the 
fabrication of several structures. Thicker structures were fabricated by layer-by-layer 
stacking of both types of scaffolds. Stacking procedures were effective and easily performed 
because scaffolds were fixed to stiff steel rings on their edges. Three-dimensional fiber 
bundle structures were formed by simply cutting the sheets according to a pattern. These 
bundle structures demonstrate a microstructure that is similar to natural aligned tissues and 
are very promising in applications involving regeneration of such tissues.  
8.5 Conclusions 
Ultra thin aligned nanofiber sheets were fabricated using technologies that we previously 
developed. It was found that practically confluent aligned cell monolayers could be grown on 
such nanofiber sheets with porosities as high as 60%. A high cell to material ratio imparts the 
potential to fabricate three-dimensional structures from aligned cell sheets that minimally 
interfere with cell migration, cell-cell contacts, and mass transport. In addition, these 
scaffolds are versatile for assembly into three-dimensional structures because they are fixed 
at their edges, and thus easy to handle and manipulate. Sheets were stacked layer-by-layer 
and assembled in to three-dimensional bundles with high cell density. The potential of 
aligned nanofiber-cell sheets for regeneration of aligned tissues such as skeletal muscle was 
demonstrated.    
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CHAPTER 9 
9.  OVERALL CONCLUSIONS AND FUTURE DIRECTIONS 
9.1 Conclusions 
The major impact of this work is in the development of three specific technologies useful in 
fabrication of tissue engineering scaffolds for aligned tissue regeneration. These technologies 
included a technology of electrospinning nanofiber collection and assembly using mobile 
tracks, a technology of aligned nanofiber/protein matrix thin film fabrication, and a 
technology of fabricating multicomponent hybrid nanofiber arrays with biomimetic 
microstructure and mechanical properties. Preliminary studies demonstrated the potential of 
several tissue engineering structures assembled using these technologies. Detailed 
conclusions are summarized below by chapter.  
 
Chapter 3: This experiment demonstrated that continuous individual nanofibers with 
nanoscale diameters could be collected across parallel plates at lengths of 35-50cm. This 
confirmed that nanofibers at lengths up to or exceeding the expected requirements of most 
tissue engineering applications could be fabricated using the parallel plate method. As 
expected, it was discovered that several electrospinning parameters such as, voltage and 
polymer solution concentration had effects on fiber properties such as, maximum fiber 
length, fiber diameter, and fiber uniformity. The most notable finding was that longer fibers 
could be collected by increasing the size of the plates used.  
 
Chapter 4: A novel technology was developed that utilized parallel mobile tracks to collect 
and distribute loose aligned nanofiber arrays. This method of nanofiber collection is unique 
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in that a uniform electric field can be maintained. This is possible because fibers are removed 
from the collection area, thus alleviating repulsive charge accumulation. The uniform electric 
field allowed for steady state indefinitely continuous delivery of loose nanofiber arrays. 
Mobile track collection also allowed for an indefinite amount of time for individual fibers to 
dry or cool before assembly into a structure, thus eliminating complications due to fiber-to-
fiber adhesions. Fixation of aligned nanofiber arrays from the violent highly charged 
electrospinning jet prior to structure assembly allows post processing of nanofiber arrays into 
complex structures with precise nanofiber density and placement. Evidence demonstrated 
that this technology may allow for precise fabrication of complex nanofiber structures 
difficult to assemble using current methods. It is hypothesized that steady state fiber 
collection makes this technology very practical for industrial scale up.  
 
Chapter 5: A technology was developed to fabricate thin nanofiber/protein matrix 
composites. When a nanofiber array was immersed and removed from a liquid, surface 
tension forces resulted in a thin liquid film that could be congealed into a thin gel. Gels 
fabricated by this method where quite uniform. Dried films had an average thickness of 2-3 
um with a standard deviation of just 10%. Results of mechanical testing showed that 
embedded nanofibers at a volume fraction as low as 3%v/v significantly increased the 
strength of protein gels. Composites combined the strengths of each material as a tissue 
engineering scaffold for aligned tissue regeneration, while addressing their individual 
weaknesses.  
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Chapter 6:  Two component hybrid nanofiber sheets with precisely arranged biomimetic 
microstructure were fabricated. These sheets were composed of a relatively elastic fiber 
component in a straight orientation and a relatively stiff fiber component in a ‘waved’ 
orientation. Under tensile strain these hybrid sheets adopted a ‘J-shaped’ mechanical profile, 
similar to natural tissues such as blood vessels, with a relatively elastic region at low strain 
that transition into a much stiffer region at a critical value of strain. It was confirmed the 
transition to the stiff region corresponded to the degree of strain when the ‘waved’ fiber 
component became taut. It was further demonstrated that this transition point could be 
predictably moved by changing the orientation of the nanofibers in the material. These 
materials were tested under cyclic loading conditions to confirm that the microstructure was 
not altered during normal loading and that the material would be suitable for tissue 
engineering applications were such loading was present. Evidence demonstrated that this 
material was extremely promising for tissue engineering applications, such as in vascular 
grafts, where mechanical property matching is of importance. 
 
Chapter 7: It was demonstrated that tubular vascular grafts with biomimetic straight-wavy 
nanofibers could be fabricated to match the mechanical properties of natural blood vessels. 
Graft mechanical behavior could be predictably modulated by precisely changing the graft 
microstructure. Optimized vascular grafts demonstrated remarkable similarity in geometry 
and mechanical properties when compared to rabbit carotid artery explants. The durability of 
grafts was sufficient to withstand surgical implantation and blood flow through the grafts 
without leakage was confirmed. Grafts retained favorable mechanical properties after long 
term in vivo implantation and smooth muscle cells were observed infiltrating deep inside the 
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volume of the grafts. Results of this study demonstrated the potential of biomimetic nanofiber 
structures in the design of compliant vascular grafts.  
 
Chapter 8. Skeletal muscle tissue engineering grafts were fabricated by seeding C2C12 
myoblasts onto aligned nanofiber sheets. Cells were able to align and form confluent sheets 
on nanofiber sheets with fiber densities above 0.5fibers/um. C2C12 cells differentiated into 
myotubes on free suspended aligned PCL nanofiber sheets, but appeared to inhibit myotube 
formation when compared to tissue culture plate. Confluent aligned skeletal muscle sheets 
were fabricated in a single step as cell/nanofiber/fibrin gel composite thin films. Three 
dimensional skeletal muscle grafts were constructed by stacking layer-by-layer aligned cell 
sheets. Individual sheets appeared to fuse into a single construct. Cell sheets were observed to 
self assemble into three dimensional bundled structures when cut in a precise method. It was 
hypothesized that this behavior was due to surface tension forces and tensions within the thin 
sheets. Skeletal muscle tissue constructs were evaluated in vivo in a skeletal muscle defect 
model. Histology demonstrated integration of the constructs with natural muscle tissue. 
Aligned cellular constructs demonstrated potential in skeletal muscle regeneration as well as 
other tissue engineering applications. 
9.2 Challenges 
Several tissue engineering scaffolds with promising results were fabricated using the novel 
nanofiber fabrication technologies presented in this dissertation. However, several challenges 
remain in the way of developing better functional tissue engineering scaffolds. Some of these 
challenges are arranged by chapter and listed below. 
 
 192 
 
Chapter 5: Aligned nanofiber/protein composite films were fabricated with PCL nanofibers 
and gelatin or fibrin protein matrices. These composite demonstrated the potential of the 
technology and showed promise as tissue engineering scaffolds, but have limitations. The 
gelatins film fabricated are water soluble and thus have limited use in tissue engineering 
applications without modification. Crosslinked gelatin films remain intact under in vitro 
conditions, but crosslinking procedures may lower the biocompatibility of the structure and a 
new technology is needed to increase the crosslinking of ECM without compromising the 
biocompatibility. Fibrin films demonstrated the ability for direct cell incorporation, but may 
degrade too quickly for many tissue engineering applications. Better matrix materials must be 
designed or identified to maximize the potential of this technology.  
 
Chapter 7: Vascular grafts with biomimetic straight-wavy nanofibers demonstrated 
mechanical properties that were remarkably similar to natural vessels and proved suitable for 
surgical implantation. The major challenges faced in this technology are to establish a anti-
thrombogenic surface but allow for fast endotheilization.  
 
Chapter 8: Aligned skeletal muscle cells were successfully grown to confluence on free 
suspended cell sheets and assembled into thicker sheets and cylindrical structures. While 
C2C12 cells proliferated and aligned well on nanofiber sheets, they did not form myotubes as 
well as controls on flat tissue culture plate. There is a need to further improve the 
adhesiveness of the nanofibers to improve myotube formation.   
Thicker stacked construct fabrication offer one major challenge. For thicker 
constructs (greater than a few hundred um) to be viable, a method of nutrient transport will 
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need to be developed and incorporated.  
9.3 Future goals 
The ultimate goals of this project are to develop novel technologies for use in advanced 
functional tissue engineering applications. Immediate goals will be to expand upon the 
technologies developed here to open the door to more tissue engineering applications. In the 
long run, more advanced technologies can be further derived from this work. Future plans 
and goals are organized by chapter and summarized below.  
 
Chapter 4: We hope to further advance the loose nanofiber array fabrication technology for 
in-situ surface modification of fabricated nanofibers, in-situ 3D structure and graft fabrication 
and cell incorporation during the fabrication process.  
 
Chapter 5: We hope to design or select several hydrogel materials to combine with aligned 
nanofibers to make slow degrading thin film composite structures. Selection criteria for these 
materials will include degradation properties, cell permeability, and bioactivity. Only 
hydrogels that are compatible with direct cell incorporation fabrication procedures will be 
considered. Therefore, hydrogels must be a viscous liquid at 37ºC with a crosslinking method 
that is conducive to cell survival. Composite design will be investigated according to specific 
tissue engineering applications such as myocardium patch, skin graft, and so on.  
 
Chapter 6: We hope to develop a cell-seeded vascular graft biofabricator by combining the 
wavy-straight nanofiber spinning and cell spraying during the tube fabrication process.  The 
other direction is to functionalization of lumen surface for endothelial precursor cell 
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recruitment from circulating blood for fast enthdothelization.  
 
Chapter 7: We hope to improve the structural properties of our vascular grafts by 
investigating modification to our design. It is our goal to optimize both circumferential and 
axial mechanical properties by modifying the orientation of fibers in the grafts. We also hope 
to investigate several designs for a composite structure where the nanofiber portion of the 
grafts is stabilized by a matrix material. Composite grafts will be designed in such a way that 
the matrix material provides support, but the nanofibers component still dominates the 
overall mechanical properties.  
We will try to incorporate the most effective biofunctional molecules for preventing 
thrombosis and promoting endothelialization by bulk incorporation and surface 
functionalization techniques.  
 
Chapter 8: We hope to investigate myotube formation of free suspended aligned nanofiber 
arrays further. Myotube formation appeared to be decreased on aligned PCL sheets compared 
to flat tissue culture plate. One possible reason is the amount of adhesive molecules available 
for myoblast adhesion, growth, and differentiation. We will compare the myotube formation 
with different types of functional surfaces. We also hope to develop new methods to stack 
aligned nanofiber/cell sheets into thicker structures by developing better ways to stabilize and 
adhere layers together during fabrication. Further development of this technology will 
involve combining multiple cell types into layered structures.  
 
 
